[2021-09-10 02:02:23,618 INFO]-[utils.py 353] Read cache from /data4/chuhan/github-code/chemical-metrics/saved_pickle/title_id_new.pkl.
[2021-09-10 02:02:24,069 INFO]-[utils.py 353] Read cache from /data4/chuhan/github-code/chemical-metrics/train_nlp_new/saved/data_set.pkl.
[2021-09-10 02:02:24,069 INFO]-[bert_tokenizer.py 397] loading vocabulary file /data4/chuhan/github-code/chemical-metrics/nlp-pre-trained-weight/bert-base-uncased/vocab.txt
[2021-09-10 02:02:25,389 INFO]-[bert.py 640] Load pre-trained BERT parameters from file /data4/chuhan/github-code/chemical-metrics/nlp-pre-trained-weight/bert-base-uncased/pytorch_model.bin.
[2021-09-10 02:02:25,390 INFO]-[bert_embedding.py 406] Bert Model will return 1 layers (layer-0 is embedding result): [-1]
[2021-09-10 02:02:32,680 INFO]-[tener.py 374] Start constructing character vocabulary.
[2021-09-10 02:02:32,797 INFO]-[tener.py 379] In total, there are 103 distinct characters.
[2021-09-10 02:02:33,489 INFO]-[static_embedding.py 168] All word in the vocab have been lowered. There are 26729 words, 26729 unique lowered words.
[2021-09-10 02:02:36,019 INFO]-[static_embedding.py 297] Found 10421 out of 26729 words in the pre-training embedding.
[2021-09-10 02:02:36,531 INFO]-[elmo_embedding.py 238] 87 out of 141 characters were found in pretrained elmo embedding.
[2021-09-10 02:02:41,786 INFO]-[utils.py 353] Read cache from /data4/chuhan/github-code/chemical-metrics/train_nlp_new/saved/data_set_test_210902F.pkl.
[2021-09-10 02:02:42,827 INFO]-[utils.py 353] Read cache from /data4/chuhan/github-code/chemical-metrics/train_nlp_new/saved/data_set_final.pkl.
[2021-09-10 02:02:43,265 INFO]-[load_test_case.py 52] [('train-Ki_MC-has-ans', 18), ('train-Kd_MC-has-ans', 55), ('train-IC50_MC-has-ans', 462), ('train-selectivity_MC-has-ans', 123), ('train-Kd_Ce-has-ans', 39), ('train-IC50_Ce-has-ans', 305), ('train-EC50_Ce-has-ans', 59), ('train-selectivity_Ce-has-ans', 94), ('train-hERG_Ce-has-ans', 41), ('train-solubility_Ce-has-ans', 43), ('train-ED50_An-has-ans', 15), ('train-AUC_An-has-ans', 53), ('train-t_half_An-has-ans', 189), ('train-bioavailability_An-has-ans', 99), ('train-compound-has-ans', 261), ('train-compound_drug-has-ans', 75)]
[2021-09-10 02:02:43,265 INFO]-[load_test_case.py 55] train-IC50_MC-has-ans: 462
[2021-09-10 02:02:43,265 INFO]-[load_test_case.py 59] train-IC50_MC-has-ans has 462 instance. start the 10-fold training
+------------------+----------------+--------------+----------------+------------------+------------------+
| raw_words        | start_span_idx | end_span_idx | contains_label | words            | content          |
+------------------+----------------+--------------+----------------+------------------+------------------+
| ['[CLS]', 'th... | 180            | 182          | 1              | [29, 14, 27, ... | [CLS] this pa... |
| ['[CLS]', 'th... | 51             | 52           | 1              | [29, 14, 27, ... | [CLS] this pa... |
| ['[CLS]', 'th... | 113            | 115          | 1              | [29, 14, 27, ... | [CLS] this pa... |
| ['[CLS]', 'wh... | 93             | 96           | 1              | [29, 321, 12,... | [CLS] what is... |
| ['[CLS]', 'th... | 101            | 102          | 1              | [29, 14, 27, ... | [CLS] this pa... |
| ['[CLS]', 'th... | 93             | 94           | 1              | [29, 14, 27, ... | [CLS] this pa... |
| ['[CLS]', 'th... | 55             | 56           | 1              | [29, 14, 27, ... | [CLS] this pa... |
| ['[CLS]', 'th... | 55             | 56           | 1              | [29, 14, 27, ... | [CLS] this pa... |
| ['[CLS]', 'th... | 55             | 56           | 1              | [29, 14, 27, ... | [CLS] this pa... |
| ['[CLS]', 'th... | 103            | 105          | 1              | [29, 14, 27, ... | [CLS] this pa... |
| ['[CLS]', 'th... | 154            | 155          | 1              | [29, 14, 27, ... | [CLS] this pa... |
| ['[CLS]', 'th... | 149            | 151          | 1              | [29, 14, 27, ... | [CLS] this pa... |
| ...              | ...            | ...          | ...            | ...              | ...              |
+------------------+----------------+--------------+----------------+------------------+------------------+
0
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
one atom makes all the difference: getting a foot in the door between sos1 and kras
nlpDict: 
single_dict: {'compound': 'bi-3406', 'ic50_mc': '4', 'ki_mc': '3 3 nm', 'kd_mc': '3', 'selectivity_mc': '20-fold', 'ic50_ce': '5 0 nm ) is 20-fold reduced compared to inhibitor 8 ( kd = 1 6 nm', 'ki_ce': '1 0 , which remained an activator , albeit with a 2–3-fold loss of binding affinity and activator activity . exchanging the 6-substituent for the larger chlorine atom ( compound 1 1 ) was sufficient to switch the molecule from an activator to an inhibitor despite the 4-fold loss of activity versus the hydrogen-containing compound 9 . the loss of activity for compound 1 1 is likely due to a repulsive interaction between the electronegative chlorine atom and π-electrons of y884 . this clearly shows that ppi inhibition is caused by sterics and is independent of affinity . the addition of a methoxy group capable of forming attractive ch−π interactions with y884 results in the inhibitor compound 1 2 , which displayed a significantly improved affinity ( kd = 2 4', 'kd_ce': '3 5 0 nm ) is 20-fold reduced compared to inhibitor 8 ( kd = 1', 'ec50_ce': '2 4', 'selectivity_ce': '2 5 0', 'herg_ce': '2 5', 'ed50_an': '7 was only marginally improved compared to compound 4 , we decided to combine both meta-substituents into a single molecule ( compound 8 ) as the overlay', 'bioavailability_an': '1 6', 'compound_drug': 'bi-3406 blocks the negative feedback relief induced by downstream mek inhibition . ( 3 3 , 4 2 ) accordingly , the combination of bi-3406 with the mek inhibitor trametinib elicited strong antitumor efficacy in kras-mutant xenograft models . the concept of dual sos1 and mek inhibition is currently being tested in clinical trials . ( 3 5 ) to demonstrate the utility of bi-3406 as an sos1 probe molecule and further elaborate the potential of sos1 inhibition in cancer combination therapies , we tested the effects of vertical pathway co-inhibition by combining bi-3406 with the egfr inhibitor afatinib . in dld-1 krasg13d mutant colorectal tumor cells , dual pathway inhibition of sos1i and afatinib leads to enhanced parp cleavage , a marker for apoptosis induction ( figure 9a ) . the effect of this combination on parp cleavage is of similar magnitude as the effect of the bi-3406 plus trametinib combination . in agreement with the in vitro data , combination of bi-3406 with afatinib resulted in significantly enhanced efficacy compared to both monotherapies in a dld-1 xenograft model ( figure 9b ) . this combination concept is in line with recent reports describing marked synergy of the anti-egfr antibody cetuximab with krasg12c'}

original_dict: {'ic50_mc': '4', 'ki_mc': '3 3 nm', 'kd_mc': '3', 'selectivity_mc': '20-fold', 'ic50_ce': '5 0 nm ) is 20-fold reduced compared to inhibitor 8 ( kd = 1 6 nm', 'ki_ce': '1 0 , which remained an activator , albeit with a 2–3-fold loss of binding affinity and activator activity . exchanging the 6-substituent for the larger chlorine atom ( compound 1 1 ) was sufficient to switch the molecule from an activator to an inhibitor despite the 4-fold loss of activity versus the hydrogen-containing compound 9 . the loss of activity for compound 1 1 is likely due to a repulsive interaction between the electronegative chlorine atom and π-electrons of y884 . this clearly shows that ppi inhibition is caused by sterics and is independent of affinity . the addition of a methoxy group capable of forming attractive ch−π interactions with y884 results in the inhibitor compound 1 2 , which displayed a significantly improved affinity ( kd = 2 4', 'kd_ce': '3 5 0 nm ) is 20-fold reduced compared to inhibitor 8 ( kd = 1', 'ec50_ce': '2 4', 'selectivity_ce': '2 5 0', 'herg_ce': '2 5', 'solubility_ce': '3', 'ed50_an': '7 was only marginally improved compared to compound 4 , we decided to combine both meta-substituents into a single molecule ( compound 8 ) as the overlay', 't_half_an': '3', 'auc_an': '2 5 0', 'bioavailability_an': '1 6', 'compound_drug': 'bi-3406', 'compound': 'bi-3406'}
====================
1
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
structure-based design and pharmacokinetic optimization of covalent allosteric inhibitors of the mutant gtpase krasg12c
nlpDict: 
single_dict: {'compound': '', 'ic50_mc': '0 . 4 9 6 μm', 'ki_mc': '2 0', 'kd_mc': '1 2 1', 'selectivity_mc': '1 0', 'ic50_ce': '2', 'ec50_ce': '3 2 ) the impact of the piperazine chiral methyl group can be seen in the pk profile of 4', 'herg_ce': '1 0 0', 'solubility_ce': '2 8 and 1 2', 'ed50_an': '0 . 4 9 6 μm in this assay format . an x-ray crystal structure of 2 6 in krasg12c was solved in-house and provided insights into the binding mode of this series of compounds , which was in good agreement with the structure of related analogues that were subsequently reported ( figure 3 ) . ( 2 4 ) the acrylamide moiety forms a covalent bond with cys12 , and lys16 additionally forms a hydrogen bond to the acrylamide carbonyl group . his95 , specific to kirsten variants of ras , forms a hydrogen bond to quinazoline n1 . at c7 of the quinazoline , a single atropisomer of the indazole is observed , and it is this group that causes a shift in', 't_half_an': '7', 'auc_an': '1 ) . synthesis of all four possible diastereomers ( from two asymmetric centers , chiral methyl and restricted rotation around the biaryl bond ) revealed that one in particular , 2 9 , showed a reasonable ∼5-fold improvement in potency relative to the untethered reference 2', 'bioavailability_an': '2 4 %', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion we were motivated to explore the impact of further substitution on the piperazine ring carrying the acrylamide , with simple methyl groups . in vitro metabolite id studies had indicated that glutathione addition to the acrylamide was the major route of clearance in rat for compounds such as 3 3 , and it was hoped that such routes of elimination might be minimized by steric crowding of the acrylamide moiety . an increase in mouse whole blood stability for compounds related to 2 6 has been reported using this approach . ( 2 8 ) methylation of the methylene group opposite the tether was achieved , with r-enantiomer 4 1 showing a 4-fold enhancement in potency compared to unsubstituted 3 3 and s-enantiomer 4 2 showing a marked loss in potency ( table 4 ) . a modest increase in lipophilicity for 3 3 was associated with a slight increase in in vitro clint values . the addition of this r-me group also contributed to a positive reduction in general reactivity with glutathione ( 4 1 6 min half-life versus 3 3 4 min ) and improved passive permeability ( ab papp 4 7 . 9 versus 3 5 . 9 ) . to help put these glutathione half-lives into context , the corresponding values for marketed reversible kinase inhibitors afatinib ( 2 9'}

original_dict: {'ic50_mc': '0 . 4 9 6 μm', 'ki_mc': '2 0', 'kd_mc': '1 2 1', 'selectivity_mc': '1 0', 'ic50_ce': '2', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '3 2 ) the impact of the piperazine chiral methyl group can be seen in the pk profile of 4', 'selectivity_ce': '1 0', 'herg_ce': '1 0 0', 'solubility_ce': '2 8 and 1 2', 'ed50_an': '0 . 4 9 6 μm in this assay format . an x-ray crystal structure of 2 6 in krasg12c was solved in-house and provided insights into the binding mode of this series of compounds , which was in good agreement with the structure of related analogues that were subsequently reported ( figure 3 ) . ( 2 4 ) the acrylamide moiety forms a covalent bond with cys12 , and lys16 additionally forms a hydrogen bond to the acrylamide carbonyl group . his95 , specific to kirsten variants of ras , forms a hydrogen bond to quinazoline n1 . at c7 of the quinazoline , a single atropisomer of the indazole is observed , and it is this group that causes a shift in', 't_half_an': '7', 'auc_an': '1 ) . synthesis of all four possible diastereomers ( from two asymmetric centers , chiral methyl and restricted rotation around the biaryl bond ) revealed that one in particular , 2 9 , showed a reasonable ∼5-fold improvement in potency relative to the untethered reference 2', 'bioavailability_an': '2 4 %', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion we were motivated to explore the impact of further substitution on the piperazine ring carrying the acrylamide , with simple methyl groups . in vitro metabolite id studies had indicated that glutathione addition to the acrylamide was the major route of clearance in rat for compounds such as 3 3 , and it was hoped that such routes of elimination might be minimized by steric crowding of the acrylamide moiety . an increase in mouse whole blood stability for compounds related to 2 6 has been reported using this approach . ( 2 8 ) methylation of the methylene group opposite the tether was achieved , with r-enantiomer 4 1 showing a 4-fold enhancement in potency compared to unsubstituted 3 3 and s-enantiomer 4 2 showing a marked loss in potency ( table 4 ) . a modest increase in lipophilicity for 3 3 was associated with a slight increase in in vitro clint values . the addition of this r-me group also contributed to a positive reduction in general reactivity with glutathione ( 4 1 6 min half-life versus 3 3 4 min ) and improved passive permeability ( ab papp 4 7 . 9 versus 3 5 . 9 ) . to help put these glutathione half-lives into context , the corresponding values for marketed reversible kinase inhibitors afatinib ( 2 9', 'compound': ''}
====================
2
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as hsp90 inhibitors suppressing tumor growth in vitro and in vivo
            
nlpDict: 
single_dict: {'compound': '6b', 'ic50_mc': '1 1 0 . 1 8 ± 3 . 1 3', 'ki_mc': '6 )', 'kd_mc': '6 ) . next , the acetyl group was converted to a tertiary alcohol ( 1', 'selectivity_mc': '1 7', 'ic50_ce': '1 1 0 . 1 8', 'ki_ce': '0 . 0 0 1', 'kd_ce': '2 depicts the synthesis of compounds 8 . compound 1 2 is commercially available and was reacted with boc anhydride or methyl iodide to attack the n-1 position of indole , followed by reduction of the nitro group and an amide coupling reaction with compound 9 to yield intermediates 13–14 . the protecting groups in compounds 8a and 8f were directly removed treatment with acid or heterolytic h2 cleavage . compounds with an alkyl group at the amide linkage ( 8b-8e and 8g-8i ) were used in similar synthetic procedures . synthesis of the intermediate compound ( 9 ) began from compound 1 5 , which is commercially available , and proceeded through five steps to yield the product ( scheme 3 ) . first , the hydroxyl groups of compound 1 5 were protected by benzyl groups ( 1 6 ) . next , the acetyl group was converted to a tertiary alcohol ( 1', 'ec50_ce': '3 . 1 3', 'selectivity_ce': '1 0', 'herg_ce': '1 μm', 'solubility_ce': '2 ( biib021 ) . moreover , compound 6b shows no evidence of toxicity in normal cell line . compound 6b also possesses the best therapeutic index among these compounds with a value of 1 2 . 4 and an ic50 value of 1 1 0 . 1 8 ± 3 . 1 3', 'ed50_an': '1 . 1 5 and 3 . 2 3 μm , using a substrate of testosterone and midazolam . this was followed by cyp2c19 ( 7 . 8 0 μm ) , cyp2c9 ( 1 4 . 9 7 μm ) , and cyp2b6 ( 3 7 . 1 7 μm ) . compound 6b partially inhibited cyp1a2 , 2c8 and 2d6 with ic50 values > 5 0 μm . a bidirectional caco-2 permeability assay was used to examine the in vitro permeability of compound 6b ( table 7 ) . verapamil and atenolol , with high and low permeability respectively , served as reference compounds . the caco-2 cell permeability coefficients for apical to basolateral ( ap→bl ) movement and basolateral to apical ( bl→ap ) movement of compound 6b were 3 1 . 9 ± 5 . 1 × 10−6cm/s and 3 0 . 6 ± 2', 't_half_an': '6 h , while the activation of caspase and parp started at 1 8 h . ectopic expression of wt-p53 partially reduced caspase-3 cleavage and rescued the cell apoptosis which was caused by compound 6b ( fig', 'bioavailability_an': '1 0 5 . 0 6', 'compound_drug': 'biib021'}

original_dict: {'ic50_mc': '1 1 0 . 1 8 ± 3 . 1 3', 'ki_mc': '6 )', 'kd_mc': '6 ) . next , the acetyl group was converted to a tertiary alcohol ( 1', 'selectivity_mc': '1 7', 'ic50_ce': '1 1 0 . 1 8', 'ki_ce': '0 . 0 0 1', 'kd_ce': '2 depicts the synthesis of compounds 8 . compound 1 2 is commercially available and was reacted with boc anhydride or methyl iodide to attack the n-1 position of indole , followed by reduction of the nitro group and an amide coupling reaction with compound 9 to yield intermediates 13–14 . the protecting groups in compounds 8a and 8f were directly removed treatment with acid or heterolytic h2 cleavage . compounds with an alkyl group at the amide linkage ( 8b-8e and 8g-8i ) were used in similar synthetic procedures . synthesis of the intermediate compound ( 9 ) began from compound 1 5 , which is commercially available , and proceeded through five steps to yield the product ( scheme 3 ) . first , the hydroxyl groups of compound 1 5 were protected by benzyl groups ( 1 6 ) . next , the acetyl group was converted to a tertiary alcohol ( 1', 'ec50_ce': '3 . 1 3', 'selectivity_ce': '1 0', 'herg_ce': '1 0', 'solubility_ce': '2 ( biib021 ) . moreover , compound 6b shows no evidence of toxicity in normal cell line . compound 6b also possesses the best therapeutic index among these compounds with a value of 1 2 . 4 and an ic50 value of 1 1 0 . 1 8 ± 3 . 1 3', 'ed50_an': '1 . 1 5 and 3 . 2 3 μm , using a substrate of testosterone and midazolam . this was followed by cyp2c19 ( 7 . 8 0 μm ) , cyp2c9 ( 1 4 . 9 7 μm ) , and cyp2b6 ( 3 7 . 1 7 μm ) . compound 6b partially inhibited cyp1a2 , 2c8 and 2d6 with ic50 values > 5 0 μm . a bidirectional caco-2 permeability assay was used to examine the in vitro permeability of compound 6b ( table 7 ) . verapamil and atenolol , with high and low permeability respectively , served as reference compounds . the caco-2 cell permeability coefficients for apical to basolateral ( ap→bl ) movement and basolateral to apical ( bl→ap ) movement of compound 6b were 3 1 . 9 ± 5 . 1 × 10−6cm/s and 3 0 . 6 ± 2', 't_half_an': '6 h , while the activation of caspase and parp started at 1 8 h . ectopic expression of wt-p53 partially reduced caspase-3 cleavage and rescued the cell apoptosis which was caused by compound 6b ( fig', 'auc_an': '1 0', 'bioavailability_an': '1 0 5 . 0 6', 'compound_drug': 'biib021', 'compound': '6b'}
====================
3
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
discovery of novel 2,4-diarylaminopyrimidine analogues (daapalogues) showing potent inhibitory activities against both wild-type and mutant alk kinases
nlpDict: 
single_dict: {'compound': '1 5', 'ic50_mc': '1 5 . 3', 'ki_mc': '7 . 7', 'kd_mc': '1 6 and 8 0 nm , respectively . n-t-butyl urea 1 4 showed significantly reduced potency at alk , whereas higher potency against c-met was retained . similar high c-met potency and selectivity were observed as well for compound 1 1 bearing a t-butoxycarbonyl moiety as the terminal capping group . quite interestingly , simple 2-amino-n-ethylacetamide 1 0 bearing a naked primary amino group showed high potency at both c-met and alk , with ic50 values of 6 . 5', 'selectivity_mc': '1000-fold', 'ki_ce': '1 0', 'kd_ce': '3 8 ) therefore , all the new synthetic compounds were initially assayed for their inhibitory effects against both c-met and alk , and compounds with high potency and selectivity for alk over c-met will be selected for further profiling . as shown in table 1 , opening the azepanone ring of cephalon’s c-met inhibitor 5 by deletion of the c4–c5 ethylene unit generated urea 1 2 , which retained good inhibitory effect against c-met , but the potency at alk was moderate ( 2 8 0 nm ) . isomerization of 1 2 to dipeptide 1 3 led to slightly enhanced potencies at both c-met and alk kinases , with ic50 values of 1 6 and 8 0 nm , respectively . n-t-butyl urea 1 4 showed significantly reduced potency at alk , whereas higher potency against c-met was retained . similar high c-met potency and selectivity were observed as well for compound 1 1 bearing a t-butoxycarbonyl moiety as the terminal capping group . quite interestingly , simple 2-amino-n-ethylacetamide 1 0 bearing a naked primary amino group showed high potency at both c-met and alk , with ic50 values of 6', 'ec50_ce': '2 8 0', 'solubility_ce': '0 . 1', 'ed50_an': '7 and 3 8 were', 't_half_an': '3', 'auc_an': '1 4', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] in 1 5 by a substituted piperazinyl moiety generated highly potent and selective alk inhibitors 36–40 . all these compounds displayed ic50 values of less than 1 0 nm at alk , but the selectivity over c-met differed . the alkyl substituted piperazine analogues 3 7 and 3 8 were more selective for alk over c-met than the nonsubstituted piperazine 3 6 . high potency was observed on n-acyl substituted piperazine analogue 3 9'}

original_dict: {'ic50_mc': '1 5 . 3', 'ki_mc': '7 . 7', 'kd_mc': '1 6 and 8 0 nm , respectively . n-t-butyl urea 1 4 showed significantly reduced potency at alk , whereas higher potency against c-met was retained . similar high c-met potency and selectivity were observed as well for compound 1 1 bearing a t-butoxycarbonyl moiety as the terminal capping group . quite interestingly , simple 2-amino-n-ethylacetamide 1 0 bearing a naked primary amino group showed high potency at both c-met and alk , with ic50 values of 6 . 5', 'selectivity_mc': '1000-fold', 'ic50_ce': '1 5 . 3', 'ki_ce': '1 0', 'kd_ce': '3 8 ) therefore , all the new synthetic compounds were initially assayed for their inhibitory effects against both c-met and alk , and compounds with high potency and selectivity for alk over c-met will be selected for further profiling . as shown in table 1 , opening the azepanone ring of cephalon’s c-met inhibitor 5 by deletion of the c4–c5 ethylene unit generated urea 1 2 , which retained good inhibitory effect against c-met , but the potency at alk was moderate ( 2 8 0 nm ) . isomerization of 1 2 to dipeptide 1 3 led to slightly enhanced potencies at both c-met and alk kinases , with ic50 values of 1 6 and 8 0 nm , respectively . n-t-butyl urea 1 4 showed significantly reduced potency at alk , whereas higher potency against c-met was retained . similar high c-met potency and selectivity were observed as well for compound 1 1 bearing a t-butoxycarbonyl moiety as the terminal capping group . quite interestingly , simple 2-amino-n-ethylacetamide 1 0 bearing a naked primary amino group showed high potency at both c-met and alk , with ic50 values of 6', 'ec50_ce': '2 8 0', 'selectivity_ce': '1000-fold', 'herg_ce': '1 0', 'solubility_ce': '0 . 1', 'ed50_an': '7 and 3 8 were', 't_half_an': '3', 'auc_an': '1 4', 'bioavailability_an': '3', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] in 1 5 by a substituted piperazinyl moiety generated highly potent and selective alk inhibitors 36–40 . all these compounds displayed ic50 values of less than 1 0 nm at alk , but the selectivity over c-met differed . the alkyl substituted piperazine analogues 3 7 and 3 8 were more selective for alk over c-met than the nonsubstituted piperazine 3 6 . high potency was observed on n-acyl substituted piperazine analogue 3 9', 'compound': '1 5'}
====================
4
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
strategies to mitigate the bioactivation of 2-anilino-7-aryl-pyrrolo[2,1-f][1,2,4]triazines: identification of orally bioavailable, efficacious alk inhibitors
nlpDict: 
single_dict: {'compound': '3 2', 'ic50_mc': '6', 'ki_mc': '4 0', 'kd_mc': '4', 'selectivity_mc': '1 6 ) to be the major pathway in vitro . the fragmentation pattern in the ms/ms spectrum narrowed the possible hydroxylation sites to the pyrrolotriazine core , although the exact position could not be unequivocally established . suspecting that pyrrole oxidation may have occurred , we prepared c5-hydroxy derivative 3 8 ( table 4 ) , which showed identical lc retention time and ms/ms spectrum to the ( m + 1 6 ) metabolite of 3 7 . thus , blocking the c5 position with either methyl ( 3 9 ) or chlorine ( 4 0 ) gave substantially more stable analogues ( table 4 ) . analogues 3 9 and 4 0 displayed not only acceptable activity and selectivity profiles ( e . g . , ir/alk > 8', 'ic50_ce': '2 0 0', 'ki_ce': '2', 'kd_ce': '2 6 to 3 0 ( table 3 ) and were in good correlation with the in vitro stability in both rat liver microsomes and s9 fraction ( t1/2 > 4 0 min for compounds 27–30 ) . with the exception of 2', 'selectivity_ce': '3', 'ed50_an': '7', 'auc_an': '1 1', 'bioavailability_an': '5 6 %', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion at this stage , we decided to reinvestigate n-methyl ( methylsulfonamide ) derivatives , focusing on the metabolic fate of compound 3 7 in liver microsomes and anticipating that we would be able to uncover the metabolic “hot-spot . ” lc/ms-based metabolite analyses were conducted for 3 7 , indicating oxidation to a compound of molecular weight ( m + 1 6 ) to be the major pathway in vitro . the fragmentation pattern in the ms/ms spectrum narrowed the possible hydroxylation sites to the pyrrolotriazine core , although the exact position could not be unequivocally established . suspecting that pyrrole oxidation may have occurred , we prepared c5-hydroxy derivative 3 8 ( table 4'}

original_dict: {'ic50_mc': '6', 'ki_mc': '4 0', 'kd_mc': '4', 'selectivity_mc': '1 6 ) to be the major pathway in vitro . the fragmentation pattern in the ms/ms spectrum narrowed the possible hydroxylation sites to the pyrrolotriazine core , although the exact position could not be unequivocally established . suspecting that pyrrole oxidation may have occurred , we prepared c5-hydroxy derivative 3 8 ( table 4 ) , which showed identical lc retention time and ms/ms spectrum to the ( m + 1 6 ) metabolite of 3 7 . thus , blocking the c5 position with either methyl ( 3 9 ) or chlorine ( 4 0 ) gave substantially more stable analogues ( table 4 ) . analogues 3 9 and 4 0 displayed not only acceptable activity and selectivity profiles ( e . g . , ir/alk > 8', 'ic50_ce': '2 0 0', 'ki_ce': '2', 'kd_ce': '2 6 to 3 0 ( table 3 ) and were in good correlation with the in vitro stability in both rat liver microsomes and s9 fraction ( t1/2 > 4 0 min for compounds 27–30 ) . with the exception of 2', 'ec50_ce': '2 0 0', 'selectivity_ce': '3', 'herg_ce': '2 0 0', 'solubility_ce': '3', 'ed50_an': '7', 't_half_an': '3', 'auc_an': '1 1', 'bioavailability_an': '5 6 %', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion at this stage , we decided to reinvestigate n-methyl ( methylsulfonamide ) derivatives , focusing on the metabolic fate of compound 3 7 in liver microsomes and anticipating that we would be able to uncover the metabolic “hot-spot . ” lc/ms-based metabolite analyses were conducted for 3 7 , indicating oxidation to a compound of molecular weight ( m + 1 6 ) to be the major pathway in vitro . the fragmentation pattern in the ms/ms spectrum narrowed the possible hydroxylation sites to the pyrrolotriazine core , although the exact position could not be unequivocally established . suspecting that pyrrole oxidation may have occurred , we prepared c5-hydroxy derivative 3 8 ( table 4', 'compound': '3 2'}
====================
5
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
the discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (alk) inhibitors with potential utility for the treatment of cancer
nlpDict: 
single_dict: {'compound': '4 9', 'ic50_mc': '1', 'ki_mc': '6 0', 'kd_mc': '4', 'ic50_ce': '3 6', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '3 0', 'herg_ce': '1 0 , 3 0 , or 6 0', 'solubility_ce': '2 0 ) very rapid clearance of the compound from plasma was observed; the clearance mechanism was traced to a murine-specific amidase , resulting in cleavage of the benzamide moiety . the compound was not subject to this route of metabolism in rat , dog , or human whole blood , but it did limit the value of performing further experiments in mice with 3 6 . a detailed study of the mechanism , kinetics , and sar of this mode of metabolism will be reported elsewhere . ( 2 1 ) in contrast , close analogue 4 9 had significantly better mouse pk ( t1/2 ( iv ) 1 . 0 5 h ) , which permitted evaluation in a range of pharmacodynamic ( pd ) and tumor xenograft models of alk driven disease . ( 2 0 ) in particular , compound 4 9 exhibited dose-dependent inhibition in an npm-alk driven tumor xenograft model utilizing the karpas-299 cell line , figure 5 . approximately 10–12 days after karpas-299 cell implantation , scid-beige mice with well-formed tumors of similar size were placed into groups ( n = 10/group ) so that the average tumor size was similar in each group ( ranging from approximately 150–250 mm3 ) at initiation of dosing . compound was dosed orally ( po ) at 1 0 , 3', 'ed50_an': '7 ) or suffered from a significant loss in cellular potency as with pyridine 2 8 . interestingly , piperazine 2 9 retained cellular potency and displayed a marked improvement in microsomal stability but had clearance greater than liver blood flow on iv dosing in rat . piperidinone analogue 3 0 behaved likewise , however , 4-aminomethylpiperidine 3 1 displayed astonishing microsomal stability , which translated into improved rat iv clearance amounting to 3 0 % of liver blood flow . as a result of this unexpected finding , a wide range of polar substituents were explored in a variety of configurations . carboxylic acids such as 3 2 and 3 3 furnished zwitterions which were stable toward microsomal transformation , however , cellular potency was significantly impacted . the primary amides of these acids were investigated and found to retain cellular potency , however , they varied significantly in their microsomal stability depending on the location of the amide moiety; compare , for example , 3', 't_half_an': '3', 'compound_drug': 'leu 1 1 9 6 , in a pocket also defined by val1180 and leu1256 . it was therefore anticipated that the substitution pattern of the aryl ring may permit fine-tuning of the kinase selectivity profile . ( 1 5'}

original_dict: {'ic50_mc': '1', 'ki_mc': '6 0', 'kd_mc': '4', 'selectivity_mc': '1', 'ic50_ce': '3 6', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '3 0', 'selectivity_ce': '1 0', 'herg_ce': '1 0 , 3 0 , or 6 0', 'solubility_ce': '2 0 ) very rapid clearance of the compound from plasma was observed; the clearance mechanism was traced to a murine-specific amidase , resulting in cleavage of the benzamide moiety . the compound was not subject to this route of metabolism in rat , dog , or human whole blood , but it did limit the value of performing further experiments in mice with 3 6 . a detailed study of the mechanism , kinetics , and sar of this mode of metabolism will be reported elsewhere . ( 2 1 ) in contrast , close analogue 4 9 had significantly better mouse pk ( t1/2 ( iv ) 1 . 0 5 h ) , which permitted evaluation in a range of pharmacodynamic ( pd ) and tumor xenograft models of alk driven disease . ( 2 0 ) in particular , compound 4 9 exhibited dose-dependent inhibition in an npm-alk driven tumor xenograft model utilizing the karpas-299 cell line , figure 5 . approximately 10–12 days after karpas-299 cell implantation , scid-beige mice with well-formed tumors of similar size were placed into groups ( n = 10/group ) so that the average tumor size was similar in each group ( ranging from approximately 150–250 mm3 ) at initiation of dosing . compound was dosed orally ( po ) at 1 0 , 3', 'ed50_an': '7 ) or suffered from a significant loss in cellular potency as with pyridine 2 8 . interestingly , piperazine 2 9 retained cellular potency and displayed a marked improvement in microsomal stability but had clearance greater than liver blood flow on iv dosing in rat . piperidinone analogue 3 0 behaved likewise , however , 4-aminomethylpiperidine 3 1 displayed astonishing microsomal stability , which translated into improved rat iv clearance amounting to 3 0 % of liver blood flow . as a result of this unexpected finding , a wide range of polar substituents were explored in a variety of configurations . carboxylic acids such as 3 2 and 3 3 furnished zwitterions which were stable toward microsomal transformation , however , cellular potency was significantly impacted . the primary amides of these acids were investigated and found to retain cellular potency , however , they varied significantly in their microsomal stability depending on the location of the amide moiety; compare , for example , 3', 't_half_an': '3', 'auc_an': '4', 'bioavailability_an': '6 0', 'compound_drug': 'leu 1 1 9 6 , in a pocket also defined by val1180 and leu1256 . it was therefore anticipated that the substitution pattern of the aryl ring may permit fine-tuning of the kinase selectivity profile . ( 1 5', 'compound': '4 9'}
====================
6
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
synthesis, structure–activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (alk) inhibitor 5-chloro-n2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-n4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (ldk378) currently in phase 1 and phase 2 clinical trials
nlpDict: 
single_dict: {'compound': '15b', 'ic50_mc': '2', 'ki_mc': '6 6 %', 'selectivity_mc': '1 9', 'ic50_ce': '2 0 1 2', 'ki_ce': '1 0', 'herg_ce': '1 0 0 nm was observed for all kinases tested and the potent inhibitions observed for igf-1r and flt3 at the enzymatic level proved to be nonreproducible in a cellular context ( ic50 of 4 1 0 and 3 1 4 3 nm , respectively ) . likewise , cellular inhibition of fgfr2 and fgfr4 was found to be >2', 'ed50_an': '9 ( schrodinger , inc . , portland , or , 2 0 1 2 ) . the mcmm/llmod simulations revealed much greater mobility in the 17e complex , especially in its terminal piperidine and the side chain of e1210 ( see figure s8 in supporting information ) . we hypothesize that this greater mobility of 17e translates into its weaker binding potency .', 't_half_an': '7', 'auc_an': '2 0 1', 'bioavailability_an': '3 1 4 3', 'compound_drug': 'ldk378'}

original_dict: {'ic50_mc': '2', 'ki_mc': '6 6 %', 'kd_mc': '2', 'selectivity_mc': '1 9', 'ic50_ce': '2 0 1 2', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '2', 'selectivity_ce': '1 0', 'herg_ce': '1 0 0 nm was observed for all kinases tested and the potent inhibitions observed for igf-1r and flt3 at the enzymatic level proved to be nonreproducible in a cellular context ( ic50 of 4 1 0 and 3 1 4 3 nm , respectively ) . likewise , cellular inhibition of fgfr2 and fgfr4 was found to be >2', 'solubility_ce': '2', 'ed50_an': '9 ( schrodinger , inc . , portland , or , 2 0 1 2 ) . the mcmm/llmod simulations revealed much greater mobility in the 17e complex , especially in its terminal piperidine and the side chain of e1210 ( see figure s8 in supporting information ) . we hypothesize that this greater mobility of 17e translates into its weaker binding potency .', 't_half_an': '7', 'auc_an': '2 0 1', 'bioavailability_an': '3 1 4 3', 'compound_drug': 'ldk378', 'compound': '15b'}
====================
7
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
synthesis, structure–activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (alk) inhibitor 5-chloro-n2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-n4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (ldk378) currently in phase 1 and phase 2 clinical trials
nlpDict: 
single_dict: {'compound': '15b', 'ic50_mc': '2', 'ki_mc': '6 6 %', 'selectivity_mc': '1 9', 'ic50_ce': '2 0 1 2', 'ki_ce': '1 0', 'herg_ce': '1 0 0 nm was observed for all kinases tested and the potent inhibitions observed for igf-1r and flt3 at the enzymatic level proved to be nonreproducible in a cellular context ( ic50 of 4 1 0 and 3 1 4 3 nm , respectively ) . likewise , cellular inhibition of fgfr2 and fgfr4 was found to be >2', 'ed50_an': '9 ( schrodinger , inc . , portland , or , 2 0 1 2 ) . the mcmm/llmod simulations revealed much greater mobility in the 17e complex , especially in its terminal piperidine and the side chain of e1210 ( see figure s8 in supporting information ) . we hypothesize that this greater mobility of 17e translates into its weaker binding potency .', 't_half_an': '7', 'auc_an': '2 0 1', 'bioavailability_an': '3 1 4 3', 'compound_drug': 'ldk378'}

original_dict: {'ic50_mc': '2', 'ki_mc': '6 6 %', 'kd_mc': '2', 'selectivity_mc': '1 9', 'ic50_ce': '2 0 1 2', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '2', 'selectivity_ce': '1 0', 'herg_ce': '1 0 0 nm was observed for all kinases tested and the potent inhibitions observed for igf-1r and flt3 at the enzymatic level proved to be nonreproducible in a cellular context ( ic50 of 4 1 0 and 3 1 4 3 nm , respectively ) . likewise , cellular inhibition of fgfr2 and fgfr4 was found to be >2', 'solubility_ce': '2', 'ed50_an': '9 ( schrodinger , inc . , portland , or , 2 0 1 2 ) . the mcmm/llmod simulations revealed much greater mobility in the 17e complex , especially in its terminal piperidine and the side chain of e1210 ( see figure s8 in supporting information ) . we hypothesize that this greater mobility of 17e translates into its weaker binding potency .', 't_half_an': '7', 'auc_an': '2 0 1', 'bioavailability_an': '3 1 4 3', 'compound_drug': 'ldk378', 'compound': '15b'}
====================
8
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
synthesis, structure–activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (alk) inhibitor 5-chloro-n2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-n4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (ldk378) currently in phase 1 and phase 2 clinical trials
nlpDict: 
single_dict: {'compound': '15b', 'ic50_mc': '2', 'ki_mc': '6 6 %', 'selectivity_mc': '1 9', 'ic50_ce': '2 0 1 2', 'ki_ce': '1 0', 'herg_ce': '1 0 0 nm was observed for all kinases tested and the potent inhibitions observed for igf-1r and flt3 at the enzymatic level proved to be nonreproducible in a cellular context ( ic50 of 4 1 0 and 3 1 4 3 nm , respectively ) . likewise , cellular inhibition of fgfr2 and fgfr4 was found to be >2', 'ed50_an': '9 ( schrodinger , inc . , portland , or , 2 0 1 2 ) . the mcmm/llmod simulations revealed much greater mobility in the 17e complex , especially in its terminal piperidine and the side chain of e1210 ( see figure s8 in supporting information ) . we hypothesize that this greater mobility of 17e translates into its weaker binding potency .', 't_half_an': '7', 'auc_an': '2 0 1', 'bioavailability_an': '3 1 4 3', 'compound_drug': 'ldk378'}

original_dict: {'ic50_mc': '2', 'ki_mc': '6 6 %', 'kd_mc': '2', 'selectivity_mc': '1 9', 'ic50_ce': '2 0 1 2', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '2', 'selectivity_ce': '1 0', 'herg_ce': '1 0 0 nm was observed for all kinases tested and the potent inhibitions observed for igf-1r and flt3 at the enzymatic level proved to be nonreproducible in a cellular context ( ic50 of 4 1 0 and 3 1 4 3 nm , respectively ) . likewise , cellular inhibition of fgfr2 and fgfr4 was found to be >2', 'solubility_ce': '2', 'ed50_an': '9 ( schrodinger , inc . , portland , or , 2 0 1 2 ) . the mcmm/llmod simulations revealed much greater mobility in the 17e complex , especially in its terminal piperidine and the side chain of e1210 ( see figure s8 in supporting information ) . we hypothesize that this greater mobility of 17e translates into its weaker binding potency .', 't_half_an': '7', 'auc_an': '2 0 1', 'bioavailability_an': '3 1 4 3', 'compound_drug': 'ldk378', 'compound': '15b'}
====================
9
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
identification of the first selective activin receptor-like kinase 1 inhibitor, a reversible version of l-783277
nlpDict: 
single_dict: {'compound': '1', 'ic50_mc': '6 2', 'ki_mc': '6 5 % yield for 2 steps', 'kd_mc': '2', 'selectivity_mc': '1 2', 'ic50_ce': '3 . 3 5 μm', 'ki_ce': '1 0', 'kd_ce': '2b ) . compound 1 turned out to be inactive against mkk6 from a titration experiment ( figure 2b ) , which is inconsistent with the single-point inhibition data ( 8', 'selectivity_ce': '1 3 ( ic50 = 1 . 5 5 μm ) ( figure 3b ) . the external olefin 1', 'ed50_an': '0 . 0 5 8 and 0 . 0 3 1 , respectively ) . in addition , the resonance for the c-5′-h proton of ( s ) -10a mtpa is at a higher field than that in (', 'bioavailability_an': '2 0 0', 'compound_drug': 'l-783277'}

original_dict: {'ic50_mc': '6 2', 'ki_mc': '6 5 % yield for 2 steps', 'kd_mc': '2', 'selectivity_mc': '1 2', 'ic50_ce': '3 . 3 5 μm', 'ki_ce': '1 0', 'kd_ce': '2b ) . compound 1 turned out to be inactive against mkk6 from a titration experiment ( figure 2b ) , which is inconsistent with the single-point inhibition data ( 8', 'ec50_ce': '2', 'selectivity_ce': '1 3 ( ic50 = 1 . 5 5 μm ) ( figure 3b ) . the external olefin 1', 'herg_ce': '1 0', 'solubility_ce': '2', 'ed50_an': '0 . 0 5 8 and 0 . 0 3 1 , respectively ) . in addition , the resonance for the c-5′-h proton of ( s ) -10a mtpa is at a higher field than that in (', 't_half_an': '2', 'auc_an': '1 0', 'bioavailability_an': '2 0 0', 'compound_drug': 'l-783277', 'compound': '1'}
====================
10
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
identification of 1,5-naphthyridine derivatives as a novel series of potent and selective tgf-β type i receptor inhibitors
nlpDict: 
single_dict: {'compound': '1 9', 'ic50_mc': '3 . 2 1', 'kd_mc': '1 . 1 4 å', 'selectivity_mc': '1 å', 'ic50_ce': '2', 'ki_ce': '4', 'kd_ce': '2 ) 0', 'selectivity_ce': '1 6', 'herg_ce': '1 0', 'solubility_ce': '3 retained the potency of 1 in the binding assay . however , the 2-fluorophenyl analogue 4 also showed a similar level of binding affinity , so , clearly , an appropriately positioned nitrogen atom is not necessary for activity , although it remains possible that the 2-fluorophenyl group could participate in hydrogen bonding . replacement of the 2-fluoro substituent by a 2-methoxy group 5 abolished the binding to alk5 . it was apparent from the docking studies that the pyridin-2-yl of 1 and the ser-280 oxygen of the protein were in close proximity , with a distance of 3 . 2 1', 'ed50_an': '3 . 2 1 å measured between the pyridine centroid and the ser-280 oxygen . this was suggestive of a possible electrostatic interaction , consistent with the observed activity of the 2-fluorophenyl analogue 4 . to explore this idea further , the pyridin-2-yl ring', 't_half_an': '3 . 1', 'auc_an': '1 in the binding assay . however , the 2-fluorophenyl analogue 4 also showed a similar level of binding affinity , so , clearly , an appropriately positioned nitrogen atom is not necessary for activity , although it remains possible that the 2-fluorophenyl group could participate in hydrogen bonding . replacement of the 2-fluoro substituent by a 2-methoxy group 5 abolished the binding to alk5 . it was apparent from the docking studies that the pyridin-2-yl of 1 and the ser-280 oxygen of the protein were in close proximity , with a distance of 3 . 2 1', 'bioavailability_an': '9 5', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion consideration of the structure of 1 strongly suggested that it might inhibit a kinase , and alk5 appeared a likely candidate . accordingly , an alk5 autophosphorylation assay was constructed using the purified human alk5 kinase domain produced in sf9 insect cells . aminothiazole 1 inhibited alk5 activity in this assay with an ic50 of 2 7 4 nm . while presenting some structural analogy with p38 map kinase inhibitors , 1 1 this compound did not exhibit p38 map kinase activity when tested in a relevant binding assay ( ic50 > 1 6 μm ) . a chemistry program was initiated with the aim of increasing potency . to support the study of structure−activity relationships ( sar ) within the series , a binding assay was set up in which the ability of the test compounds to displace a rhodamine green-labeled ligand from recombinant gst-alk5 was measured . in this assay , 1 exhibited an ic50 of 7 2 4 nm . the compounds were evaluated in both the binding and the tgf-β-dependent cellular assay , and the most potent compounds were also tested in the alk5 autophosphorylation assay . at the outset of this work , no structures of alk5 inhibitors cocrystallized with the protein had been published . however , the crystal structure of an inactive form of alk5 complexed to fkbp129 was available and this was used as a basis for docking studies .'}

original_dict: {'ic50_mc': '3 . 2 1', 'ki_mc': '3 . 2 1', 'kd_mc': '1 . 1 4 å', 'selectivity_mc': '1 å', 'ic50_ce': '2', 'ki_ce': '4', 'kd_ce': '2 ) 0', 'ec50_ce': '3 . 2 1', 'selectivity_ce': '1 6', 'herg_ce': '1 0', 'solubility_ce': '3 retained the potency of 1 in the binding assay . however , the 2-fluorophenyl analogue 4 also showed a similar level of binding affinity , so , clearly , an appropriately positioned nitrogen atom is not necessary for activity , although it remains possible that the 2-fluorophenyl group could participate in hydrogen bonding . replacement of the 2-fluoro substituent by a 2-methoxy group 5 abolished the binding to alk5 . it was apparent from the docking studies that the pyridin-2-yl of 1 and the ser-280 oxygen of the protein were in close proximity , with a distance of 3 . 2 1', 'ed50_an': '3 . 2 1 å measured between the pyridine centroid and the ser-280 oxygen . this was suggestive of a possible electrostatic interaction , consistent with the observed activity of the 2-fluorophenyl analogue 4 . to explore this idea further , the pyridin-2-yl ring', 't_half_an': '3 . 1', 'auc_an': '1 in the binding assay . however , the 2-fluorophenyl analogue 4 also showed a similar level of binding affinity , so , clearly , an appropriately positioned nitrogen atom is not necessary for activity , although it remains possible that the 2-fluorophenyl group could participate in hydrogen bonding . replacement of the 2-fluoro substituent by a 2-methoxy group 5 abolished the binding to alk5 . it was apparent from the docking studies that the pyridin-2-yl of 1 and the ser-280 oxygen of the protein were in close proximity , with a distance of 3 . 2 1', 'bioavailability_an': '9 5', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion consideration of the structure of 1 strongly suggested that it might inhibit a kinase , and alk5 appeared a likely candidate . accordingly , an alk5 autophosphorylation assay was constructed using the purified human alk5 kinase domain produced in sf9 insect cells . aminothiazole 1 inhibited alk5 activity in this assay with an ic50 of 2 7 4 nm . while presenting some structural analogy with p38 map kinase inhibitors , 1 1 this compound did not exhibit p38 map kinase activity when tested in a relevant binding assay ( ic50 > 1 6 μm ) . a chemistry program was initiated with the aim of increasing potency . to support the study of structure−activity relationships ( sar ) within the series , a binding assay was set up in which the ability of the test compounds to displace a rhodamine green-labeled ligand from recombinant gst-alk5 was measured . in this assay , 1 exhibited an ic50 of 7 2 4 nm . the compounds were evaluated in both the binding and the tgf-β-dependent cellular assay , and the most potent compounds were also tested in the alk5 autophosphorylation assay . at the outset of this work , no structures of alk5 inhibitors cocrystallized with the protein had been published . however , the crystal structure of an inactive form of alk5 complexed to fkbp129 was available and this was used as a basis for docking studies .', 'compound': '1 9'}
====================
11
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
discovery of n-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl)methyl)-2-fluoroaniline (ew-7197): a highly potent, selective, and orally bioavailable inhibitor of tgf-β type i receptor kinase as cancer immunotherapeutic/antifibrotic agent
nlpDict: 
single_dict: {'compound': '12b', 'ic50_mc': '0 . 0 3 μm', 'ki_mc': '2 0 . 5 9 nm', 'kd_mc': '3', 'selectivity_mc': '1', 'ki_ce': '1 0', 'kd_ce': '2', 'ed50_an': '1 0 and 1', 'auc_an': '6', 'bioavailability_an': '6 3', 'compound_drug': 'ew-7197'}

original_dict: {'ic50_mc': '0 . 0 3 μm', 'ki_mc': '2 0 . 5 9 nm', 'kd_mc': '3', 'selectivity_mc': '1', 'ic50_ce': '3', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '2', 'selectivity_ce': '1', 'herg_ce': '1 0', 'solubility_ce': '3', 'ed50_an': '1 0 and 1', 't_half_an': '3', 'auc_an': '6', 'bioavailability_an': '6 3', 'compound_drug': 'ew-7197', 'compound': '12b'}
====================
12
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
synthesis and biological evaluation of 4(5)-(6-alkylpyridin-2-yl)imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors
nlpDict: 
single_dict: {'compound': '13e', 'ic50_mc': '1 2', 'ki_mc': '6 2 ± 2 4 7', 'kd_mc': '3', 'selectivity_mc': '39%; sbe-luciferase , 34%; are-luciferase , 0 % ) . table 1', 'ic50_ce': '1 7', 'ki_ce': '1 0', 'ec50_ce': '3 8', 'herg_ce': '1 0 17b 0', 'solubility_ce': '2', 'ed50_an': '7 , 8 , 1 7 a bulkier group than a methyl group seems to reduce binding of those inhibitors in the atp binding site of alk5 . compounds with either a carbonitrile or a caboxamide substituent in the meta-position', 'auc_an': '4 ( 5', 'bioavailability_an': '4 5 %', 'compound_drug': 'p3tp-luciferase ,'}

original_dict: {'ic50_mc': '1 2', 'ki_mc': '6 2 ± 2 4 7', 'kd_mc': '3', 'selectivity_mc': '39%; sbe-luciferase , 34%; are-luciferase , 0 % ) . table 1', 'ic50_ce': '1 7', 'ki_ce': '1 0', 'kd_ce': '3', 'ec50_ce': '3 8', 'selectivity_ce': '39%; sbe-luciferase , 34%; are-luciferase , 0 % ) . table 1', 'herg_ce': '1 0 17b 0', 'solubility_ce': '2', 'ed50_an': '7 , 8 , 1 7 a bulkier group than a methyl group seems to reduce binding of those inhibitors in the atp binding site of alk5 . compounds with either a carbonitrile or a caboxamide substituent in the meta-position', 't_half_an': '3', 'auc_an': '4 ( 5', 'bioavailability_an': '4 5 %', 'compound_drug': 'p3tp-luciferase ,', 'compound': '13e'}
====================
13
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
discovery of novel mutant-combating alk and ros1 dual inhibitors bearing imidazolidin-2-one moiety with reasonable pk properties
nlpDict: 
single_dict: {'compound': '1 5', 'ic50_mc': '1 . 2 to 7 . 3', 'ki_mc': '0 . 4 3 nm , 7-fold more active than ceritinib ( ic50 = 3 . 1', 'kd_mc': '0 . 4 3', 'selectivity_mc': '30-fold more potent than ceritinib ( 2 0 1 nm ) while another six compounds performed a little bit weaker than 1 5 with ic50 values ranging from 8 . 5 to 2 3 . 4 nm . as a continuation , additional profiling of compound 1 5 for its kinase selectivity was conducted . table 4 displayed a selected enzymatic kinase profile of 1 5 . compound 1 5 exerted a remarkable selectivity against an enzyme panel of 8 kinases , showing biochemical inhibition below 1 0 0 0 nm for four kinases: c-met , cdk-4 , fgfr , igf-1r with ic50 values of 2 1', 'ic50_ce': '3 5 0', 'kd_ce': '2', 'ec50_ce': '4', 'selectivity_ce': '1 0 mg/kg p . o . ) on spf-grade sd rats ( no . 4 4 0 0 7 2 0 0 0 3 9 6 7 5 ) and the results were shown in fig . 5 and table . 5 . it could be easily found that the t1/2 of 1 5 was significantly extended to 7 . 4 h . compared with ceritinib as well as 6 , compound 1 5 exhibited improved cmax ( 2 9 7 . 3', 'herg_ce': '1 0 0 0', 'solubility_ce': '2 2', 'ed50_an': '7 was further hydrolyzed with naoh to give the acetic compound 8 . condensation of 8 with various aliphatic amines in dmf using 1-[bis ( dimethylamino ) methylene]-1h-1 , 2 , 3-triazolo-[4 , 5-b]pyridinium 3-oxid hexafluorophosphate ( hatu ) as condensation agent gave rise to 18–33 which was purified by column chromatography with the eluting system of dcm and methanol in different ratios .', 't_half_an': '3 . 2 2', 'auc_an': '4 5 1 3', 'bioavailability_an': '2 3', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion pharmacokinetic ( pk ) profile pk properties are of great significance for drugs in clinical development stage . to preliminarily examine the druggability of these analogs , a pk study ( 1 0 mg/kg p . o . ) on hit 6 was performed at the beginning while a relatively short half-life ( t1/2 = 1 . 4 h ) was observed . after the dedicated structural modification , the most promising compound 1 5 was available for a new stage pk study . pk profiles of compound 1 5'}

original_dict: {'ic50_mc': '1 . 2 to 7 . 3', 'ki_mc': '0 . 4 3 nm , 7-fold more active than ceritinib ( ic50 = 3 . 1', 'kd_mc': '0 . 4 3', 'selectivity_mc': '30-fold more potent than ceritinib ( 2 0 1 nm ) while another six compounds performed a little bit weaker than 1 5 with ic50 values ranging from 8 . 5 to 2 3 . 4 nm . as a continuation , additional profiling of compound 1 5 for its kinase selectivity was conducted . table 4 displayed a selected enzymatic kinase profile of 1 5 . compound 1 5 exerted a remarkable selectivity against an enzyme panel of 8 kinases , showing biochemical inhibition below 1 0 0 0 nm for four kinases: c-met , cdk-4 , fgfr , igf-1r with ic50 values of 2 1', 'ic50_ce': '3 5 0', 'ki_ce': '0 . 4 3', 'kd_ce': '2', 'ec50_ce': '4', 'selectivity_ce': '1 0 mg/kg p . o . ) on spf-grade sd rats ( no . 4 4 0 0 7 2 0 0 0 3 9 6 7 5 ) and the results were shown in fig . 5 and table . 5 . it could be easily found that the t1/2 of 1 5 was significantly extended to 7 . 4 h . compared with ceritinib as well as 6 , compound 1 5 exhibited improved cmax ( 2 9 7 . 3', 'herg_ce': '1 0 0 0', 'solubility_ce': '2 2', 'ed50_an': '7 was further hydrolyzed with naoh to give the acetic compound 8 . condensation of 8 with various aliphatic amines in dmf using 1-[bis ( dimethylamino ) methylene]-1h-1 , 2 , 3-triazolo-[4 , 5-b]pyridinium 3-oxid hexafluorophosphate ( hatu ) as condensation agent gave rise to 18–33 which was purified by column chromatography with the eluting system of dcm and methanol in different ratios .', 't_half_an': '3 . 2 2', 'auc_an': '4 5 1 3', 'bioavailability_an': '2 3', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion pharmacokinetic ( pk ) profile pk properties are of great significance for drugs in clinical development stage . to preliminarily examine the druggability of these analogs , a pk study ( 1 0 mg/kg p . o . ) on hit 6 was performed at the beginning while a relatively short half-life ( t1/2 = 1 . 4 h ) was observed . after the dedicated structural modification , the most promising compound 1 5 was available for a new stage pk study . pk profiles of compound 1 5', 'compound': '1 5'}
====================
14
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 1,8-naphthyridin-2-one moiety
nlpDict: 
single_dict: {'compound': '3 3', 'ic50_mc': '2 . 3 6', 'ki_mc': '0 . 2 3 ± 0 . 0 1 μm , 0 . 4 2 ± 0 . 0 6 μm', 'kd_mc': '0 . 2 3', 'selectivity_mc': '1 μm , 0 . 4 2 ± 0 . 0 6 μm and 0 . 2 1', 'ic50_ce': '0 . 2 3 ± 0 . 0 1', 'kd_ce': '2 5 ( ic50 = 0 . 7 6 ± 0 . 0 2 ) , 3 0 ( ic50 = 4', 'ec50_ce': '7', 'selectivity_ce': '1 . 1', 'herg_ce': '2 3 ± 0', 'solubility_ce': '2 5 ( ic50 = 0 . 7 6 ± 0 . 0 2', 'ed50_an': '7 ± 0 . 8', 't_half_an': '6', 'bioavailability_an': '3 0 ( ic50 = 4 . 1 7', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] significant selectivity for hepg2 , which will make some contribution to the field of anti-liver cancer , such as representative compounds 2 5 ( ic50 = 0 . 7 6 ± 0 . 0 2 ) , 3 0 ( ic50 = 4 . 1 7 ± 0 . 8 7 ) , 3 3 ( ic50 = 0 . 2 3 ± 0 . 0 1 ) , 3 4 ( ic50 = 2 . 3 5 ± 0 . 9 2 ) , 3 7 ( ic50 = 0 . 3 6 ± 0 . 0 1 ) , 4 1 ( ic50 = 0 . 3 3 ± 0 . 0 1 ) , 4 2 ( ic50 = 1 . 4 9 ± 0 . 4 1 ) , 4 3 ( ic50 = 0 . 4 6 ± 0 . 1 2 ) and 5 2 ( ic50 = 2 . 3 9 ± 0 . 7 2 ) against hepg2 cell . subsequent studies focused on the mechanism of compounds on hepg2 cells . as showed in table 1 , when r1 was a different water-soluble group , it has a significant effect on the inhibitory activity of the target compounds . it is worth mentioning that the 1-methylpiperazine group ( r1 group ) is superior to 4-methylpiperidine , piperidine and morpholine . such as compound 3 3 ( r1'}

original_dict: {'ic50_mc': '2 . 3 6', 'ki_mc': '0 . 2 3 ± 0 . 0 1 μm , 0 . 4 2 ± 0 . 0 6 μm', 'kd_mc': '0 . 2 3', 'selectivity_mc': '1 μm , 0 . 4 2 ± 0 . 0 6 μm and 0 . 2 1', 'ic50_ce': '0 . 2 3 ± 0 . 0 1', 'ki_ce': '0 . 2 3 ± 0 . 0 1', 'kd_ce': '2 5 ( ic50 = 0 . 7 6 ± 0 . 0 2 ) , 3 0 ( ic50 = 4', 'ec50_ce': '7', 'selectivity_ce': '1 . 1', 'herg_ce': '2 3 ± 0', 'solubility_ce': '2 5 ( ic50 = 0 . 7 6 ± 0 . 0 2', 'ed50_an': '7 ± 0 . 8', 't_half_an': '6', 'auc_an': '1 . 1', 'bioavailability_an': '3 0 ( ic50 = 4 . 1 7', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] significant selectivity for hepg2 , which will make some contribution to the field of anti-liver cancer , such as representative compounds 2 5 ( ic50 = 0 . 7 6 ± 0 . 0 2 ) , 3 0 ( ic50 = 4 . 1 7 ± 0 . 8 7 ) , 3 3 ( ic50 = 0 . 2 3 ± 0 . 0 1 ) , 3 4 ( ic50 = 2 . 3 5 ± 0 . 9 2 ) , 3 7 ( ic50 = 0 . 3 6 ± 0 . 0 1 ) , 4 1 ( ic50 = 0 . 3 3 ± 0 . 0 1 ) , 4 2 ( ic50 = 1 . 4 9 ± 0 . 4 1 ) , 4 3 ( ic50 = 0 . 4 6 ± 0 . 1 2 ) and 5 2 ( ic50 = 2 . 3 9 ± 0 . 7 2 ) against hepg2 cell . subsequent studies focused on the mechanism of compounds on hepg2 cells . as showed in table 1 , when r1 was a different water-soluble group , it has a significant effect on the inhibitory activity of the target compounds . it is worth mentioning that the 1-methylpiperazine group ( r1 group ) is superior to 4-methylpiperidine , piperidine and morpholine . such as compound 3 3 ( r1', 'compound': '3 3'}
====================
15
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
a chemical tuned strategy to develop novel irreversible egfr-tk inhibitors with improved safety and pharmacokinetic profiles
nlpDict: 
single_dict: {'compound': '5a', 'ic50_mc': '0 . 2 0 and 6 . 6 7', 'ki_mc': '3 0', 'kd_mc': '3 3 . 3', 'selectivity_mc': '9', 'ic50_ce': '4 2 . 5 % , 1 9 . 5 % , and 9 . 4 % at dosages of 1 5 , 3 0', 'ki_ce': '2 μl/min/mg protein and 6 0 μl/min/mg protein , respectively . the same trend was observed for 2a/2b ( 2a , 3 7 μl/min/mg protein; 2b , 1 5 1 μl/min/mg protein ) , 4a/4b ( 4a , 2 2 μl/min/mg protein; 4b , 1 2 4 μl/min/mg protein ) and 6a/6b ( 6a , 1 8 μl/min/mg protein; 6b , 1 9 0 μl/min/mg protein ) . replacing the n', 'kd_ce': '2 1 4 nm ) . fitting the titration data provides an apparent kd of 3 3', 'ec50_ce': '2 1 4 nm ) . fitting the titration data provides an apparent kd of 3 3 . 3', 'selectivity_ce': '1 5', 'herg_ce': '1 0 μm', 'solubility_ce': '2 2 μl/min/mg protein; 4b , 1 2 4 μl/min/mg protein ) and 6a/6b ( 6a , 1 8 μl/min/mg protein; 6b , 1 9', 'ed50_an': '1 . 3 8 nm ) . activities of compounds 1–12 against tumor cells expressing egfr mutations are demonstrated in two cancer cell lines ( table 1 ) . gefitinib-sensitive cell line a431 is an epidermoid cell that is driven by amplified wild-type egfr . gefitinib-resistant cell line nci-h1975 harbors the egfrl858r/t790m', 't_half_an': '1 . 3 nm; 4b , 4 2 . 9 nm ) . the trans-isomers displayed more potent than the cis-isomers in the egfrt790m kinase assay . on the other hand , the profile against her2 shows that quinazoline analogues bearing α-fluoro acrylamide are 2 . 5–89-fold less potent than afatinib ( ic50 = 1 7 . 3 nm ) , with the exception of compound 3a ( ic50 = 1', 'auc_an': '2 5', 'bioavailability_an': '1 6 . 5 %', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion biological evaluation the concentration of selected compounds in various tissues was detected at multiple time points over 6 h following a 3 0 mg/kg oral dose in balb/c mice ( table 4 and supporting information , table s4–s7 ) . the mean drug concentration of all tested compounds in the lung is 10–25-fold higher than in plasma . additionally , the concentration in the brain is higher than that of afatinib , especially with compounds 2a and 5a . this indicates that the quinazoline analogues bearing fluoro-substituted olefins experience enhanced brain uptake thereby rendering them viable for the treatment of nsclc patients with brain metastasis . also , the herg potassium channel patch clamp assay ( 2 5'}

original_dict: {'ic50_mc': '0 . 2 0 and 6 . 6 7', 'ki_mc': '3 0', 'kd_mc': '3 3 . 3', 'selectivity_mc': '9', 'ic50_ce': '4 2 . 5 % , 1 9 . 5 % , and 9 . 4 % at dosages of 1 5 , 3 0', 'ki_ce': '2 μl/min/mg protein and 6 0 μl/min/mg protein , respectively . the same trend was observed for 2a/2b ( 2a , 3 7 μl/min/mg protein; 2b , 1 5 1 μl/min/mg protein ) , 4a/4b ( 4a , 2 2 μl/min/mg protein; 4b , 1 2 4 μl/min/mg protein ) and 6a/6b ( 6a , 1 8 μl/min/mg protein; 6b , 1 9 0 μl/min/mg protein ) . replacing the n', 'kd_ce': '2 1 4 nm ) . fitting the titration data provides an apparent kd of 3 3', 'ec50_ce': '2 1 4 nm ) . fitting the titration data provides an apparent kd of 3 3 . 3', 'selectivity_ce': '1 5', 'herg_ce': '1 0 μm', 'solubility_ce': '2 2 μl/min/mg protein; 4b , 1 2 4 μl/min/mg protein ) and 6a/6b ( 6a , 1 8 μl/min/mg protein; 6b , 1 9', 'ed50_an': '1 . 3 8 nm ) . activities of compounds 1–12 against tumor cells expressing egfr mutations are demonstrated in two cancer cell lines ( table 1 ) . gefitinib-sensitive cell line a431 is an epidermoid cell that is driven by amplified wild-type egfr . gefitinib-resistant cell line nci-h1975 harbors the egfrl858r/t790m', 't_half_an': '1 . 3 nm; 4b , 4 2 . 9 nm ) . the trans-isomers displayed more potent than the cis-isomers in the egfrt790m kinase assay . on the other hand , the profile against her2 shows that quinazoline analogues bearing α-fluoro acrylamide are 2 . 5–89-fold less potent than afatinib ( ic50 = 1 7 . 3 nm ) , with the exception of compound 3a ( ic50 = 1', 'auc_an': '2 5', 'bioavailability_an': '1 6 . 5 %', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion biological evaluation the concentration of selected compounds in various tissues was detected at multiple time points over 6 h following a 3 0 mg/kg oral dose in balb/c mice ( table 4 and supporting information , table s4–s7 ) . the mean drug concentration of all tested compounds in the lung is 10–25-fold higher than in plasma . additionally , the concentration in the brain is higher than that of afatinib , especially with compounds 2a and 5a . this indicates that the quinazoline analogues bearing fluoro-substituted olefins experience enhanced brain uptake thereby rendering them viable for the treatment of nsclc patients with brain metastasis . also , the herg potassium channel patch clamp assay ( 2 5', 'compound': '5a'}
====================
16
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
a chemical tuned strategy to develop novel irreversible egfr-tk inhibitors with improved safety and pharmacokinetic profiles
nlpDict: 
single_dict: {'compound': '5a', 'ic50_mc': '0 . 2 0 and 6 . 6 7', 'ki_mc': '3 0', 'kd_mc': '3 3 . 3', 'selectivity_mc': '9', 'ic50_ce': '4 2 . 5 % , 1 9 . 5 % , and 9 . 4 % at dosages of 1 5 , 3 0', 'ki_ce': '2 μl/min/mg protein and 6 0 μl/min/mg protein , respectively . the same trend was observed for 2a/2b ( 2a , 3 7 μl/min/mg protein; 2b , 1 5 1 μl/min/mg protein ) , 4a/4b ( 4a , 2 2 μl/min/mg protein; 4b , 1 2 4 μl/min/mg protein ) and 6a/6b ( 6a , 1 8 μl/min/mg protein; 6b , 1 9 0 μl/min/mg protein ) . replacing the n', 'kd_ce': '2 1 4 nm ) . fitting the titration data provides an apparent kd of 3 3', 'ec50_ce': '2 1 4 nm ) . fitting the titration data provides an apparent kd of 3 3 . 3', 'selectivity_ce': '1 5', 'herg_ce': '1 0 μm', 'solubility_ce': '2 2 μl/min/mg protein; 4b , 1 2 4 μl/min/mg protein ) and 6a/6b ( 6a , 1 8 μl/min/mg protein; 6b , 1 9', 'ed50_an': '1 . 3 8 nm ) . activities of compounds 1–12 against tumor cells expressing egfr mutations are demonstrated in two cancer cell lines ( table 1 ) . gefitinib-sensitive cell line a431 is an epidermoid cell that is driven by amplified wild-type egfr . gefitinib-resistant cell line nci-h1975 harbors the egfrl858r/t790m', 't_half_an': '1 . 3 nm; 4b , 4 2 . 9 nm ) . the trans-isomers displayed more potent than the cis-isomers in the egfrt790m kinase assay . on the other hand , the profile against her2 shows that quinazoline analogues bearing α-fluoro acrylamide are 2 . 5–89-fold less potent than afatinib ( ic50 = 1 7 . 3 nm ) , with the exception of compound 3a ( ic50 = 1', 'auc_an': '2 5', 'bioavailability_an': '1 6 . 5 %', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion biological evaluation the concentration of selected compounds in various tissues was detected at multiple time points over 6 h following a 3 0 mg/kg oral dose in balb/c mice ( table 4 and supporting information , table s4–s7 ) . the mean drug concentration of all tested compounds in the lung is 10–25-fold higher than in plasma . additionally , the concentration in the brain is higher than that of afatinib , especially with compounds 2a and 5a . this indicates that the quinazoline analogues bearing fluoro-substituted olefins experience enhanced brain uptake thereby rendering them viable for the treatment of nsclc patients with brain metastasis . also , the herg potassium channel patch clamp assay ( 2 5'}

original_dict: {'ic50_mc': '0 . 2 0 and 6 . 6 7', 'ki_mc': '3 0', 'kd_mc': '3 3 . 3', 'selectivity_mc': '9', 'ic50_ce': '4 2 . 5 % , 1 9 . 5 % , and 9 . 4 % at dosages of 1 5 , 3 0', 'ki_ce': '2 μl/min/mg protein and 6 0 μl/min/mg protein , respectively . the same trend was observed for 2a/2b ( 2a , 3 7 μl/min/mg protein; 2b , 1 5 1 μl/min/mg protein ) , 4a/4b ( 4a , 2 2 μl/min/mg protein; 4b , 1 2 4 μl/min/mg protein ) and 6a/6b ( 6a , 1 8 μl/min/mg protein; 6b , 1 9 0 μl/min/mg protein ) . replacing the n', 'kd_ce': '2 1 4 nm ) . fitting the titration data provides an apparent kd of 3 3', 'ec50_ce': '2 1 4 nm ) . fitting the titration data provides an apparent kd of 3 3 . 3', 'selectivity_ce': '1 5', 'herg_ce': '1 0 μm', 'solubility_ce': '2 2 μl/min/mg protein; 4b , 1 2 4 μl/min/mg protein ) and 6a/6b ( 6a , 1 8 μl/min/mg protein; 6b , 1 9', 'ed50_an': '1 . 3 8 nm ) . activities of compounds 1–12 against tumor cells expressing egfr mutations are demonstrated in two cancer cell lines ( table 1 ) . gefitinib-sensitive cell line a431 is an epidermoid cell that is driven by amplified wild-type egfr . gefitinib-resistant cell line nci-h1975 harbors the egfrl858r/t790m', 't_half_an': '1 . 3 nm; 4b , 4 2 . 9 nm ) . the trans-isomers displayed more potent than the cis-isomers in the egfrt790m kinase assay . on the other hand , the profile against her2 shows that quinazoline analogues bearing α-fluoro acrylamide are 2 . 5–89-fold less potent than afatinib ( ic50 = 1 7 . 3 nm ) , with the exception of compound 3a ( ic50 = 1', 'auc_an': '2 5', 'bioavailability_an': '1 6 . 5 %', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion biological evaluation the concentration of selected compounds in various tissues was detected at multiple time points over 6 h following a 3 0 mg/kg oral dose in balb/c mice ( table 4 and supporting information , table s4–s7 ) . the mean drug concentration of all tested compounds in the lung is 10–25-fold higher than in plasma . additionally , the concentration in the brain is higher than that of afatinib , especially with compounds 2a and 5a . this indicates that the quinazoline analogues bearing fluoro-substituted olefins experience enhanced brain uptake thereby rendering them viable for the treatment of nsclc patients with brain metastasis . also , the herg potassium channel patch clamp assay ( 2 5', 'compound': '5a'}
====================
17
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
design and synthesis of tetrahydropyridothieno[2,3-d]pyrimidine scaffold based epidermal growth factor receptor (egfr) kinase inhibitors: the role of side chain chirality and michael acceptor group for maximal potency
nlpDict: 
single_dict: {'compound': '1 9', 'ic50_mc': '7', 'ki_mc': '1 0 μm', 'kd_mc': '6 and 2', 'selectivity_mc': '200-fold', 'ic50_ce': '2', 'ki_ce': '1 0', 'kd_ce': '2 3 ) again lost the activity for both wild and double mutant kinase completely . removal of hydroxyl group ( 2 4 ) only led to 2-fold loss of wild-type and double mutant kinase activity , while converting it to methyl group ( 2 5 ) led to loss of double mutant kinase activity ( ic50 > 5 μm ) without much affecting the wild-type kinase activity compared to that of 1 9 . these findings in the chiral phenylaminoethanol side chain are very similar to the sar observation in 1 1 containing the acrylamide michael acceptor group . this demonstrates that apart from the presence of michael acceptor functionality , the presence of the hydroxyl group and the orientation of the phenyl group in the side chain has played a critical role determining the activity in this series , in particular for double mutant kinase activity . to further explore the role of the phenyl group , it was moved one carbon away from the chiral center or completely removed from the side chain , which resulted in 2 6 and 2', 'ec50_ce': '2 2 3', 'solubility_ce': '2 6', 'ed50_an': '7 , respectively . both moving the', 't_half_an': '6', 'auc_an': '1 1 . for this purpose , we first turned our attention to the chiral phenylaminoethanol side chain linked to the pyrimidine core . when the s-enatiomer 1 1 was converted to r-enatiomer 1 5 , the compound lost egfr wild and double mutant kinase activity over 200-fold compared to that of 1 1 . however , either the removal of hydroxyl group ( 1 6 ) or converting it to methyl group ( 1 7 ) led to loss of 3−6-fold potency for wild-type and 8−22-fold loss of potency for double mutant kinase compared to that of 1 1 . these results suggest that presence of hydroxyl group plays an important role in maintaining potent activity for both wild-type and double mutant egfr kinase . hence , by retaining the chiral phenylaminoethanol side chain linked to the pyrimidine core , we attempted modification in the michael acceptor region of 1', 'bioavailability_an': '2 7', 'compound_drug': 'aee788'}

original_dict: {'ic50_mc': '7', 'ki_mc': '1 0 μm', 'kd_mc': '6 and 2', 'selectivity_mc': '200-fold', 'ic50_ce': '2', 'ki_ce': '1 0', 'kd_ce': '2 3 ) again lost the activity for both wild and double mutant kinase completely . removal of hydroxyl group ( 2 4 ) only led to 2-fold loss of wild-type and double mutant kinase activity , while converting it to methyl group ( 2 5 ) led to loss of double mutant kinase activity ( ic50 > 5 μm ) without much affecting the wild-type kinase activity compared to that of 1 9 . these findings in the chiral phenylaminoethanol side chain are very similar to the sar observation in 1 1 containing the acrylamide michael acceptor group . this demonstrates that apart from the presence of michael acceptor functionality , the presence of the hydroxyl group and the orientation of the phenyl group in the side chain has played a critical role determining the activity in this series , in particular for double mutant kinase activity . to further explore the role of the phenyl group , it was moved one carbon away from the chiral center or completely removed from the side chain , which resulted in 2 6 and 2', 'ec50_ce': '2 2 3', 'selectivity_ce': '1 0', 'herg_ce': '1 0', 'solubility_ce': '2 6', 'ed50_an': '7 , respectively . both moving the', 't_half_an': '6', 'auc_an': '1 1 . for this purpose , we first turned our attention to the chiral phenylaminoethanol side chain linked to the pyrimidine core . when the s-enatiomer 1 1 was converted to r-enatiomer 1 5 , the compound lost egfr wild and double mutant kinase activity over 200-fold compared to that of 1 1 . however , either the removal of hydroxyl group ( 1 6 ) or converting it to methyl group ( 1 7 ) led to loss of 3−6-fold potency for wild-type and 8−22-fold loss of potency for double mutant kinase compared to that of 1 1 . these results suggest that presence of hydroxyl group plays an important role in maintaining potent activity for both wild-type and double mutant egfr kinase . hence , by retaining the chiral phenylaminoethanol side chain linked to the pyrimidine core , we attempted modification in the michael acceptor region of 1', 'bioavailability_an': '2 7', 'compound_drug': 'aee788', 'compound': '1 9'}
====================
18
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
protein kinase inhibitor design by targeting the asp-phe-gly (dfg) motif: the role of the dfg motif in the design of epidermal growth factor receptor inhibitors
nlpDict: 
single_dict: {'compound': '4b', 'ic50_mc': '8', 'ki_mc': 'five carbons ( 4e', 'kd_mc': 'second position', 'selectivity_mc': '9 9 % at 1 μm ) , l834r mutant ( 1 0 0 % at 1 μm ) , and l837q mutant ( 1 0 6 % at 1 μm ) , better than all of the other tested kinases . of the 3 1 7 kinases profiled , only eight kinases ( eight of 3 1 7', 'ic50_ce': '2', 'ki_ce': 'n', 'ec50_ce': '7 6 å', 'herg_ce': 'five carbons', 'solubility_ce': '2b ) . the furanopyrimidine core ( ring-2 and ring-3 ) of 2a ( figure 2a , b', 'ed50_an': '2a , b ) . the phenyl substitution ( ring-5 ) at the r1 position is perpendicular to the furanopyrimidine core ( figure 2a , b ) . it forms hydrophobic', 't_half_an': '3', 'auc_an': '4b , which provides additional salt bridge interactions with the protein . moreover , in comparison with structure of egfr/2a , the side chain of asp831 rotates and moves closer to the primary hydroxyl group , resulting in the formation of an additional h-bond between 4b and the dfg motif . an extra intramolecular h-bond is also observed between the oxygen atom on the hydroxyl group ( h-bond acceptor ) and amine group ( h-bond donor', 'bioavailability_an': 'last , but most significantly , the cationic dimethylamino group forms a salt bridge with the anionic carboxylate group of asp831 in the dfg motif ( figure 3a', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion structural biology study of compound 2a concurrently with the aforementioned sar study , 2a was cocrystallized with the wild-type egfr kinase domain and the structure complex was solved in order to elucidate the binding mode and obtain the structural insights necessary to design a more potent egfr kinase inhibitor . the electron density maps of egfr in complex with 2a clearly shows that egfr adopts an active conformation with a salt bridge between lys721 and glu738 , and 2a is located in the atp binding cleft between the n- and c-lobes ( figure 2b ) . the furanopyrimidine core ( ring-2 and ring-3 ) of 2a ( figure 2a , b ) aligns in the hinge region of egfr , forming one h-bond with the main chain of met769 and making hydrophobic interactions with surrounding residues , including leu694 , ala719 , met769 , and leu820 ( figure 2a , b ) . the phenyl moiety ( ring-1 ) ( figure 2a ) also forms extensive hydrophobic interactions with residues of val702 , ala719 , lys721 , leu764 , and thr766 in the n-lobe β-sheet and met742 in the αc helix . the phenyl moiety ( ring-4'}

original_dict: {'ic50_mc': '8', 'ki_mc': 'five carbons ( 4e', 'kd_mc': 'second position', 'selectivity_mc': '9 9 % at 1 μm ) , l834r mutant ( 1 0 0 % at 1 μm ) , and l837q mutant ( 1 0 6 % at 1 μm ) , better than all of the other tested kinases . of the 3 1 7 kinases profiled , only eight kinases ( eight of 3 1 7', 'ic50_ce': '2', 'ki_ce': 'n', 'kd_ce': '2', 'ec50_ce': '7 6 å', 'selectivity_ce': 'n', 'herg_ce': 'five carbons', 'solubility_ce': '2b ) . the furanopyrimidine core ( ring-2 and ring-3 ) of 2a ( figure 2a , b', 'ed50_an': '2a , b ) . the phenyl substitution ( ring-5 ) at the r1 position is perpendicular to the furanopyrimidine core ( figure 2a , b ) . it forms hydrophobic', 't_half_an': '3', 'auc_an': '4b , which provides additional salt bridge interactions with the protein . moreover , in comparison with structure of egfr/2a , the side chain of asp831 rotates and moves closer to the primary hydroxyl group , resulting in the formation of an additional h-bond between 4b and the dfg motif . an extra intramolecular h-bond is also observed between the oxygen atom on the hydroxyl group ( h-bond acceptor ) and amine group ( h-bond donor', 'bioavailability_an': 'last , but most significantly , the cationic dimethylamino group forms a salt bridge with the anionic carboxylate group of asp831 in the dfg motif ( figure 3a', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion structural biology study of compound 2a concurrently with the aforementioned sar study , 2a was cocrystallized with the wild-type egfr kinase domain and the structure complex was solved in order to elucidate the binding mode and obtain the structural insights necessary to design a more potent egfr kinase inhibitor . the electron density maps of egfr in complex with 2a clearly shows that egfr adopts an active conformation with a salt bridge between lys721 and glu738 , and 2a is located in the atp binding cleft between the n- and c-lobes ( figure 2b ) . the furanopyrimidine core ( ring-2 and ring-3 ) of 2a ( figure 2a , b ) aligns in the hinge region of egfr , forming one h-bond with the main chain of met769 and making hydrophobic interactions with surrounding residues , including leu694 , ala719 , met769 , and leu820 ( figure 2a , b ) . the phenyl moiety ( ring-1 ) ( figure 2a ) also forms extensive hydrophobic interactions with residues of val702 , ala719 , lys721 , leu764 , and thr766 in the n-lobe β-sheet and met742 in the αc helix . the phenyl moiety ( ring-4', 'compound': '4b'}
====================
19
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
discovery of a novel her-1/her-2 dual tyrosine kinase inhibitor for the treatment of her-1 selective inhibitor-resistant non-small cell lung cancer
nlpDict: 
single_dict: {'compound': '19d', 'ic50_mc': '8', 'ki_mc': '2 8 6 nm ) . in addition , the 1-acryloyl-piperidine-4-carboxamide derivative 13g ( ic50 = 5 1 3 nm', 'kd_mc': '2 3', 'selectivity_mc': '1 6 and 1 7 ( see scheme 2 ) . the final products with c4- and c7-modifications ( 1 8 and 1 9 ) were prepared from intermediates 1', 'ic50_ce': '7', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '2 3 ) on day 11: 6 6 % for 19c , 7 4 % for 19d', 'selectivity_ce': '1 ( gefitinib ) - and 2 ( erlotinib ) -resistant t790m mutation of her-1 tyrosine kinase to include drug resistance to these therapeutic agents . as shown in table 3 , 19c and 19d demonstrated strong inhibition activities against her-1/her-2 kinase than 3 ( lapatinib ) , and 19c and 19d also demonstrated excellent potency toward the t790m mutation of her-1 tyrosine kinase . the additional fluorine at the para-position of the c4-aniline ( 19d ) enhanced its potency in the enzymatic inhibition assay as compared to compound 19c . this conclusion was confirmed by the results of the cell-based proliferation assay . in addition to her-1-positive a431 and her-2-positive sk-br3 , we tested 19c and 19d with h1975 , an 1 ( gefitinib ) /2 ( erlotinib ) -resistant non-small cell lung cancer cell line that harbors the t790 m and l858r mutations . ( 2 2', 'solubility_ce': '2 ( erlotinib ) -resistant t790m mutation of her-1 tyrosine kinase to include drug resistance to these therapeutic agents . as shown in table 3 , 19c and 19d demonstrated strong inhibition activities against her-1/her-2 kinase than 3 ( lapatinib ) , and 19c and 19d also demonstrated excellent potency toward the t790m mutation of her-1 tyrosine kinase . the additional fluorine at the para-position of the c4-aniline ( 19d ) enhanced its potency in the enzymatic inhibition assay as compared to compound 19c . this conclusion was confirmed by the results of the cell-based proliferation assay . in addition to her-1-positive a431 and her-2-positive sk-br3 , we tested 19c and 19d with h1975 , an 1 ( gefitinib ) /2 ( erlotinib ) -resistant non-small cell lung cancer cell line that harbors the t790 m and l858r mutations . ( 2', 'ed50_an': '8 ) as linker moieties with conformational rigidity .', 't_half_an': '6', 'auc_an': '1 1 nm ) and in vitro cellular activity against the 1 ( gefitinib ) /2 ( erlotinib ) -resistant cancer cell line h1975 ( 19c , ic50 = 2 1 3 nm and 19d , ic50 = 6 3 nm ) . but 19c and 19d did not show growth inhibitory activity against normal cell line , hs27 ( 19c , ic50 = 6 6 0 3 nm and 19d , ic50 = 7 4 4 2 nm ) . next , we checked the selectivity profile of 19c and 19d against a panel of 2 5 kinases including receptor tyrosine kinases , cytoplasmic tyrosine kinases , and serine/threonine kinases . as shown in table 4 , our leading compound 19c showed excellent activities ( ic50 < 0 . 1 μm ) against egfr tyrosine kinases ( her-1 , -2 , and -4 ) with superb selectivity . but , we observed some cross-activities ( ic50 < 0 . 1', 'bioavailability_an': '1 4 . 6', 'compound_drug': 'ci-1033'}

original_dict: {'ic50_mc': '8', 'ki_mc': '2 8 6 nm ) . in addition , the 1-acryloyl-piperidine-4-carboxamide derivative 13g ( ic50 = 5 1 3 nm', 'kd_mc': '2 3', 'selectivity_mc': '1 6 and 1 7 ( see scheme 2 ) . the final products with c4- and c7-modifications ( 1 8 and 1 9 ) were prepared from intermediates 1', 'ic50_ce': '7', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '2 3 ) on day 11: 6 6 % for 19c , 7 4 % for 19d', 'selectivity_ce': '1 ( gefitinib ) - and 2 ( erlotinib ) -resistant t790m mutation of her-1 tyrosine kinase to include drug resistance to these therapeutic agents . as shown in table 3 , 19c and 19d demonstrated strong inhibition activities against her-1/her-2 kinase than 3 ( lapatinib ) , and 19c and 19d also demonstrated excellent potency toward the t790m mutation of her-1 tyrosine kinase . the additional fluorine at the para-position of the c4-aniline ( 19d ) enhanced its potency in the enzymatic inhibition assay as compared to compound 19c . this conclusion was confirmed by the results of the cell-based proliferation assay . in addition to her-1-positive a431 and her-2-positive sk-br3 , we tested 19c and 19d with h1975 , an 1 ( gefitinib ) /2 ( erlotinib ) -resistant non-small cell lung cancer cell line that harbors the t790 m and l858r mutations . ( 2 2', 'herg_ce': '1 0', 'solubility_ce': '2 ( erlotinib ) -resistant t790m mutation of her-1 tyrosine kinase to include drug resistance to these therapeutic agents . as shown in table 3 , 19c and 19d demonstrated strong inhibition activities against her-1/her-2 kinase than 3 ( lapatinib ) , and 19c and 19d also demonstrated excellent potency toward the t790m mutation of her-1 tyrosine kinase . the additional fluorine at the para-position of the c4-aniline ( 19d ) enhanced its potency in the enzymatic inhibition assay as compared to compound 19c . this conclusion was confirmed by the results of the cell-based proliferation assay . in addition to her-1-positive a431 and her-2-positive sk-br3 , we tested 19c and 19d with h1975 , an 1 ( gefitinib ) /2 ( erlotinib ) -resistant non-small cell lung cancer cell line that harbors the t790 m and l858r mutations . ( 2', 'ed50_an': '8 ) as linker moieties with conformational rigidity .', 't_half_an': '6', 'auc_an': '1 1 nm ) and in vitro cellular activity against the 1 ( gefitinib ) /2 ( erlotinib ) -resistant cancer cell line h1975 ( 19c , ic50 = 2 1 3 nm and 19d , ic50 = 6 3 nm ) . but 19c and 19d did not show growth inhibitory activity against normal cell line , hs27 ( 19c , ic50 = 6 6 0 3 nm and 19d , ic50 = 7 4 4 2 nm ) . next , we checked the selectivity profile of 19c and 19d against a panel of 2 5 kinases including receptor tyrosine kinases , cytoplasmic tyrosine kinases , and serine/threonine kinases . as shown in table 4 , our leading compound 19c showed excellent activities ( ic50 < 0 . 1 μm ) against egfr tyrosine kinases ( her-1 , -2 , and -4 ) with superb selectivity . but , we observed some cross-activities ( ic50 < 0 . 1', 'bioavailability_an': '1 4 . 6', 'compound_drug': 'ci-1033', 'compound': '19d'}
====================
20
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
first bispecific inhibitors of the epidermal growth factor receptor kinase and the nf-κb activity as novel anticancer agents
nlpDict: 
single_dict: {'compound': '9b', 'ic50_mc': '0 . 3 μm', 'ki_mc': '8 . 2 and >30', 'kd_mc': '3', 'selectivity_mc': '9', 'ic50_ce': '2', 'ki_ce': '4', 'selectivity_ce': '2 4', 'herg_ce': '1 0 0', 'ed50_an': '0 . 3 μm , table 6 ) compared with 6c and 6h (', 't_half_an': '7 . 8 h', 'auc_an': '1 0', 'bioavailability_an': '4 9', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] , as the latter had inhibited in a previously reported screening the kinases mnk2 , sik2 , mnk1 , lok/stk10 , erbb2/her2 , ripk2 , epha6 , and erbb4/her4 by 46–76% at 0 . 5 μm ( supporting information , table s3 in ref 3 7 ) . from these kinases , mnk2 , lok , ripk2 , and erbb4 were also present in the panel screened with 6c , but only mnk2 and erbb4 were appreciably inhibited , by 7 8 % and 5 4 % , respectively , however at a 1 0 times higher concentration ( 5 μm ) . the cell-free potency of 6c for mnk2 inhibition appeared too low to explain the efficacy of 6c in the cell-based nf-κb reporter gene assay ( ic50 = 1 . 9 μm ) . moreover , gefitinib displayed a higher off-target inhibition of mnk2 ( 3 7 ) than 6c but was less potent in our reporter gene assay . thus , mnk2 could be excluded as a potential target of the dual inhibitors in the nf-κb activation pathway . the inhibition of pim-1 by 6c was also rather weak , nevertheless , we decided to check the potential role of pim-1 in the nf-κb activation pathway using the potent pim-1 inhibitor sim-4a ( ic50 for pim-1: 1 7 nm at 1 0 0 μm atp in the cell-free assay ( 3 8 ) ) . testing sim-4a in the nf-κb reporter gene assay in concentrations from 1'}

original_dict: {'ic50_mc': '0 . 3 μm', 'ki_mc': '8 . 2 and >30', 'kd_mc': '3', 'selectivity_mc': '9', 'ic50_ce': '2', 'ki_ce': '4', 'kd_ce': '2', 'ec50_ce': '3', 'selectivity_ce': '2 4', 'herg_ce': '1 0 0', 'solubility_ce': '2', 'ed50_an': '0 . 3 μm , table 6 ) compared with 6c and 6h (', 't_half_an': '7 . 8 h', 'auc_an': '1 0', 'bioavailability_an': '4 9', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] , as the latter had inhibited in a previously reported screening the kinases mnk2 , sik2 , mnk1 , lok/stk10 , erbb2/her2 , ripk2 , epha6 , and erbb4/her4 by 46–76% at 0 . 5 μm ( supporting information , table s3 in ref 3 7 ) . from these kinases , mnk2 , lok , ripk2 , and erbb4 were also present in the panel screened with 6c , but only mnk2 and erbb4 were appreciably inhibited , by 7 8 % and 5 4 % , respectively , however at a 1 0 times higher concentration ( 5 μm ) . the cell-free potency of 6c for mnk2 inhibition appeared too low to explain the efficacy of 6c in the cell-based nf-κb reporter gene assay ( ic50 = 1 . 9 μm ) . moreover , gefitinib displayed a higher off-target inhibition of mnk2 ( 3 7 ) than 6c but was less potent in our reporter gene assay . thus , mnk2 could be excluded as a potential target of the dual inhibitors in the nf-κb activation pathway . the inhibition of pim-1 by 6c was also rather weak , nevertheless , we decided to check the potential role of pim-1 in the nf-κb activation pathway using the potent pim-1 inhibitor sim-4a ( ic50 for pim-1: 1 7 nm at 1 0 0 μm atp in the cell-free assay ( 3 8 ) ) . testing sim-4a in the nf-κb reporter gene assay in concentrations from 1', 'compound': '9b'}
====================
21
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
one atom makes all the difference: getting a foot in the door between sos1 and kras
nlpDict: 
single_dict: {'compound': 'bi-3406', 'ic50_mc': '4', 'ki_mc': '3 3 nm', 'kd_mc': '3', 'selectivity_mc': '20-fold', 'ic50_ce': '5 0 nm ) is 20-fold reduced compared to inhibitor 8 ( kd = 1 6 nm', 'ki_ce': '1 0 , which remained an activator , albeit with a 2–3-fold loss of binding affinity and activator activity . exchanging the 6-substituent for the larger chlorine atom ( compound 1 1 ) was sufficient to switch the molecule from an activator to an inhibitor despite the 4-fold loss of activity versus the hydrogen-containing compound 9 . the loss of activity for compound 1 1 is likely due to a repulsive interaction between the electronegative chlorine atom and π-electrons of y884 . this clearly shows that ppi inhibition is caused by sterics and is independent of affinity . the addition of a methoxy group capable of forming attractive ch−π interactions with y884 results in the inhibitor compound 1 2 , which displayed a significantly improved affinity ( kd = 2 4', 'kd_ce': '3 5 0 nm ) is 20-fold reduced compared to inhibitor 8 ( kd = 1', 'ec50_ce': '2 4', 'selectivity_ce': '2 5 0', 'herg_ce': '2 5', 'ed50_an': '7 was only marginally improved compared to compound 4 , we decided to combine both meta-substituents into a single molecule ( compound 8 ) as the overlay', 'bioavailability_an': '1 6', 'compound_drug': 'bi-3406 blocks the negative feedback relief induced by downstream mek inhibition . ( 3 3 , 4 2 ) accordingly , the combination of bi-3406 with the mek inhibitor trametinib elicited strong antitumor efficacy in kras-mutant xenograft models . the concept of dual sos1 and mek inhibition is currently being tested in clinical trials . ( 3 5 ) to demonstrate the utility of bi-3406 as an sos1 probe molecule and further elaborate the potential of sos1 inhibition in cancer combination therapies , we tested the effects of vertical pathway co-inhibition by combining bi-3406 with the egfr inhibitor afatinib . in dld-1 krasg13d mutant colorectal tumor cells , dual pathway inhibition of sos1i and afatinib leads to enhanced parp cleavage , a marker for apoptosis induction ( figure 9a ) . the effect of this combination on parp cleavage is of similar magnitude as the effect of the bi-3406 plus trametinib combination . in agreement with the in vitro data , combination of bi-3406 with afatinib resulted in significantly enhanced efficacy compared to both monotherapies in a dld-1 xenograft model ( figure 9b ) . this combination concept is in line with recent reports describing marked synergy of the anti-egfr antibody cetuximab with krasg12c'}

original_dict: {'ic50_mc': '4', 'ki_mc': '3 3 nm', 'kd_mc': '3', 'selectivity_mc': '20-fold', 'ic50_ce': '5 0 nm ) is 20-fold reduced compared to inhibitor 8 ( kd = 1 6 nm', 'ki_ce': '1 0 , which remained an activator , albeit with a 2–3-fold loss of binding affinity and activator activity . exchanging the 6-substituent for the larger chlorine atom ( compound 1 1 ) was sufficient to switch the molecule from an activator to an inhibitor despite the 4-fold loss of activity versus the hydrogen-containing compound 9 . the loss of activity for compound 1 1 is likely due to a repulsive interaction between the electronegative chlorine atom and π-electrons of y884 . this clearly shows that ppi inhibition is caused by sterics and is independent of affinity . the addition of a methoxy group capable of forming attractive ch−π interactions with y884 results in the inhibitor compound 1 2 , which displayed a significantly improved affinity ( kd = 2 4', 'kd_ce': '3 5 0 nm ) is 20-fold reduced compared to inhibitor 8 ( kd = 1', 'ec50_ce': '2 4', 'selectivity_ce': '2 5 0', 'herg_ce': '2 5', 'solubility_ce': '3', 'ed50_an': '7 was only marginally improved compared to compound 4 , we decided to combine both meta-substituents into a single molecule ( compound 8 ) as the overlay', 't_half_an': '3', 'auc_an': '2 5 0', 'bioavailability_an': '1 6', 'compound_drug': 'bi-3406', 'compound': 'bi-3406'}
====================
22
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
development of selective clk1 and -4 inhibitors for cellular depletion of cancer-relevant proteins
nlpDict: 
single_dict: {'compound': '21b', 'ic50_mc': '6 . 9', 'ki_mc': '2 0 6 nm', 'kd_mc': '2', 'selectivity_mc': '1 were shorter , had fewer splicing factor binding sites and', 'ki_ce': '1 1', 'selectivity_ce': '2 1', 'herg_ce': '1 0 0', 'ed50_an': '2 . 8 μm , respectively ) . intriguingly , these two cell lines also exhibited the highest mrna and protein expression levels of clk1 . in contrast , both thp-1 and t47d were considerably less sensitive toward our inhibitors , which correlated with lower mrna and protein expression levels of clk1 . in line with this relationship , the mda-mb-231 cell line showed moderate sensitivity toward 21b and intermediate clk1 expression ( table 4 ) . altogether , our', 'auc_an': '2 0 μm ) . again , all other proteins in the analyzed panel remained unchanged , with respect to amount and size . thus , in both t24 and mda-mb-231 cells , the effect of 21b on egfr might be a major reason for the suppression of cell growth because the ic50 values for egfr depletion were in good agreement with the respective gi50 values . in the light of this finding , it was interesting to analyze the effects of 21b in the hepg2 cells , which lack a strong expression of egfr . ( 2 5 ) indeed , we could not detect any egfr protein signals in this cell line , indicating a rather low expression . on the other hand , although there was a 4 4 % reduction of both hdac1 and s6k protein levels at 2 0', 'bioavailability_an': '2 3', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion biological evaluation having identified the benzylamide derivative 16a as the most promising scaffold , we aimed at fine-tuning of the clk1 inhibitory potency through modulation of the π-electron density . the obtained sar indicated that this parameter strongly influenced the activity , with the electron withdrawing m-fluorine substitution being most advantageous . the resulting inhibitor 21b was more potent than the unsubstituted analog 16a , showing an ic50 of 7 nm ( table 3 ) . in contrast , the analogs with electron-donating methyl ( 24a ) or methoxy substituents ( 23b ) exhibited a substantially reduced activity compared with 16a . interestingly , fluorine was only favorable in the meta-position , since the ortho- and para-regioisomers ( 20b and 22b , respectively ) were also less active than 16a . in our binding model , the m-fluorophenyl ring was buried in a small , partially hydrophobic pocket in the lid of the atp-binding site ( figure 2 ) . while such a pocket was not induced by the type of compounds bound in the four available clk1 cocrystal structures , it was observed before in cocrystals of the highly homologous dyrk1a with compounds containing a branched 3-chlorobenzyl motif at the corresponding position ( cf . pdb entries 2wo6 and 2vx3 ) . ( 2 1 ) due to the limited size of this pocket , the m-methyl ( 24a ) , m-methoxy ( 23b'}

original_dict: {'ic50_mc': '6 . 9', 'ki_mc': '2 0 6 nm', 'kd_mc': '2', 'selectivity_mc': '1 were shorter , had fewer splicing factor binding sites and', 'ic50_ce': '2', 'ki_ce': '1 1', 'kd_ce': '2', 'ec50_ce': '2', 'selectivity_ce': '2 1', 'herg_ce': '1 0 0', 'solubility_ce': '2', 'ed50_an': '2 . 8 μm , respectively ) . intriguingly , these two cell lines also exhibited the highest mrna and protein expression levels of clk1 . in contrast , both thp-1 and t47d were considerably less sensitive toward our inhibitors , which correlated with lower mrna and protein expression levels of clk1 . in line with this relationship , the mda-mb-231 cell line showed moderate sensitivity toward 21b and intermediate clk1 expression ( table 4 ) . altogether , our', 't_half_an': '2', 'auc_an': '2 0 μm ) . again , all other proteins in the analyzed panel remained unchanged , with respect to amount and size . thus , in both t24 and mda-mb-231 cells , the effect of 21b on egfr might be a major reason for the suppression of cell growth because the ic50 values for egfr depletion were in good agreement with the respective gi50 values . in the light of this finding , it was interesting to analyze the effects of 21b in the hepg2 cells , which lack a strong expression of egfr . ( 2 5 ) indeed , we could not detect any egfr protein signals in this cell line , indicating a rather low expression . on the other hand , although there was a 4 4 % reduction of both hdac1 and s6k protein levels at 2 0', 'bioavailability_an': '2 3', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion biological evaluation having identified the benzylamide derivative 16a as the most promising scaffold , we aimed at fine-tuning of the clk1 inhibitory potency through modulation of the π-electron density . the obtained sar indicated that this parameter strongly influenced the activity , with the electron withdrawing m-fluorine substitution being most advantageous . the resulting inhibitor 21b was more potent than the unsubstituted analog 16a , showing an ic50 of 7 nm ( table 3 ) . in contrast , the analogs with electron-donating methyl ( 24a ) or methoxy substituents ( 23b ) exhibited a substantially reduced activity compared with 16a . interestingly , fluorine was only favorable in the meta-position , since the ortho- and para-regioisomers ( 20b and 22b , respectively ) were also less active than 16a . in our binding model , the m-fluorophenyl ring was buried in a small , partially hydrophobic pocket in the lid of the atp-binding site ( figure 2 ) . while such a pocket was not induced by the type of compounds bound in the four available clk1 cocrystal structures , it was observed before in cocrystals of the highly homologous dyrk1a with compounds containing a branched 3-chlorobenzyl motif at the corresponding position ( cf . pdb entries 2wo6 and 2vx3 ) . ( 2 1 ) due to the limited size of this pocket , the m-methyl ( 24a ) , m-methoxy ( 23b', 'compound': '21b'}
====================
23
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
bioisosteric discovery of npa101.3, a second-generation ret/vegfr2 inhibitor optimized for single-agent polypharmacology
nlpDict: 
single_dict: {'compound': 'npa101 . 3 , lacking the structural liability for demethylation . npa101 . 3 showed a selective inhibitory profile and an inhibitory concentration 5', 'ic50_mc': '3', 'ki_mc': '3 2 and 4 6 nm', 'kd_mc': '2 9', 'selectivity_mc': '1 , or 3 mg/kg/day p . o . ) of npa101 . 3 for 2 days and then performing western blot analysis on protein extracts . as shown in figure s11 , a 3 mg/kg/day dose of npa101 . 3 strongly inhibited ret autophosphorylation and signaling as well as vegfr2 phosphorylation . then , to determine antitumorigenic activity and to better distinguish ret- and vegfr2-mediated effects , we tested npa101 . 3 in nude mice transplanted with nih3t3 cells transformed by either ret/c634y or hras/g12v . before tumors appeared , animals were treated daily with npa101 . 3 ( 1 . 0 , 3 . 0 , or 1 0 . 0 mg/kg/day ) or left untreated . npa101 . 3 preferentially inhibited ret compared to ras-driven tumors . while 1 0 . 0 mg of compound/kg completely prevented tumor formation induced by oncogenic ret , the treatment reduced , but did not abrogate , formation of tumors driven by ras; moreover , at lower doses , the compound significantly reduced the rate of growth of ret-driven , but not ras-driven , tumors ( figure 6 ) . at 1 . 0 mg/kg , npa101 . 3 exhibited strong ret phosphorylation and signaling inhibition in nih3t3 ret/c634y tumors ( figure s12', 'ic50_ce': '3 2', 'ki_ce': '1 0 . 0', 'kd_ce': '3 2 and 4', 'herg_ce': '1 0', 'ed50_an': '9 , 34−36 ) npa101 . 3 was also predicted', 't_half_an': '6 . 1', 'auc_an': '1 , 3 2', 'compound_drug': 'pz-1'}

original_dict: {'ic50_mc': '3', 'ki_mc': '3 2 and 4 6 nm', 'kd_mc': '2 9', 'selectivity_mc': '1 , or 3 mg/kg/day p . o . ) of npa101 . 3 for 2 days and then performing western blot analysis on protein extracts . as shown in figure s11 , a 3 mg/kg/day dose of npa101 . 3 strongly inhibited ret autophosphorylation and signaling as well as vegfr2 phosphorylation . then , to determine antitumorigenic activity and to better distinguish ret- and vegfr2-mediated effects , we tested npa101 . 3 in nude mice transplanted with nih3t3 cells transformed by either ret/c634y or hras/g12v . before tumors appeared , animals were treated daily with npa101 . 3 ( 1 . 0 , 3 . 0 , or 1 0 . 0 mg/kg/day ) or left untreated . npa101 . 3 preferentially inhibited ret compared to ras-driven tumors . while 1 0 . 0 mg of compound/kg completely prevented tumor formation induced by oncogenic ret , the treatment reduced , but did not abrogate , formation of tumors driven by ras; moreover , at lower doses , the compound significantly reduced the rate of growth of ret-driven , but not ras-driven , tumors ( figure 6 ) . at 1 . 0 mg/kg , npa101 . 3 exhibited strong ret phosphorylation and signaling inhibition in nih3t3 ret/c634y tumors ( figure s12', 'ic50_ce': '3 2', 'ki_ce': '1 0 . 0', 'kd_ce': '3 2 and 4', 'ec50_ce': '3', 'selectivity_ce': '1 0 . 0', 'herg_ce': '1 0', 'solubility_ce': '3 2', 'ed50_an': '9 , 34−36 ) npa101 . 3 was also predicted', 't_half_an': '6 . 1', 'auc_an': '1 , 3 2', 'bioavailability_an': '2 9', 'compound_drug': 'pz-1', 'compound': 'npa101 . 3 , lacking the structural liability for demethylation . npa101 . 3 showed a selective inhibitory profile and an inhibitory concentration 5'}
====================
24
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
bioisosteric discovery of npa101.3, a second-generation ret/vegfr2 inhibitor optimized for single-agent polypharmacology
nlpDict: 
single_dict: {'compound': 'npa101 . 3 , lacking the structural liability for demethylation . npa101 . 3 showed a selective inhibitory profile and an inhibitory concentration 5', 'ic50_mc': '3', 'ki_mc': '3 2 and 4 6 nm', 'kd_mc': '2 9', 'selectivity_mc': '1 , or 3 mg/kg/day p . o . ) of npa101 . 3 for 2 days and then performing western blot analysis on protein extracts . as shown in figure s11 , a 3 mg/kg/day dose of npa101 . 3 strongly inhibited ret autophosphorylation and signaling as well as vegfr2 phosphorylation . then , to determine antitumorigenic activity and to better distinguish ret- and vegfr2-mediated effects , we tested npa101 . 3 in nude mice transplanted with nih3t3 cells transformed by either ret/c634y or hras/g12v . before tumors appeared , animals were treated daily with npa101 . 3 ( 1 . 0 , 3 . 0 , or 1 0 . 0 mg/kg/day ) or left untreated . npa101 . 3 preferentially inhibited ret compared to ras-driven tumors . while 1 0 . 0 mg of compound/kg completely prevented tumor formation induced by oncogenic ret , the treatment reduced , but did not abrogate , formation of tumors driven by ras; moreover , at lower doses , the compound significantly reduced the rate of growth of ret-driven , but not ras-driven , tumors ( figure 6 ) . at 1 . 0 mg/kg , npa101 . 3 exhibited strong ret phosphorylation and signaling inhibition in nih3t3 ret/c634y tumors ( figure s12', 'ic50_ce': '3 2', 'ki_ce': '1 0 . 0', 'kd_ce': '3 2 and 4', 'herg_ce': '1 0', 'ed50_an': '9 , 34−36 ) npa101 . 3 was also predicted', 't_half_an': '6 . 1', 'auc_an': '1 , 3 2', 'compound_drug': 'pz-1'}

original_dict: {'ic50_mc': '3', 'ki_mc': '3 2 and 4 6 nm', 'kd_mc': '2 9', 'selectivity_mc': '1 , or 3 mg/kg/day p . o . ) of npa101 . 3 for 2 days and then performing western blot analysis on protein extracts . as shown in figure s11 , a 3 mg/kg/day dose of npa101 . 3 strongly inhibited ret autophosphorylation and signaling as well as vegfr2 phosphorylation . then , to determine antitumorigenic activity and to better distinguish ret- and vegfr2-mediated effects , we tested npa101 . 3 in nude mice transplanted with nih3t3 cells transformed by either ret/c634y or hras/g12v . before tumors appeared , animals were treated daily with npa101 . 3 ( 1 . 0 , 3 . 0 , or 1 0 . 0 mg/kg/day ) or left untreated . npa101 . 3 preferentially inhibited ret compared to ras-driven tumors . while 1 0 . 0 mg of compound/kg completely prevented tumor formation induced by oncogenic ret , the treatment reduced , but did not abrogate , formation of tumors driven by ras; moreover , at lower doses , the compound significantly reduced the rate of growth of ret-driven , but not ras-driven , tumors ( figure 6 ) . at 1 . 0 mg/kg , npa101 . 3 exhibited strong ret phosphorylation and signaling inhibition in nih3t3 ret/c634y tumors ( figure s12', 'ic50_ce': '3 2', 'ki_ce': '1 0 . 0', 'kd_ce': '3 2 and 4', 'ec50_ce': '3', 'selectivity_ce': '1 0 . 0', 'herg_ce': '1 0', 'solubility_ce': '3 2', 'ed50_an': '9 , 34−36 ) npa101 . 3 was also predicted', 't_half_an': '6 . 1', 'auc_an': '1 , 3 2', 'bioavailability_an': '2 9', 'compound_drug': 'pz-1', 'compound': 'npa101 . 3 , lacking the structural liability for demethylation . npa101 . 3 showed a selective inhibitory profile and an inhibitory concentration 5'}
====================
25
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
7-aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors
nlpDict: 
single_dict: {'compound': '34a', 'ic50_mc': '4', 'ki_mc': '1 . 4 mg/kg', 'selectivity_mc': '1 . 4', 'ki_ce': '1', 'kd_ce': '4-n , n′-diphenyl ) ureas that potently inhibited a panel of vascular endothelial growth factor receptor ( vegfr ) and platelet-derived growth factor receptor ( pdgfr ) kinases . several of these compounds , such as <b> 34a </b> , are potent inhibitors of kinase insert domain-containing receptor tyrosine kinase ( kdr ) both enzymatically ( <10 nm ) and cellularly ( <10 nm ) . in addition , compound <b> 34a </b> possesses a favorable pharmacokinetic profile and demonstrates efficacy in the estradiol-induced murine uterine edema ( ue ) model ( ed50 = 1', 'solubility_ce': '7-aminopyrazolo[1 , 5-a]pyrimidine urea receptor tyrosine kinase inhibitors have been discovered . investigation of structure−activity relationships of the pyrazolo[1 , 5-a]pyrimidine nucleus led to a series of 6- ( 4-n , n′-diphenyl ) ureas that potently inhibited a panel of vascular endothelial growth factor receptor ( vegfr ) and platelet-derived growth factor receptor ( pdgfr ) kinases . several of these compounds , such as <b> 34a </b> , are potent inhibitors of kinase insert domain-containing receptor tyrosine kinase ( kdr ) both enzymatically ( <10', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] [CLS] what is the compound in this paper ? [SEP] 7-aminopyrazolo[1 , 5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors 7-aminopyrazolo[1 , 5-a]pyrimidine urea receptor tyrosine kinase inhibitors have been discovered . investigation of structure−activity relationships of the pyrazolo[1 , 5-a]pyrimidine nucleus led to a series of 6- ( 4-n , n′-diphenyl ) ureas that potently inhibited a panel of vascular endothelial growth factor receptor ( vegfr ) and platelet-derived growth factor receptor ( pdgfr ) kinases . several of these compounds , such as <b> 34a'}

original_dict: {'ic50_mc': '4', 'ki_mc': '1 . 4 mg/kg', 'selectivity_mc': '1 . 4', 'ic50_ce': '1 . 4 mg/kg', 'ki_ce': '1', 'kd_ce': '4-n , n′-diphenyl ) ureas that potently inhibited a panel of vascular endothelial growth factor receptor ( vegfr ) and platelet-derived growth factor receptor ( pdgfr ) kinases . several of these compounds , such as <b> 34a </b> , are potent inhibitors of kinase insert domain-containing receptor tyrosine kinase ( kdr ) both enzymatically ( <10 nm ) and cellularly ( <10 nm ) . in addition , compound <b> 34a </b> possesses a favorable pharmacokinetic profile and demonstrates efficacy in the estradiol-induced murine uterine edema ( ue ) model ( ed50 = 1', 'herg_ce': '1 . 4', 'solubility_ce': '7-aminopyrazolo[1 , 5-a]pyrimidine urea receptor tyrosine kinase inhibitors have been discovered . investigation of structure−activity relationships of the pyrazolo[1 , 5-a]pyrimidine nucleus led to a series of 6- ( 4-n , n′-diphenyl ) ureas that potently inhibited a panel of vascular endothelial growth factor receptor ( vegfr ) and platelet-derived growth factor receptor ( pdgfr ) kinases . several of these compounds , such as <b> 34a </b> , are potent inhibitors of kinase insert domain-containing receptor tyrosine kinase ( kdr ) both enzymatically ( <10', 'ed50_an': '1 . 4 mg/kg', 't_half_an': '1', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] [CLS] what is the compound in this paper ? [SEP] 7-aminopyrazolo[1 , 5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors 7-aminopyrazolo[1 , 5-a]pyrimidine urea receptor tyrosine kinase inhibitors have been discovered . investigation of structure−activity relationships of the pyrazolo[1 , 5-a]pyrimidine nucleus led to a series of 6- ( 4-n , n′-diphenyl ) ureas that potently inhibited a panel of vascular endothelial growth factor receptor ( vegfr ) and platelet-derived growth factor receptor ( pdgfr ) kinases . several of these compounds , such as <b> 34a', 'compound': '34a'}
====================
26
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
discovery of novel 2,4-diarylaminopyrimidine derivatives as potent and selective epidermal growth factor receptor (egfr) inhibitors against l858r/t790m resistance mutation
nlpDict: 
single_dict: {'compound': '8a', 'ic50_mc': '5', 'ki_mc': '2 0 % even at 2 0 mg/kg dose treatment . during the course of experiment , no obvious body weight loss of mice was observed in 8a treatment group both in nci-h1975 model ( fig . 6b ) and in a431 model ( fig . 6d ) , indicating this compound was well tolerated . the target inhibition of 8a in nci-h1975 and a431 tumor was investigated by western blot analysis . as shown in fig . 6e and f , 8a ( 1 0', 'kd_mc': '0 . 0', 'selectivity_mc': 'met790; the amine motif positions in the solvent exposed region . ( fig . 7', 'ic50_ce': '5 9', 'kd_ce': '2 0 mg/kg ) and azd9291 ( 1 0 mg/kg ) was used for comparison . as illustrated in fig . 6 a , 8a significantly and dose-dependently suppressed the tumor growth in nci-h1975 xenograft model , which was comparable with azd9291 . whereas , in a431 xenograft mouse model ( fig . 6c ) , 8a only exhibited moderate tumor growth inhibition , with tgi less than 2 0 % even at 2 0 mg/kg dose treatment . during the course of experiment , no obvious body weight loss of mice was observed in 8a treatment group both in nci-h1975 model ( fig . 6b ) and in a431 model ( fig . 6d ) , indicating this compound was well tolerated . the target inhibition of 8a in nci-h1975 and a431 tumor was investigated by western blot analysis . as shown in fig . 6e and f , 8a ( 1 0 mg/kg ) treatment significantly blocked the phosphorylation of egfr t790 m/l858r and the activation of downstream molecule akt in nci-h1975 cells ( ∗ p < 0 . 0', 'ec50_ce': '2 0 % even at 2 0 mg/kg dose treatment . during the course of experiment , no obvious body weight loss of mice was observed in 8a treatment group both in nci-h1975 model ( fig . 6b ) and in a431 model ( fig . 6d ) , indicating this compound was well tolerated . the target inhibition of 8a in nci-h1975 and a431 tumor was investigated by western blot analysis . as shown in fig . 6e and f , 8a ( 1 0 mg/kg ) treatment significantly blocked the phosphorylation of egfr t790 m/l858r and the activation of downstream molecule akt in nci-h1975 cells ( ∗ p < 0 . 0', 'selectivity_ce': '1 6', 'herg_ce': '124-fold and 148-fold selectivity over a431 cells', 'solubility_ce': '8a , 8b , 8f , 8j and 8m were chosen to further evaluate their anti-proliferative activities against the a431 epidermoid carcinoma cell line and the nci-h1975 non-small cell lung cancer cell line , which expressed high levels of egfr wt or egfr t790 m/l858r , respectively . as shown in table 2 , all compounds demonstrated comparable anti-proliferative activities against nci-h1975 cells to that of azd9291 , and displayed less inhibition of the growth of a431 cells . intriguingly , compounds 8a and 8f showed 124-fold and', 'ed50_an': '4 . 1 nm ) , while other heterocycle such as 1-methyl-1h-1 , 2 , 4-triazole was well tolerated ( 8h and 8m ) . the hydrophilic motif r showed a great impact on activities . the ether linked analogue 8b was a replacement that was tolerated which resulted in a very similar profile with a slight erosion in kinase inhibition potency ( egfr t790 m/l858r ic50 = 1 6 . 4 nm ) and a loss in selectivity . when the r was replaced with other amines such as piperazine and morpholine , the inhibitory activities against egfr wt and egfr t790 m/l858r were diminished significantly ( 8c , 8g ) , in some cases resulted in a complete loss of potency ( 8d , 8e and 8h ) . as mentioned in a previous study [17] , they employed a glutathione ( gsh ) reaction assay to determine the relative reactivity of inhibtiors , results showed a dependence of gsh half-life on the pka of the basic group . the intramolecular base', 't_half_an': '1 0 mg/kg or 2 0 mg/kg ) and azd9291 ( 1 0 mg/kg ) was used for comparison . as illustrated in fig . 6 a , 8a significantly and dose-dependently suppressed the tumor growth in nci-h1975 xenograft model , which was comparable with azd9291 . whereas , in a431 xenograft mouse model ( fig . 6c ) , 8a only exhibited moderate tumor growth inhibition , with tgi less than 2 0 % even at 2 0 mg/kg dose treatment . during the course of experiment , no obvious body weight loss of mice was observed in 8a treatment group both in nci-h1975 model ( fig . 6b ) and in a431 model ( fig . 6d ) , indicating this compound was well tolerated . the target inhibition of 8a in nci-h1975 and a431 tumor was investigated by western blot analysis . as shown in fig . 6e and f , 8a ( 1 0 mg/kg ) treatment significantly blocked the phosphorylation of egfr t790 m/l858r and the activation of downstream molecule akt in nci-h1975 cells ( ∗ p < 0 . 0 5', 'auc_an': '8f showed 124-fold and 148-fold selectivity over a431 cells', 'bioavailability_an': '1 6 . 4 nm ) and a loss in selectivity . when the r was replaced with other amines such as piperazine and morpholine , the inhibitory activities against egfr wt and egfr t790 m/l858r were diminished significantly ( 8c , 8g', 'compound_drug': 'azd9291'}

original_dict: {'ic50_mc': '5', 'ki_mc': '2 0 % even at 2 0 mg/kg dose treatment . during the course of experiment , no obvious body weight loss of mice was observed in 8a treatment group both in nci-h1975 model ( fig . 6b ) and in a431 model ( fig . 6d ) , indicating this compound was well tolerated . the target inhibition of 8a in nci-h1975 and a431 tumor was investigated by western blot analysis . as shown in fig . 6e and f , 8a ( 1 0', 'kd_mc': '0 . 0', 'selectivity_mc': 'met790; the amine motif positions in the solvent exposed region . ( fig . 7', 'ic50_ce': '5 9', 'ki_ce': '5', 'kd_ce': '2 0 mg/kg ) and azd9291 ( 1 0 mg/kg ) was used for comparison . as illustrated in fig . 6 a , 8a significantly and dose-dependently suppressed the tumor growth in nci-h1975 xenograft model , which was comparable with azd9291 . whereas , in a431 xenograft mouse model ( fig . 6c ) , 8a only exhibited moderate tumor growth inhibition , with tgi less than 2 0 % even at 2 0 mg/kg dose treatment . during the course of experiment , no obvious body weight loss of mice was observed in 8a treatment group both in nci-h1975 model ( fig . 6b ) and in a431 model ( fig . 6d ) , indicating this compound was well tolerated . the target inhibition of 8a in nci-h1975 and a431 tumor was investigated by western blot analysis . as shown in fig . 6e and f , 8a ( 1 0 mg/kg ) treatment significantly blocked the phosphorylation of egfr t790 m/l858r and the activation of downstream molecule akt in nci-h1975 cells ( ∗ p < 0 . 0', 'ec50_ce': '2 0 % even at 2 0 mg/kg dose treatment . during the course of experiment , no obvious body weight loss of mice was observed in 8a treatment group both in nci-h1975 model ( fig . 6b ) and in a431 model ( fig . 6d ) , indicating this compound was well tolerated . the target inhibition of 8a in nci-h1975 and a431 tumor was investigated by western blot analysis . as shown in fig . 6e and f , 8a ( 1 0 mg/kg ) treatment significantly blocked the phosphorylation of egfr t790 m/l858r and the activation of downstream molecule akt in nci-h1975 cells ( ∗ p < 0 . 0', 'selectivity_ce': '1 6', 'herg_ce': '124-fold and 148-fold selectivity over a431 cells', 'solubility_ce': '8a , 8b , 8f , 8j and 8m were chosen to further evaluate their anti-proliferative activities against the a431 epidermoid carcinoma cell line and the nci-h1975 non-small cell lung cancer cell line , which expressed high levels of egfr wt or egfr t790 m/l858r , respectively . as shown in table 2 , all compounds demonstrated comparable anti-proliferative activities against nci-h1975 cells to that of azd9291 , and displayed less inhibition of the growth of a431 cells . intriguingly , compounds 8a and 8f showed 124-fold and', 'ed50_an': '4 . 1 nm ) , while other heterocycle such as 1-methyl-1h-1 , 2 , 4-triazole was well tolerated ( 8h and 8m ) . the hydrophilic motif r showed a great impact on activities . the ether linked analogue 8b was a replacement that was tolerated which resulted in a very similar profile with a slight erosion in kinase inhibition potency ( egfr t790 m/l858r ic50 = 1 6 . 4 nm ) and a loss in selectivity . when the r was replaced with other amines such as piperazine and morpholine , the inhibitory activities against egfr wt and egfr t790 m/l858r were diminished significantly ( 8c , 8g ) , in some cases resulted in a complete loss of potency ( 8d , 8e and 8h ) . as mentioned in a previous study [17] , they employed a glutathione ( gsh ) reaction assay to determine the relative reactivity of inhibtiors , results showed a dependence of gsh half-life on the pka of the basic group . the intramolecular base', 't_half_an': '1 0 mg/kg or 2 0 mg/kg ) and azd9291 ( 1 0 mg/kg ) was used for comparison . as illustrated in fig . 6 a , 8a significantly and dose-dependently suppressed the tumor growth in nci-h1975 xenograft model , which was comparable with azd9291 . whereas , in a431 xenograft mouse model ( fig . 6c ) , 8a only exhibited moderate tumor growth inhibition , with tgi less than 2 0 % even at 2 0 mg/kg dose treatment . during the course of experiment , no obvious body weight loss of mice was observed in 8a treatment group both in nci-h1975 model ( fig . 6b ) and in a431 model ( fig . 6d ) , indicating this compound was well tolerated . the target inhibition of 8a in nci-h1975 and a431 tumor was investigated by western blot analysis . as shown in fig . 6e and f , 8a ( 1 0 mg/kg ) treatment significantly blocked the phosphorylation of egfr t790 m/l858r and the activation of downstream molecule akt in nci-h1975 cells ( ∗ p < 0 . 0 5', 'auc_an': '8f showed 124-fold and 148-fold selectivity over a431 cells', 'bioavailability_an': '1 6 . 4 nm ) and a loss in selectivity . when the r was replaced with other amines such as piperazine and morpholine , the inhibitory activities against egfr wt and egfr t790 m/l858r were diminished significantly ( 8c , 8g', 'compound_drug': 'azd9291', 'compound': '8a'}
====================
27
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
6,7-dimorpholinoalkoxy quinazoline derivatives as potent egfr inhibitors with enhanced antiproliferative activities against tumor cells
nlpDict: 
single_dict: {'compound': '8d', 'ic50_mc': '7 . 0', 'ki_mc': '6 , 7-position of quinazoline core , such as 8e and 8f , can afford similar antiproliferative activities as gefitinib against hcc827 cells . and the bioactive contribution of the bis ( 3-morpholinopropoxy ) group at 6 , 7-position of scaffold , was also consistent with the antiproliferative activities of 1b and 8d-8f against', 'kd_mc': '2 1 . 1 7', 'selectivity_mc': '9 0 8', 'ki_ce': '2 1 . 1', 'kd_ce': '2 1', 'ec50_ce': '0 . 2', 'selectivity_ce': '9 0 8 å', 'herg_ce': '2 3 5 . 5 nm ) . the inhibitory activities of 1b and 8d against above two egfr-tk were consistent with cellular antiproliferative effects observed in cells expressing wild type egfr ( a431 , a549 and sw480 cells ) and cells harboring gefitinib-sensitive egfr mutant del e746-a750 in exon 1 9 ( hcc827 cells ) . the inhibition on the egfrl858r/t790m-tk of 8d , 1b and gefitinib was less than 5', 'ed50_an': '3-morpholinopropoxy ) moiety of 8d to the residue lys745 with the length of', 't_half_an': '1 . 1 7', 'bioavailability_an': '1 . 0 5 3 å . the docking results revealed that 8d was involved in a different pose compared with lapatinib . as shown in fig . 3 , compound 8d formed a hydrogen bond ( 2 . 0 5 5 å', 'compound_drug': 't202/y204'}

original_dict: {'ic50_mc': '7 . 0', 'ki_mc': '6 , 7-position of quinazoline core , such as 8e and 8f , can afford similar antiproliferative activities as gefitinib against hcc827 cells . and the bioactive contribution of the bis ( 3-morpholinopropoxy ) group at 6 , 7-position of scaffold , was also consistent with the antiproliferative activities of 1b and 8d-8f against', 'kd_mc': '2 1 . 1 7', 'selectivity_mc': '9 0 8', 'ic50_ce': '2 1 . 1 7', 'ki_ce': '2 1 . 1', 'kd_ce': '2 1', 'ec50_ce': '0 . 2', 'selectivity_ce': '9 0 8 å', 'herg_ce': '2 3 5 . 5 nm ) . the inhibitory activities of 1b and 8d against above two egfr-tk were consistent with cellular antiproliferative effects observed in cells expressing wild type egfr ( a431 , a549 and sw480 cells ) and cells harboring gefitinib-sensitive egfr mutant del e746-a750 in exon 1 9 ( hcc827 cells ) . the inhibition on the egfrl858r/t790m-tk of 8d , 1b and gefitinib was less than 5', 'solubility_ce': '2 1 . 1 7', 'ed50_an': '3-morpholinopropoxy ) moiety of 8d to the residue lys745 with the length of', 't_half_an': '1 . 1 7', 'auc_an': '2 3 5 . 5 nm ) . the inhibitory activities of 1b and 8d against above two egfr-tk were consistent with cellular antiproliferative effects observed in cells expressing wild type egfr ( a431 , a549 and sw480 cells ) and cells harboring gefitinib-sensitive egfr mutant del e746-a750 in exon 1 9 ( hcc827 cells ) . the inhibition on the egfrl858r/t790m-tk of 8d , 1b and gefitinib was less than 5', 'bioavailability_an': '1 . 0 5 3 å . the docking results revealed that 8d was involved in a different pose compared with lapatinib . as shown in fig . 3 , compound 8d formed a hydrogen bond ( 2 . 0 5 5 å', 'compound_drug': 't202/y204', 'compound': '8d'}
====================
28
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential egfr inhibitory activity
nlpDict: 
single_dict: {'compound': '7b', 'ic50_mc': '1 1 . 4 7', 'ki_mc': '2 4 h with 1 0 μm from each tested compound . the obtained results are shown in fig . 5 . the total percent of cell death are represented in table 6 . compounds 7b and 1 0 proved to induce apoptosis by 1 3 . 7 7', 'kd_mc': '4 5 . 8 and 2 2 . 9', 'selectivity_mc': '7', 'ic50_ce': '1 2 μm', 'ki_ce': '1 0', 'kd_ce': '2 7 . 3 , 4 6 . 1 and 6 6 . 3 ppm for ch3 and ch2 , also two signals were observed at 1 6 3', 'ec50_ce': '2h', 'herg_ce': '1 2', 'solubility_ce': '4 6 . 4', 'ed50_an': '3 in compound', 't_half_an': '3', 'auc_an': '1 6 1 2', 'bioavailability_an': '1 6', 'compound_drug': "<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] 5 and 3 . 6 2 ppm due to the morpholinyl protons , in addition to the aromatic protons that were observed as multiplet in the region of 6 . 95–8 . 6 3 ppm . from the previous data it's clear that the condensation reaction which occurred upon reacting phenylenediamine with isatin derivatives depends on the position of the second amino group . as shown in scheme 2 , p-phenylenediamine reacts with additional molecule of isatin derivative 1 , while in case of o-phenylenediamine , schiff's bases in presence of carbonyl group in position two in isatin ( indol-2 , 3-dione ) , smoothly causes condensation and cyclization to produce quinoxaline nucleus . spectral data supported both structures 3 and 4 as we have mentioned . treatment of compound 1 with 1 , 6-diaminopyridone derivative afforded the corresponding schiff's base derivative 5 ( scheme 1"}

original_dict: {'ic50_mc': '1 1 . 4 7', 'ki_mc': '2 4 h with 1 0 μm from each tested compound . the obtained results are shown in fig . 5 . the total percent of cell death are represented in table 6 . compounds 7b and 1 0 proved to induce apoptosis by 1 3 . 7 7', 'kd_mc': '4 5 . 8 and 2 2 . 9', 'selectivity_mc': '7', 'ic50_ce': '1 2 μm', 'ki_ce': '1 0', 'kd_ce': '2 7 . 3 , 4 6 . 1 and 6 6 . 3 ppm for ch3 and ch2 , also two signals were observed at 1 6 3', 'ec50_ce': '2h', 'selectivity_ce': '1 0', 'herg_ce': '1 2', 'solubility_ce': '4 6 . 4', 'ed50_an': '3 in compound', 't_half_an': '3', 'auc_an': '1 6 1 2', 'bioavailability_an': '1 6', 'compound_drug': "<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] 5 and 3 . 6 2 ppm due to the morpholinyl protons , in addition to the aromatic protons that were observed as multiplet in the region of 6 . 95–8 . 6 3 ppm . from the previous data it's clear that the condensation reaction which occurred upon reacting phenylenediamine with isatin derivatives depends on the position of the second amino group . as shown in scheme 2 , p-phenylenediamine reacts with additional molecule of isatin derivative 1 , while in case of o-phenylenediamine , schiff's bases in presence of carbonyl group in position two in isatin ( indol-2 , 3-dione ) , smoothly causes condensation and cyclization to produce quinoxaline nucleus . spectral data supported both structures 3 and 4 as we have mentioned . treatment of compound 1 with 1 , 6-diaminopyridone derivative afforded the corresponding schiff's base derivative 5 ( scheme 1", 'compound': '7b'}
====================
29
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
synthesis and biological evaluation of morpholine-substituted diphenylpyrimidine derivatives (mor-dppys) as potent egfr t790m inhibitors with improved activity toward the gefitinib-resistant non-small cell lung cancers (nsclc)
nlpDict: 
single_dict: {'compound': '10c', 'ic50_mc': '0 . 7 1', 'ki_mc': '2 4 . 8 nm', 'kd_mc': '1 7 . 0 nm ) , or a chloride atom at c-3′ position ( compound 10e with an ic50 of more than 1 0 0 nm ) are uneffective . when the methylene linker was replaced by an acetamide linker , the yielded compounds 10f and 10g only exhibited moderate activity against the egfrt790m/l858r kinase , with ic50 values of 9 6 . 6 nm and 1 0 0 . 5 nm , respectively . notably , the class of compounds 10h-l , which bear an acryl amide functional group at the c-2″ position of the c-4 aniline side chain , were also potent to inhibit the egfrt790m activity , possessing the ic50 values in the range of 1 3 . 4 nm', 'selectivity_mc': '7', 'ic50_ce': '2 ) a covalent bond between the acryl amide and the amino acid cys797; ( 2 ) van der walls force produced by the c-5 chlorine atom in pyrimidine core with the mutant gatekeeper amino acid met790 . the major difference in egfrt790m binding models is that there is less distance between the c-5 chlorine atom of 10c ( 3 . 7 4 å ) and met790 than in wz4002 ( 3 . 8', 'ki_ce': '1 0 0', 'kd_ce': '2 9 9 μm ) , compound 10c showed approximately 8 times higher inhibitory potency against h1975 cells . when it comes to the activity against the wild type a431 cells , most of these molecules displayed stronger inhibitory capability than rociletinib ( ic50 = 1', 'ec50_ce': '7 9', 'selectivity_ce': '1 0', 'herg_ce': '1 . 6 6 2 μm . moreover , all mor-dppy analogues were also tested the cytotoxic activity against the normal hbe cells , which showed that these inhibitors are not sensitive to the normal hbe cells with concentrations up to 4 0', 'solubility_ce': '3 . 7 4 å ) and met790 than in wz4002 ( 3 . 8 2', 'ed50_an': '7a-g , these molecules slightly reduced the anti-egfrt790m/l858r activity . whereas , with the', 't_half_an': '3 . 7', 'auc_an': '1 . 7 9 4', 'bioavailability_an': '2 4 . 8', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion chemistry the title molecules 10a-l were prepared according to the general strategy [26 , 27] , as shown in schemes 1–5 . commercially available material anilines 11a-c were converted to acrylamide-substituted phenols and acrylamide-substituted anilines 12a-c by reacting with acryloyl chloride in almost quantitative yields . anilines 12a-c regioselectively reacted with the 4-chloro atom of the 2 , 4-dichloropyrimidine reagent in the presence of n , n-diisopropylethylamine ( dipea ) to produce the key pyrimidine intermediates 13a-d . finally , the desired diphenylpyrimidine derivatives 10a-c , f , g , h were conveniently synthesized by coupling various morpholine-substituted anilines with pyrimidines 13a-d . the key intermediates morpholine-substituted anilines 1 8 , 2 3 , 2 7 , 3 1 were prepared as specified in schemes 2–4 through classical nucleophilic substitution , acylation , and reduction reactions [28–31] . after coupling various morpholine-substituted anilines with the 2-chloropyrimidines 13a-d utilizing trifluoroacetic acid ( tfa ) reagent at reflux temperature , the desired molecules 10d-e'}

original_dict: {'ic50_mc': '0 . 7 1', 'ki_mc': '2 4 . 8 nm', 'kd_mc': '1 7 . 0 nm ) , or a chloride atom at c-3′ position ( compound 10e with an ic50 of more than 1 0 0 nm ) are uneffective . when the methylene linker was replaced by an acetamide linker , the yielded compounds 10f and 10g only exhibited moderate activity against the egfrt790m/l858r kinase , with ic50 values of 9 6 . 6 nm and 1 0 0 . 5 nm , respectively . notably , the class of compounds 10h-l , which bear an acryl amide functional group at the c-2″ position of the c-4 aniline side chain , were also potent to inhibit the egfrt790m activity , possessing the ic50 values in the range of 1 3 . 4 nm', 'selectivity_mc': '7', 'ic50_ce': '2 ) a covalent bond between the acryl amide and the amino acid cys797; ( 2 ) van der walls force produced by the c-5 chlorine atom in pyrimidine core with the mutant gatekeeper amino acid met790 . the major difference in egfrt790m binding models is that there is less distance between the c-5 chlorine atom of 10c ( 3 . 7 4 å ) and met790 than in wz4002 ( 3 . 8', 'ki_ce': '1 0 0', 'kd_ce': '2 9 9 μm ) , compound 10c showed approximately 8 times higher inhibitory potency against h1975 cells . when it comes to the activity against the wild type a431 cells , most of these molecules displayed stronger inhibitory capability than rociletinib ( ic50 = 1', 'ec50_ce': '7 9', 'selectivity_ce': '1 0', 'herg_ce': '1 . 6 6 2 μm . moreover , all mor-dppy analogues were also tested the cytotoxic activity against the normal hbe cells , which showed that these inhibitors are not sensitive to the normal hbe cells with concentrations up to 4 0', 'solubility_ce': '3 . 7 4 å ) and met790 than in wz4002 ( 3 . 8 2', 'ed50_an': '7a-g , these molecules slightly reduced the anti-egfrt790m/l858r activity . whereas , with the', 't_half_an': '3 . 7', 'auc_an': '1 . 7 9 4', 'bioavailability_an': '2 4 . 8', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion chemistry the title molecules 10a-l were prepared according to the general strategy [26 , 27] , as shown in schemes 1–5 . commercially available material anilines 11a-c were converted to acrylamide-substituted phenols and acrylamide-substituted anilines 12a-c by reacting with acryloyl chloride in almost quantitative yields . anilines 12a-c regioselectively reacted with the 4-chloro atom of the 2 , 4-dichloropyrimidine reagent in the presence of n , n-diisopropylethylamine ( dipea ) to produce the key pyrimidine intermediates 13a-d . finally , the desired diphenylpyrimidine derivatives 10a-c , f , g , h were conveniently synthesized by coupling various morpholine-substituted anilines with pyrimidines 13a-d . the key intermediates morpholine-substituted anilines 1 8 , 2 3 , 2 7 , 3 1 were prepared as specified in schemes 2–4 through classical nucleophilic substitution , acylation , and reduction reactions [28–31] . after coupling various morpholine-substituted anilines with the 2-chloropyrimidines 13a-d utilizing trifluoroacetic acid ( tfa ) reagent at reflux temperature , the desired molecules 10d-e', 'compound': '10c'}
====================
30
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor
nlpDict: 
single_dict: {'compound': '12c', 'ic50_mc': '2 . 9 7', 'ki_mc': '4 . 9 2 μm', 'kd_mc': '6 shows the binding poses of the two active compounds 12c and 12e in the binding pocket of egfr . as illustrated in fig . 6 , the binding modes of 12c and 12e from md simulated results are nearly the same as the docked structures . the quinazoline moiety inserts into deep hydrophobic pocket , the aniline moiety is deeply in the back of the atp-binding pocket . the pyrazole substituent', 'selectivity_mc': '1 0', 'ic50_ce': '2 μm', 'ki_ce': '1 8', 'kd_ce': '3 , the redocked gefitinib is almost in the same position with co-crystallized gefitinib at the active site of egfr except the flexible long chain extending into the solvent accessible region , which have revealed that the high reliability of surflex-dock in reproducing the experimentally observed binding mode for the egfr inhibitors . therefore , surflex-dock method was used in search of the binding conformations of the newly synthesised compounds . all compounds , except 2-amino-quinazoline derivatives 1', 'ec50_ce': '1 0 0 μm ) . some of the synthesized compounds exhibited similar anti-proliferative activities as gefitinib against the three to four cell lines . specifically compounds 6 , 12d , 13a–13b , 1 8 , and 19a–19b showed higher antiproliferative activities than gefitinib against mcf-7 cell line . in addition , five compounds ( 12c–12e and 13c–13d ) exhibited remarkable inhibitory activity with the ic50 values ranging from 0 . 0 6 4 to 5 . 8 7 μm , which were comparable to that of gefitinib ( ic50 = 4 . 9', 'herg_ce': '6 , the binding modes of 12c and 12e from md simulated results are nearly the same as the docked structures . the quinazoline moiety inserts into deep hydrophobic pocket , the aniline moiety is deeply in the back of the atp-binding pocket', 'solubility_ce': '7a . the binding free energies were calculated by using mm-gbsa program in amber taking the last 1 0', 'ed50_an': '7a binding to egfr is approximately 3 kcal/mol more than that', 't_half_an': '4 . 9 2', 'auc_an': '1 0 0', 'bioavailability_an': '1 8 and 19a–19b , were successfully docked into the active site of egfr ( fig . 4', 'compound_drug': 't790m/l858r'}

original_dict: {'ic50_mc': '2 . 9 7', 'ki_mc': '4 . 9 2 μm', 'kd_mc': '6 shows the binding poses of the two active compounds 12c and 12e in the binding pocket of egfr . as illustrated in fig . 6 , the binding modes of 12c and 12e from md simulated results are nearly the same as the docked structures . the quinazoline moiety inserts into deep hydrophobic pocket , the aniline moiety is deeply in the back of the atp-binding pocket . the pyrazole substituent', 'selectivity_mc': '1 0', 'ic50_ce': '2 μm', 'ki_ce': '1 8', 'kd_ce': '3 , the redocked gefitinib is almost in the same position with co-crystallized gefitinib at the active site of egfr except the flexible long chain extending into the solvent accessible region , which have revealed that the high reliability of surflex-dock in reproducing the experimentally observed binding mode for the egfr inhibitors . therefore , surflex-dock method was used in search of the binding conformations of the newly synthesised compounds . all compounds , except 2-amino-quinazoline derivatives 1', 'ec50_ce': '1 0 0 μm ) . some of the synthesized compounds exhibited similar anti-proliferative activities as gefitinib against the three to four cell lines . specifically compounds 6 , 12d , 13a–13b , 1 8 , and 19a–19b showed higher antiproliferative activities than gefitinib against mcf-7 cell line . in addition , five compounds ( 12c–12e and 13c–13d ) exhibited remarkable inhibitory activity with the ic50 values ranging from 0 . 0 6 4 to 5 . 8 7 μm , which were comparable to that of gefitinib ( ic50 = 4 . 9', 'selectivity_ce': '1 0', 'herg_ce': '6 , the binding modes of 12c and 12e from md simulated results are nearly the same as the docked structures . the quinazoline moiety inserts into deep hydrophobic pocket , the aniline moiety is deeply in the back of the atp-binding pocket', 'solubility_ce': '7a . the binding free energies were calculated by using mm-gbsa program in amber taking the last 1 0', 'ed50_an': '7a binding to egfr is approximately 3 kcal/mol more than that', 't_half_an': '4 . 9 2', 'auc_an': '1 0 0', 'bioavailability_an': '1 8 and 19a–19b , were successfully docked into the active site of egfr ( fig . 4', 'compound_drug': 't790m/l858r', 'compound': '12c'}
====================
31
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
design, synthesis, and biological evaluation of a series of resorcinol-based n-benzyl benzamide derivatives as potent hsp90 inhibitors
nlpDict: 
single_dict: {'compound': '30f', 'ic50_mc': '5 . 3', 'ki_mc': '6', 'kd_mc': '1 6', 'selectivity_mc': '1 0 days after the treatment . the growth rates of the tumors were delayed at 1', 'ic50_ce': '2', 'ki_ce': '1 ) . alternatively , benzoic acids 10a-b was converted to amides 11a-b in 11–41% yields using edc , hobt and dipea in dmf , which was then reduced using lithium aluminum hydride to furnish benzyl amines 12a-b in 65–81% yields . we next synthesized compound 2 0 and 21a-h , which had chloro substituent on resorcinol ring ( scheme 2 ) . the synthesis of 2 0 and 21a-h commenced with esterification of commercially available 1 3 , providing ester 1 4 in 8 6 % yield . subsequent chlorination of 1 4 with sulfuryl chloride in dichloromethane gave 1 5 in 4 5 % yield . compound 1 5 was then protected with allyl bromide and potassium carbonate in dmf , quantitatively to furnish compound 1 6 . compound 1 6 was hydrolyzed with sodium hydroxide in methanol and water to give carboxylic acid 1 7 in 8 0 % yield . with carboxylic acid 1 7 and amine 9a-h in hand , we carried out amide coupling reactions of 1 7 with 9a-h or benzyl amine using edc , hobt and dipea in dmf , followed by cleavage of allyl-protecting group using pdcl2 ( pph3 ) 2 reaction , consequently to provide compound 2 0', 'kd_ce': '2 ) . the binding pose of 30f represented that n-propyl amide substituent on phenyl ring formed additional two hydrogen-bonding interactions with the carboxylate of asp102 and the amide of asn106 residues , as we anticipated by fragment-growing drug design from compound 21a in fig . 2', 'selectivity_ce': '1 4 with isopropyl bromide in the presence of aluminum chloride provided 2 4 in 4 6 % yield . subsequent hydrolysis of 2 4 with lithium hydroxide gave carboxylic acid 2 5 in 1 0', 'herg_ce': 'lower binding affinity to hsp90α', 'ed50_an': '3', 't_half_an': '2 ) . the binding pose of 30f represented that n-propyl amide substituent on phenyl ring formed additional two hydrogen-bonding interactions with the carboxylate of asp102 and the amide of asn106 residues , as we anticipated by fragment-growing drug design from compound 21a in fig', 'auc_an': '30f strongly bound to hsp90α with k d value of 3 . 0 8 nm ( supplementary fig . 1 ) . at this point in the discovery effort , 30f represented the most advanced analogue . it demonstrated the strongest binding affinity to hsp90α and the most potent cellular activity', 'bioavailability_an': '1 supported the assumption as well', 'compound_drug': '2xjx'}

original_dict: {'ic50_mc': '5 . 3', 'ki_mc': '6', 'kd_mc': '1 6', 'selectivity_mc': '1 0 days after the treatment . the growth rates of the tumors were delayed at 1', 'ic50_ce': '2', 'ki_ce': '1 ) . alternatively , benzoic acids 10a-b was converted to amides 11a-b in 11–41% yields using edc , hobt and dipea in dmf , which was then reduced using lithium aluminum hydride to furnish benzyl amines 12a-b in 65–81% yields . we next synthesized compound 2 0 and 21a-h , which had chloro substituent on resorcinol ring ( scheme 2 ) . the synthesis of 2 0 and 21a-h commenced with esterification of commercially available 1 3 , providing ester 1 4 in 8 6 % yield . subsequent chlorination of 1 4 with sulfuryl chloride in dichloromethane gave 1 5 in 4 5 % yield . compound 1 5 was then protected with allyl bromide and potassium carbonate in dmf , quantitatively to furnish compound 1 6 . compound 1 6 was hydrolyzed with sodium hydroxide in methanol and water to give carboxylic acid 1 7 in 8 0 % yield . with carboxylic acid 1 7 and amine 9a-h in hand , we carried out amide coupling reactions of 1 7 with 9a-h or benzyl amine using edc , hobt and dipea in dmf , followed by cleavage of allyl-protecting group using pdcl2 ( pph3 ) 2 reaction , consequently to provide compound 2 0', 'kd_ce': '2 ) . the binding pose of 30f represented that n-propyl amide substituent on phenyl ring formed additional two hydrogen-bonding interactions with the carboxylate of asp102 and the amide of asn106 residues , as we anticipated by fragment-growing drug design from compound 21a in fig . 2', 'ec50_ce': '2', 'selectivity_ce': '1 4 with isopropyl bromide in the presence of aluminum chloride provided 2 4 in 4 6 % yield . subsequent hydrolysis of 2 4 with lithium hydroxide gave carboxylic acid 2 5 in 1 0', 'herg_ce': 'lower binding affinity to hsp90α', 'solubility_ce': '2', 'ed50_an': '3', 't_half_an': '2 ) . the binding pose of 30f represented that n-propyl amide substituent on phenyl ring formed additional two hydrogen-bonding interactions with the carboxylate of asp102 and the amide of asn106 residues , as we anticipated by fragment-growing drug design from compound 21a in fig', 'auc_an': '30f strongly bound to hsp90α with k d value of 3 . 0 8 nm ( supplementary fig . 1 ) . at this point in the discovery effort , 30f represented the most advanced analogue . it demonstrated the strongest binding affinity to hsp90α and the most potent cellular activity', 'bioavailability_an': '1 supported the assumption as well', 'compound_drug': '2xjx', 'compound': '30f'}
====================
32
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
structure–activity relationship study of novel quinazoline-based 1,6-naphthyridinones as met inhibitors with potent antitumor efficacy
nlpDict: 
single_dict: {'compound': '22a', 'ic50_mc': '3 . 5', 'ki_mc': '7 . 1 nm ) led to the rotation of glu1127 sidechain and the disappearance of h-bond between 22c and glu1127 . however , the methyl can form hydrophobic interactions with the sidechain of met1131 , which makes up for the loss of binding energy caused by the loss of h-bond and therefore make 10l and 22c keep the enzyme activity at the same level . this was also can be observed from the free energy calculation result . although 22c has less contribution on δe ele than 10l , it has more contribution on δe vdw ( shown in table 4 ) . as shown in fig . 4d , after introduced a methoxyethyl group into n ( 1 ) in block c of 10l , there is a steric clash between the resulted compound 22e ( ic50 = 1 6 4 . 0 nm', 'kd_mc': '2 1 . 7', 'selectivity_mc': '7 . 1 nm ) led to the rotation of glu1127 sidechain and the disappearance of h-bond between 22c and glu1127 . however , the methyl can form hydrophobic interactions with the sidechain of met1131 , which makes up for the loss of binding energy caused by the loss of h-bond and therefore make 10l and 22c keep the enzyme activity at the same level . this was also can be observed from the free energy calculation result . although 22c has less contribution on δe ele than 10l , it has more contribution on δe vdw ( shown in table 4 ) . as shown in fig . 4d , after introduced a methoxyethyl group into n ( 1', 'ic50_ce': '2 . 0', 'kd_ce': '2 2 6', 'ec50_ce': '2 . 3 nm ) to that of 3 ( cabozantinib ) , and 10a-m and 10o-r showed good to moderate inhibition against vegfr-2 kinase with ic50 values ranging from 2 1 . 7 to 2 2 6 . 7', 'selectivity_ce': '1 2 . 3 nm ) to that of 3 ( cabozantinib ) , and 10a-m and 10o-r showed good to moderate inhibition against vegfr-2 kinase with ic50 values ranging from 2 1 . 7', 'herg_ce': '4 2 . 0 nm', 'solubility_ce': '2 1 . 7 to 2 2 6 . 7', 'ed50_an': '3 . 0 å ) between the c ( 4 ) carboxyl group in block c of 22c', 'auc_an': '1 2 . 3 nm ) to that of 3 ( cabozantinib ) , and 10a-m and 10o-r showed good to moderate inhibition against vegfr-2 kinase with ic50 values ranging from 2 1 . 7 to 2 2 6', 'bioavailability_an': '4 2 %', 'compound_drug': '10f'}

original_dict: {'ic50_mc': '3 . 5', 'ki_mc': '7 . 1 nm ) led to the rotation of glu1127 sidechain and the disappearance of h-bond between 22c and glu1127 . however , the methyl can form hydrophobic interactions with the sidechain of met1131 , which makes up for the loss of binding energy caused by the loss of h-bond and therefore make 10l and 22c keep the enzyme activity at the same level . this was also can be observed from the free energy calculation result . although 22c has less contribution on δe ele than 10l , it has more contribution on δe vdw ( shown in table 4 ) . as shown in fig . 4d , after introduced a methoxyethyl group into n ( 1 ) in block c of 10l , there is a steric clash between the resulted compound 22e ( ic50 = 1 6 4 . 0 nm', 'kd_mc': '2 1 . 7', 'selectivity_mc': '7 . 1 nm ) led to the rotation of glu1127 sidechain and the disappearance of h-bond between 22c and glu1127 . however , the methyl can form hydrophobic interactions with the sidechain of met1131 , which makes up for the loss of binding energy caused by the loss of h-bond and therefore make 10l and 22c keep the enzyme activity at the same level . this was also can be observed from the free energy calculation result . although 22c has less contribution on δe ele than 10l , it has more contribution on δe vdw ( shown in table 4 ) . as shown in fig . 4d , after introduced a methoxyethyl group into n ( 1', 'ic50_ce': '2 . 0', 'ki_ce': '2 . 0', 'kd_ce': '2 2 6', 'ec50_ce': '2 . 3 nm ) to that of 3 ( cabozantinib ) , and 10a-m and 10o-r showed good to moderate inhibition against vegfr-2 kinase with ic50 values ranging from 2 1 . 7 to 2 2 6 . 7', 'selectivity_ce': '1 2 . 3 nm ) to that of 3 ( cabozantinib ) , and 10a-m and 10o-r showed good to moderate inhibition against vegfr-2 kinase with ic50 values ranging from 2 1 . 7', 'herg_ce': '4 2 . 0 nm', 'solubility_ce': '2 1 . 7 to 2 2 6 . 7', 'ed50_an': '3 . 0 å ) between the c ( 4 ) carboxyl group in block c of 22c', 't_half_an': '2 . 0', 'auc_an': '1 2 . 3 nm ) to that of 3 ( cabozantinib ) , and 10a-m and 10o-r showed good to moderate inhibition against vegfr-2 kinase with ic50 values ranging from 2 1 . 7 to 2 2 6', 'bioavailability_an': '4 2 %', 'compound_drug': '10f', 'compound': '22a'}
====================
33
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones
nlpDict: 
single_dict: {'compound': '8', 'ic50_mc': '2 7 . 1 5 μg/ml', 'ki_mc': '9 3 6 , and 8 8 6 , 4 6 2 ) relative to their control ( 3 3 , 3 2 2 ) . in addition , the tumor suppressor gene p53 was also expressed strongly by the effect of both compounds with expression value ( 3 3 3 , 1 1 1', 'kd_mc': '2 . 4', 'selectivity_mc': '9', 'ki_ce': '1 1', 'kd_ce': '2 . 4 , and 2', 'ec50_ce': '3 3 3 , 1 1 1 ) for compound 5 and ( 4 4 0', 'selectivity_ce': '1 4', 'herg_ce': '1 1 ) for compound 5 and ( 4 4 0 , 2 7 2', 'solubility_ce': '3 3 3 , 1 1 1 ) for compound 5 and ( 4 4 0 , 2 7 2', 'ed50_an': '8 achieved four binding while one binding mode was achieved by compound', 't_half_an': '2 . 6', 'auc_an': '4 8 h at 3 7 °c , then the treated cells plus control were collected for real-time pcr analysis for the following six genes ( bax , p53 , caspase-3 , bcl2 , cdk4 , and mmp1 ) , using specific primers for each one ( experimental section ) . results in table 2 demonstrated that compounds 5 and 8 have strongly stimulated apoptotic induction of the human breast carcinoma ( mcf7 cells ) through induction of the proapoptotic protein bax with expression values ( 8 5 , 9 3 6 , and 8 8 6 , 4 6 2 ) relative to their control ( 3 3 , 3 2 2 ) . in addition , the tumor suppressor gene p53 was also expressed strongly by the effect of both compounds with expression value ( 3 3 3 , 1 1 1', 'bioavailability_an': '2 7', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion mtt assay cytotoxicity was performed on a novel series of tetrahydro[1 , 2 , 4]triazolo[3 , 4-a]isoquinoline chalcones derivatives 3–8 . the data obtained in table 1 indicated that all compounds exhibited strong to weak effect against all selected cancer cell lines . generally , breast carcinoma revealed higher and promising sensitivity with all prepared derivatives especially compounds 5'}

original_dict: {'ic50_mc': '2 7 . 1 5 μg/ml', 'ki_mc': '9 3 6 , and 8 8 6 , 4 6 2 ) relative to their control ( 3 3 , 3 2 2 ) . in addition , the tumor suppressor gene p53 was also expressed strongly by the effect of both compounds with expression value ( 3 3 3 , 1 1 1', 'kd_mc': '2 . 4', 'selectivity_mc': '9', 'ic50_ce': '2 . 4', 'ki_ce': '1 1', 'kd_ce': '2 . 4 , and 2', 'ec50_ce': '3 3 3 , 1 1 1 ) for compound 5 and ( 4 4 0', 'selectivity_ce': '1 4', 'herg_ce': '1 1 ) for compound 5 and ( 4 4 0 , 2 7 2', 'solubility_ce': '3 3 3 , 1 1 1 ) for compound 5 and ( 4 4 0 , 2 7 2', 'ed50_an': '8 achieved four binding while one binding mode was achieved by compound', 't_half_an': '2 . 6', 'auc_an': '4 8 h at 3 7 °c , then the treated cells plus control were collected for real-time pcr analysis for the following six genes ( bax , p53 , caspase-3 , bcl2 , cdk4 , and mmp1 ) , using specific primers for each one ( experimental section ) . results in table 2 demonstrated that compounds 5 and 8 have strongly stimulated apoptotic induction of the human breast carcinoma ( mcf7 cells ) through induction of the proapoptotic protein bax with expression values ( 8 5 , 9 3 6 , and 8 8 6 , 4 6 2 ) relative to their control ( 3 3 , 3 2 2 ) . in addition , the tumor suppressor gene p53 was also expressed strongly by the effect of both compounds with expression value ( 3 3 3 , 1 1 1', 'bioavailability_an': '2 7', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion mtt assay cytotoxicity was performed on a novel series of tetrahydro[1 , 2 , 4]triazolo[3 , 4-a]isoquinoline chalcones derivatives 3–8 . the data obtained in table 1 indicated that all compounds exhibited strong to weak effect against all selected cancer cell lines . generally , breast carcinoma revealed higher and promising sensitivity with all prepared derivatives especially compounds 5', 'compound': '8'}
====================
34
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
her2 kinase-targeted breast cancer therapy: design, synthesis, and in vitro and in vivo evaluation of novel lapatinib congeners as selective and potent her2 inhibitors with favorable metabolic stability
nlpDict: 
single_dict: {'compound': '17d', 'ic50_mc': '9 5 . 5', 'ki_mc': '3 9', 'kd_mc': '1 8 . 8', 'selectivity_mc': '1 0', 'ic50_ce': '8', 'kd_ce': '2', 'herg_ce': '1 0 μm', 'ed50_an': '0 . 4 μm ( figure s2 ) .', 't_half_an': '1 . 5', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] a quartet signal at δ 3 . 54–3 . 4 9 and a triplet signal at δ 2 . 69–2 . 6 6 were representing the four protons of the ethanolamine terminal in the target compound ( 10a ) , and two triplet signals at δ 2 . 55–3 . 6 9 were detected for the eight protons of the morpholino ring in compound ( 10b ) . another two broad singlet signals at δ 2 . 41–2 . 5 7 were assigned for the eight protons of the piperazino ring in compound ( 10c ) . an additional panel of novel target compounds ( 15a–l and 17a–d ) was prepared to study the structure–activity relationship ( sar ) and to enhance the selectivity , as shown in scheme 3 . the lapatinib anilino moiety at position 4 , namely , 3-chloro-4- ( ( 3-fluorobenzyl ) oxy ) aniline in scheme 2 , was replaced by substituted phenoxyaniline fragments to enhance the selectivity against her2 kinase , whereas the 6-acetamido linker was kept in compounds ( 15a–l ) or replaced by a bulkier 6-methyl benzamido linker in compounds ( 17a–d ) . reaction of 2-amino-5-nitrobenzonitrile ( 5 ) with triethylorthoformate in the presence of acetic anhydride produced the formimidate derivative ( 1 1 ) , which was then cyclized upon reflux with the appropriately substituted phenoxyaniline ( 4b–d ) to afford 6-nitro-4-anilinoquinazoline derivatives ( 12a–c'}

original_dict: {'ic50_mc': '9 5 . 5', 'ki_mc': '3 9', 'kd_mc': '1 8 . 8', 'selectivity_mc': '1 0', 'ic50_ce': '8', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '2', 'selectivity_ce': '1 0', 'herg_ce': '1 0 μm', 'solubility_ce': '2', 'ed50_an': '0 . 4 μm ( figure s2 ) .', 't_half_an': '1 . 5', 'auc_an': '1 0', 'bioavailability_an': '3 9', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] a quartet signal at δ 3 . 54–3 . 4 9 and a triplet signal at δ 2 . 69–2 . 6 6 were representing the four protons of the ethanolamine terminal in the target compound ( 10a ) , and two triplet signals at δ 2 . 55–3 . 6 9 were detected for the eight protons of the morpholino ring in compound ( 10b ) . another two broad singlet signals at δ 2 . 41–2 . 5 7 were assigned for the eight protons of the piperazino ring in compound ( 10c ) . an additional panel of novel target compounds ( 15a–l and 17a–d ) was prepared to study the structure–activity relationship ( sar ) and to enhance the selectivity , as shown in scheme 3 . the lapatinib anilino moiety at position 4 , namely , 3-chloro-4- ( ( 3-fluorobenzyl ) oxy ) aniline in scheme 2 , was replaced by substituted phenoxyaniline fragments to enhance the selectivity against her2 kinase , whereas the 6-acetamido linker was kept in compounds ( 15a–l ) or replaced by a bulkier 6-methyl benzamido linker in compounds ( 17a–d ) . reaction of 2-amino-5-nitrobenzonitrile ( 5 ) with triethylorthoformate in the presence of acetic anhydride produced the formimidate derivative ( 1 1 ) , which was then cyclized upon reflux with the appropriately substituted phenoxyaniline ( 4b–d ) to afford 6-nitro-4-anilinoquinazoline derivatives ( 12a–c', 'compound': '17d'}
====================
35
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: combined ligand and target-based approach
nlpDict: 
single_dict: {'compound': '3', 'ic50_mc': '9', 'ki_mc': '9 ± 0 . 5 and 1 4 ± 0 . 4 µm', 'kd_mc': '1 4', 'selectivity_mc': '7', 'ic50_ce': '2 0', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '1 2', 'herg_ce': '1 6 ± 0 . 3', 'ed50_an': '7 ) . a', 't_half_an': '0 . 5 µm ) . interestingly , compound 3 7 , a thieno[2 , 3-d]pyrimidine-4-thiol analogue , showed moderate inhibitory activity with an ic50 value of 1 6 ± 0 . 3 µm . the [1 , 2 , 4]triazolo[1 , 5-a]pyrimidin-7-amine scaffold containing compounds 3 8 and 3 9 also displayed moderate growth inhibition with ic50 values of 9 ± 0 . 5', 'auc_an': '1 4 , ( d ) mapping of hypo5 onto an inactive compound 2', 'bioavailability_an': '1 5', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion database screening the hypo5 model was used as a query to screen a database of 3 5 0 0 0 0 compounds . the search retrieved 9 6 1 hits ( 0 . 2 7 % of database ) . a set of 5 3 1 compounds with a predicted ic50 value < 1 µm were selected and docked onto the active and inactive states of her2 using gold , glide , and ehits . the hypo5 predicted activity and docking scores from all three docking algorithms were substituted in to consensus eqs and to predict activity for the 5 3 1 pharmacophore hits . finally , 5 7 hits with a predicted activity value of <100 µm were selected for an in vitro assay against the skbr3 cell line , a her2-overexpressing human breast cancer cell line . ( 16-18'}

original_dict: {'ic50_mc': '9', 'ki_mc': '9 ± 0 . 5 and 1 4 ± 0 . 4 µm', 'kd_mc': '1 4', 'selectivity_mc': '7', 'ic50_ce': '2 0', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '1 2', 'selectivity_ce': '2', 'herg_ce': '1 6 ± 0 . 3', 'solubility_ce': '2', 'ed50_an': '7 ) . a', 't_half_an': '0 . 5 µm ) . interestingly , compound 3 7 , a thieno[2 , 3-d]pyrimidine-4-thiol analogue , showed moderate inhibitory activity with an ic50 value of 1 6 ± 0 . 3 µm . the [1 , 2 , 4]triazolo[1 , 5-a]pyrimidin-7-amine scaffold containing compounds 3 8 and 3 9 also displayed moderate growth inhibition with ic50 values of 9 ± 0 . 5', 'auc_an': '1 4 , ( d ) mapping of hypo5 onto an inactive compound 2', 'bioavailability_an': '1 5', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion database screening the hypo5 model was used as a query to screen a database of 3 5 0 0 0 0 compounds . the search retrieved 9 6 1 hits ( 0 . 2 7 % of database ) . a set of 5 3 1 compounds with a predicted ic50 value < 1 µm were selected and docked onto the active and inactive states of her2 using gold , glide , and ehits . the hypo5 predicted activity and docking scores from all three docking algorithms were substituted in to consensus eqs and to predict activity for the 5 3 1 pharmacophore hits . finally , 5 7 hits with a predicted activity value of <100 µm were selected for an in vitro assay against the skbr3 cell line , a her2-overexpressing human breast cancer cell line . ( 16-18', 'compound': '3'}
====================
36
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
surmounting the resistance against egfr inhibitors through the development of thieno[2,3-d]pyrimidine-based dual egfr/her2 inhibitors
nlpDict: 
single_dict: {'compound': '27b', 'ic50_mc': '9 1 . 7', 'ki_mc': '18a showed the same binding modes as lapatinib in both egfr ( pdb: 3poz ) and her2 ( pdb: 3rcd ) ( exemplified by the binding modes of compound 2 1 in fig . 1 0', 'kd_mc': '1 5 and 18a showed the same binding modes as lapatinib in both egfr ( pdb: 3poz ) and her2 ( pdb: 3rcd ) ( exemplified by the binding modes of compound 2 1 in fig . 1 0', 'selectivity_mc': '68–87%', 'ic50_ce': '2', 'ki_ce': '1 0', 'ed50_an': '2 . 5 h followed by egf stimulation ( supplementary fig . s4 ) .', 't_half_an': '2 . 5', 'auc_an': '1 2 ) , and a negative correlation between the cellular activity and the psa ( fig . 1 3', 'bioavailability_an': '9 6', 'compound_drug': 'thr798/her2'}

original_dict: {'ic50_mc': '9 1 . 7', 'ki_mc': '18a showed the same binding modes as lapatinib in both egfr ( pdb: 3poz ) and her2 ( pdb: 3rcd ) ( exemplified by the binding modes of compound 2 1 in fig . 1 0', 'kd_mc': '1 5 and 18a showed the same binding modes as lapatinib in both egfr ( pdb: 3poz ) and her2 ( pdb: 3rcd ) ( exemplified by the binding modes of compound 2 1 in fig . 1 0', 'selectivity_mc': '68–87%', 'ic50_ce': '2', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '2', 'selectivity_ce': '1 5 and 18a showed the same binding modes as lapatinib in both egfr ( pdb: 3poz ) and her2 ( pdb: 3rcd ) ( exemplified by the binding modes of compound 2 1 in fig . 1 0', 'herg_ce': '1 0', 'solubility_ce': '2', 'ed50_an': '2 . 5 h followed by egf stimulation ( supplementary fig . s4 ) .', 't_half_an': '2 . 5', 'auc_an': '1 2 ) , and a negative correlation between the cellular activity and the psa ( fig . 1 3', 'bioavailability_an': '9 6', 'compound_drug': 'thr798/her2', 'compound': '27b'}
====================
37
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
discovery of n-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl)phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (chmfl-btk-01) as a highly selective irreversible bruton's tyrosine kinase (btk) inhibitor
nlpDict: 
single_dict: {'compound': '9', 'ic50_mc': '5 . 8', 'ki_mc': '8 . 9 nm', 'kd_mc': '4 . 7', 'selectivity_mc': '1 8 0 0 ng/ml*h and bioavailability 1 1 . 4 8 % ) . the cmax of 3 0 reached over 7 6 0 0 ng/ml and 1 1', 'ic50_ce': '2 1', 'ki_ce': '1 0', 'kd_ce': '3', 'ec50_ce': '3 0', 'solubility_ce': '2 1 nm ) . however , decreasing the hydrophilicity by adding methyl ether to the piperidine ( 4 1 ) resulted in slight activity loss ( ic50: 6 5 nm ) . when r4 position was the para-dimethyl amino benzene moiety as in 1 9 , aliphatic peg-like chains ( 4 2', 'ed50_an': '7 nm ) . installment of the terminal dimethyl amide moiety at', 't_half_an': '7', 'auc_an': '1 4 3 6 nm ) . these sar explorations indicated that the hydrophobic substituent at para- position of the benzene ring on the r4 position was critical for the inhibitory activity and the tert-butyl group ( 9 ) or the dimethyl amino group ( 1 9 ) was the best choice . we then fixed the r1 substituent and explored the sar of the r4 and r5 positions ( table 3 ) . when r4 position was the para-tert butyl benzene moiety as in 9 , simply taking off the acyl morpholine moiety from 9 offered 3 2 that completely lost the inhibitory activity ( ic50 > 1 0', 'bioavailability_an': '1 1 . 4 8', 'compound_drug': 'chmfl-btk-01'}

original_dict: {'ic50_mc': '5 . 8', 'ki_mc': '8 . 9 nm', 'kd_mc': '4 . 7', 'selectivity_mc': '1 8 0 0 ng/ml*h and bioavailability 1 1 . 4 8 % ) . the cmax of 3 0 reached over 7 6 0 0 ng/ml and 1 1', 'ic50_ce': '2 1', 'ki_ce': '1 0', 'kd_ce': '3', 'ec50_ce': '3 0', 'selectivity_ce': '1 0', 'herg_ce': '1 0', 'solubility_ce': '2 1 nm ) . however , decreasing the hydrophilicity by adding methyl ether to the piperidine ( 4 1 ) resulted in slight activity loss ( ic50: 6 5 nm ) . when r4 position was the para-dimethyl amino benzene moiety as in 1 9 , aliphatic peg-like chains ( 4 2', 'ed50_an': '7 nm ) . installment of the terminal dimethyl amide moiety at', 't_half_an': '7', 'auc_an': '1 4 3 6 nm ) . these sar explorations indicated that the hydrophobic substituent at para- position of the benzene ring on the r4 position was critical for the inhibitory activity and the tert-butyl group ( 9 ) or the dimethyl amino group ( 1 9 ) was the best choice . we then fixed the r1 substituent and explored the sar of the r4 and r5 positions ( table 3 ) . when r4 position was the para-tert butyl benzene moiety as in 9 , simply taking off the acyl morpholine moiety from 9 offered 3 2 that completely lost the inhibitory activity ( ic50 > 1 0', 'bioavailability_an': '1 1 . 4 8', 'compound_drug': 'chmfl-btk-01', 'compound': '9'}
====================
38
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
discovery of n-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl)phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (chmfl-btk-01) as a highly selective irreversible bruton's tyrosine kinase (btk) inhibitor
nlpDict: 
single_dict: {'compound': '9', 'ic50_mc': '5 . 8', 'ki_mc': '8 . 9 nm', 'kd_mc': '4 . 7', 'selectivity_mc': '1 8 0 0 ng/ml*h and bioavailability 1 1 . 4 8 % ) . the cmax of 3 0 reached over 7 6 0 0 ng/ml and 1 1', 'ic50_ce': '2 1', 'ki_ce': '1 0', 'kd_ce': '3', 'ec50_ce': '3 0', 'solubility_ce': '2 1 nm ) . however , decreasing the hydrophilicity by adding methyl ether to the piperidine ( 4 1 ) resulted in slight activity loss ( ic50: 6 5 nm ) . when r4 position was the para-dimethyl amino benzene moiety as in 1 9 , aliphatic peg-like chains ( 4 2', 'ed50_an': '7 nm ) . installment of the terminal dimethyl amide moiety at', 't_half_an': '7', 'auc_an': '1 4 3 6 nm ) . these sar explorations indicated that the hydrophobic substituent at para- position of the benzene ring on the r4 position was critical for the inhibitory activity and the tert-butyl group ( 9 ) or the dimethyl amino group ( 1 9 ) was the best choice . we then fixed the r1 substituent and explored the sar of the r4 and r5 positions ( table 3 ) . when r4 position was the para-tert butyl benzene moiety as in 9 , simply taking off the acyl morpholine moiety from 9 offered 3 2 that completely lost the inhibitory activity ( ic50 > 1 0', 'bioavailability_an': '1 1 . 4 8', 'compound_drug': 'chmfl-btk-01'}

original_dict: {'ic50_mc': '5 . 8', 'ki_mc': '8 . 9 nm', 'kd_mc': '4 . 7', 'selectivity_mc': '1 8 0 0 ng/ml*h and bioavailability 1 1 . 4 8 % ) . the cmax of 3 0 reached over 7 6 0 0 ng/ml and 1 1', 'ic50_ce': '2 1', 'ki_ce': '1 0', 'kd_ce': '3', 'ec50_ce': '3 0', 'selectivity_ce': '1 0', 'herg_ce': '1 0', 'solubility_ce': '2 1 nm ) . however , decreasing the hydrophilicity by adding methyl ether to the piperidine ( 4 1 ) resulted in slight activity loss ( ic50: 6 5 nm ) . when r4 position was the para-dimethyl amino benzene moiety as in 1 9 , aliphatic peg-like chains ( 4 2', 'ed50_an': '7 nm ) . installment of the terminal dimethyl amide moiety at', 't_half_an': '7', 'auc_an': '1 4 3 6 nm ) . these sar explorations indicated that the hydrophobic substituent at para- position of the benzene ring on the r4 position was critical for the inhibitory activity and the tert-butyl group ( 9 ) or the dimethyl amino group ( 1 9 ) was the best choice . we then fixed the r1 substituent and explored the sar of the r4 and r5 positions ( table 3 ) . when r4 position was the para-tert butyl benzene moiety as in 9 , simply taking off the acyl morpholine moiety from 9 offered 3 2 that completely lost the inhibitory activity ( ic50 > 1 0', 'bioavailability_an': '1 1 . 4 8', 'compound_drug': 'chmfl-btk-01', 'compound': '9'}
====================
39
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
bifunctional naphthoquinone aromatic amide-oxime derivatives exert combined immunotherapeutic and antitumor effects through simultaneous targeting of indoleamine-2,3-dioxygenase and signal transducer and activator of transcription 3
nlpDict: 
single_dict: {'compound': '8u', 'ic50_mc': '0 . 5 3 μm', 'ki_mc': '1 0 μm', 'kd_mc': '4 8', 'selectivity_mc': '1 8 h , followed by hydroxylamine hydrochloride in ethyl alcohol at 8', 'ic50_ce': '3 7', 'ki_ce': '1 0', 'kd_ce': '3', 'ec50_ce': '7', 'selectivity_ce': '9', 'solubility_ce': '2', 'ed50_an': '8 . 2 7 μm ) and', 'auc_an': '4 0 3 nm , as described in the literature . ( 4 6 ) the soret peak shifted to 4 1 3 nm in the presence of 8u , indicative of binding to ido1 and coordination with the iron of the heme group . ( 2 3', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion uv–visible spectroscopy uv–visible spectroscopy was performed to further confirm binding of compound 8u with heme-containing ido1 protein . the unique uv absorption properties of porphyrins are useful in heme protein studies . ( 4 6 ) heme is a porphyrin ring with an iron at its center , which absorbs light at the uv–vis spectrum maximally at a wavelength of ∼400 nm depending on the oxidation and coordination states of its iron , characterized by the soret band . absorbance spectra of the heme group are highly sensitive to changes in the polarity of the heme environment upon ligand/substrate binding , usually resulting in pronounced changes in the spectral properties of heme . ( 4 7'}

original_dict: {'ic50_mc': '0 . 5 3 μm', 'ki_mc': '1 0 μm', 'kd_mc': '4 8', 'selectivity_mc': '1 8 h , followed by hydroxylamine hydrochloride in ethyl alcohol at 8', 'ic50_ce': '3 7', 'ki_ce': '1 0', 'kd_ce': '3', 'ec50_ce': '7', 'selectivity_ce': '9', 'herg_ce': '1 0 μm', 'solubility_ce': '2', 'ed50_an': '8 . 2 7 μm ) and', 't_half_an': '7', 'auc_an': '4 0 3 nm , as described in the literature . ( 4 6 ) the soret peak shifted to 4 1 3 nm in the presence of 8u , indicative of binding to ido1 and coordination with the iron of the heme group . ( 2 3', 'bioavailability_an': '1 0', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion uv–visible spectroscopy uv–visible spectroscopy was performed to further confirm binding of compound 8u with heme-containing ido1 protein . the unique uv absorption properties of porphyrins are useful in heme protein studies . ( 4 6 ) heme is a porphyrin ring with an iron at its center , which absorbs light at the uv–vis spectrum maximally at a wavelength of ∼400 nm depending on the oxidation and coordination states of its iron , characterized by the soret band . absorbance spectra of the heme group are highly sensitive to changes in the polarity of the heme environment upon ligand/substrate binding , usually resulting in pronounced changes in the spectral properties of heme . ( 4 7', 'compound': '8u'}
====================
40
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
identification of cyanamide-based janus kinase 3 (jak3) covalent inhibitors
nlpDict: 
single_dict: {'compound': '<b> 3 2 </b>', 'ic50_mc': '1 2', 'ki_mc': '4 9', 'selectivity_mc': '1 0', 'ic50_ce': '2', 'kd_ce': '3 3', 'ec50_ce': '4 . 5', 'selectivity_ce': '1', 'solubility_ce': '3 3 1 4 6 9', 'ed50_an': '7 . in particular , among the compounds with', 't_half_an': '6 . 3', 'auc_an': '6', 'bioavailability_an': '1 2 0', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion identification of n-aryl-based cyanamides the benzoxazine scaffold utilized for 8 was chosen for providing reversible binding to jak3 ( ki ) and was selected to start investigation of a crg replacement . following this plan , cyanamide 9 was prepared , which to our surprise exhibited significant loss of jak3 potency and selectivity ( ic50 = 1 2 2 6 nm; ∼5-fold selectivity vs jak1 , table 1 ) . the significant potency difference between 8 and 9 , differing only by the crg , may be derived from the intrinsic reactivity changes of the electrophile and/or suboptimal positioning to react with cys909 in jak3 . indeed , data from the gsh reactivity assay indicated a large reduction in reactivity with this crg replacement ( 9t1/2 > 1 9 0 min vs 8t1/2 = 3 min ) . thus , modification of this scaffold was pursued to adjust reactivity . the effects of fluorine substitution on piperidine to modulate pka are well-known , with a 3 , 3-difluoro substitution leading to significant reduction in the pka value when compared to unsubstituted piperidine ( δpka exp = −3 . 7 ) . ( 3 7 ) it was proposed that similar modification of 9 would lead to an adjustment of cyanamide reactivity , and thus 1 0 was prepared . this analog provided marked improvement in both potency and selectivity ( ic50 = 4 5 6 nm; >22-fold selectivity vs jak1 ) when compared to 9 . data'}

original_dict: {'ic50_mc': '1 2', 'ki_mc': '4 9', 'kd_mc': '1 2', 'selectivity_mc': '1 0', 'ic50_ce': '2', 'ki_ce': '1 0', 'kd_ce': '3 3', 'ec50_ce': '4 . 5', 'selectivity_ce': '1', 'herg_ce': '1 0', 'solubility_ce': '3 3 1 4 6 9', 'ed50_an': '7 . in particular , among the compounds with', 't_half_an': '6 . 3', 'auc_an': '6', 'bioavailability_an': '1 2 0', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion identification of n-aryl-based cyanamides the benzoxazine scaffold utilized for 8 was chosen for providing reversible binding to jak3 ( ki ) and was selected to start investigation of a crg replacement . following this plan , cyanamide 9 was prepared , which to our surprise exhibited significant loss of jak3 potency and selectivity ( ic50 = 1 2 2 6 nm; ∼5-fold selectivity vs jak1 , table 1 ) . the significant potency difference between 8 and 9 , differing only by the crg , may be derived from the intrinsic reactivity changes of the electrophile and/or suboptimal positioning to react with cys909 in jak3 . indeed , data from the gsh reactivity assay indicated a large reduction in reactivity with this crg replacement ( 9t1/2 > 1 9 0 min vs 8t1/2 = 3 min ) . thus , modification of this scaffold was pursued to adjust reactivity . the effects of fluorine substitution on piperidine to modulate pka are well-known , with a 3 , 3-difluoro substitution leading to significant reduction in the pka value when compared to unsubstituted piperidine ( δpka exp = −3 . 7 ) . ( 3 7 ) it was proposed that similar modification of 9 would lead to an adjustment of cyanamide reactivity , and thus 1 0 was prepared . this analog provided marked improvement in both potency and selectivity ( ic50 = 4 5 6 nm; >22-fold selectivity vs jak1 ) when compared to 9 . data', 'compound': '<b> 3 2 </b>'}
====================
41
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
n-(pyrimidin-2-yl)-1,2,3,4-tetrahydroisoquinolin-6-amine derivatives as selective janus kinase 2 inhibitors for the treatment of myeloproliferative neoplasms
nlpDict: 
single_dict: {'compound': '<b> 13ac </b>', 'ic50_mc': '1 1 . 7', 'ki_mc': '1 0 0 0', 'kd_mc': '1 4', 'selectivity_mc': '35-fold', 'ic50_ce': '9', 'kd_ce': '2', 'selectivity_ce': '3 4', 'solubility_ce': '5 0 nm while barely showed obvious inhibition for other stat subtypes even at a concentration of 1 0', 'ed50_an': '1 , 2 , 3 , 4-tetrahydro-isoquinolin exhibited desirable selectivity , it was selected as a skeleton . next , we further examined the effects of substituents around the skeleton .', 't_half_an': '3 . 0 6', 'auc_an': '1 0', 'bioavailability_an': '2 5 . 7', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion molecular docking study of 13ac the screening results at the cell and kinase levels indicated our previous hypothesis , modification of the tail of lead compound 18e retained the activity for jak2 but reduced the potency for flt3 . further in vivo study indicated the effectiveness in mice . in order to explore the protein-binding mode of 13ac , the crystal structure of the protein kinase domain of jak2 from the protein data bank ( pdb code: 2xa4'}

original_dict: {'ic50_mc': '1 1 . 7', 'ki_mc': '1 0 0 0', 'kd_mc': '1 4', 'selectivity_mc': '35-fold', 'ic50_ce': '9', 'ki_ce': '1 0 0 0', 'kd_ce': '2', 'ec50_ce': '1 0 0 0', 'selectivity_ce': '3 4', 'herg_ce': '1 0 0 0', 'solubility_ce': '5 0 nm while barely showed obvious inhibition for other stat subtypes even at a concentration of 1 0', 'ed50_an': '1 , 2 , 3 , 4-tetrahydro-isoquinolin exhibited desirable selectivity , it was selected as a skeleton . next , we further examined the effects of substituents around the skeleton .', 't_half_an': '3 . 0 6', 'auc_an': '1 0', 'bioavailability_an': '2 5 . 7', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion molecular docking study of 13ac the screening results at the cell and kinase levels indicated our previous hypothesis , modification of the tail of lead compound 18e retained the activity for jak2 but reduced the potency for flt3 . further in vivo study indicated the effectiveness in mice . in order to explore the protein-binding mode of 13ac , the crystal structure of the protein kinase domain of jak2 from the protein data bank ( pdb code: 2xa4', 'compound': '<b> 13ac </b>'}
====================
42
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
n-(pyrimidin-2-yl)-1,2,3,4-tetrahydroisoquinolin-6-amine derivatives as selective janus kinase 2 inhibitors for the treatment of myeloproliferative neoplasms
nlpDict: 
single_dict: {'compound': '<b> 13ac </b>', 'ic50_mc': '1 1 . 7', 'ki_mc': '1 0 0 0', 'kd_mc': '1 4', 'selectivity_mc': '35-fold', 'ic50_ce': '9', 'kd_ce': '2', 'selectivity_ce': '3 4', 'solubility_ce': '5 0 nm while barely showed obvious inhibition for other stat subtypes even at a concentration of 1 0', 'ed50_an': '1 , 2 , 3 , 4-tetrahydro-isoquinolin exhibited desirable selectivity , it was selected as a skeleton . next , we further examined the effects of substituents around the skeleton .', 't_half_an': '3 . 0 6', 'auc_an': '1 0', 'bioavailability_an': '2 5 . 7', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion molecular docking study of 13ac the screening results at the cell and kinase levels indicated our previous hypothesis , modification of the tail of lead compound 18e retained the activity for jak2 but reduced the potency for flt3 . further in vivo study indicated the effectiveness in mice . in order to explore the protein-binding mode of 13ac , the crystal structure of the protein kinase domain of jak2 from the protein data bank ( pdb code: 2xa4'}

original_dict: {'ic50_mc': '1 1 . 7', 'ki_mc': '1 0 0 0', 'kd_mc': '1 4', 'selectivity_mc': '35-fold', 'ic50_ce': '9', 'ki_ce': '1 0 0 0', 'kd_ce': '2', 'ec50_ce': '1 0 0 0', 'selectivity_ce': '3 4', 'herg_ce': '1 0 0 0', 'solubility_ce': '5 0 nm while barely showed obvious inhibition for other stat subtypes even at a concentration of 1 0', 'ed50_an': '1 , 2 , 3 , 4-tetrahydro-isoquinolin exhibited desirable selectivity , it was selected as a skeleton . next , we further examined the effects of substituents around the skeleton .', 't_half_an': '3 . 0 6', 'auc_an': '1 0', 'bioavailability_an': '2 5 . 7', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion molecular docking study of 13ac the screening results at the cell and kinase levels indicated our previous hypothesis , modification of the tail of lead compound 18e retained the activity for jak2 but reduced the potency for flt3 . further in vivo study indicated the effectiveness in mice . in order to explore the protein-binding mode of 13ac , the crystal structure of the protein kinase domain of jak2 from the protein data bank ( pdb code: 2xa4', 'compound': '<b> 13ac </b>'}
====================
43
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
design and synthesis of janus kinase 2 (jak2) and histone deacetlyase (hdac) bispecific inhibitors based on pacritinib and evidence of dual pathway inhibition in hematological cell lines
nlpDict: 
single_dict: {'compound': '<b> 5 1 </b>', 'ic50_mc': '1 . 4', 'ki_mc': '1 . 0 8 to 2 . 1 1', 'kd_mc': '9', 'selectivity_mc': '7', 'ic50_ce': '5 0', 'ki_ce': '1 0', 'kd_ce': '2', 'solubility_ce': '5 1', 'ed50_an': '2 . 8', 't_half_an': '2 4', 'auc_an': '4', 'compound_drug': 'ruxolitinib ) and hdac inhibitor sensitive t-cell lymphomas ( including compound 1 , and belinostat ) . recently panobinostat was approved as the first targeted hdac agent to treat multiple myeloma . ( 4 7 ) broadening of therapy into leukemias/lymphomas and solid tumors is highly desirable , and with this aim in mind much effort has been expended in the clinic to evaluate compounds inhibiting either the jak or hdac families with varying degrees of isoform selectivity . notably , ruxolitinib has recently received wide coverage of its encouraging initial responses in combination with capecitabine ( a prodrug of 5-fu ) in patients with recurrent or treatment refractory metastatic pancreatic cancer , hinting at the potential value of jak inhibitors in difficult to treat solid tumors . ( 9 8 ) combination of ruxolitinib with panobinostat is being studied in the clinic for myelofibrosis , with the expectation that this combination could be extended to other indications if successful . ( 9 9'}

original_dict: {'ic50_mc': '1 . 4', 'ki_mc': '1 . 0 8 to 2 . 1 1', 'kd_mc': '9', 'selectivity_mc': '7', 'ic50_ce': '5 0', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '7', 'selectivity_ce': '1 0', 'herg_ce': '1 0', 'solubility_ce': '5 1', 'ed50_an': '2 . 8', 't_half_an': '2 4', 'auc_an': '4', 'bioavailability_an': '9', 'compound_drug': 'ruxolitinib ) and hdac inhibitor sensitive t-cell lymphomas ( including compound 1 , and belinostat ) . recently panobinostat was approved as the first targeted hdac agent to treat multiple myeloma . ( 4 7 ) broadening of therapy into leukemias/lymphomas and solid tumors is highly desirable , and with this aim in mind much effort has been expended in the clinic to evaluate compounds inhibiting either the jak or hdac families with varying degrees of isoform selectivity . notably , ruxolitinib has recently received wide coverage of its encouraging initial responses in combination with capecitabine ( a prodrug of 5-fu ) in patients with recurrent or treatment refractory metastatic pancreatic cancer , hinting at the potential value of jak inhibitors in difficult to treat solid tumors . ( 9 8 ) combination of ruxolitinib with panobinostat is being studied in the clinic for myelofibrosis , with the expectation that this combination could be extended to other indications if successful . ( 9 9', 'compound': '<b> 5 1 </b>'}
====================
44
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
dual inhibition of tyk2 and jak1 for the treatment of autoimmune diseases: discovery of ((s)-2,2-difluorocyclopropyl)((1r,5s)-3-(2-((1-methyl-1h-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (pf-06700841)
nlpDict: 
single_dict: {'compound': '<b> 2 3', 'ic50_mc': '1 6 nm', 'ki_mc': '6 0 %', 'kd_mc': '2', 'selectivity_mc': '9', 'ki_ce': '1 0', 'ec50_ce': '7', 'selectivity_ce': '1 8 . 8 × 10–6 cm/s ) . the pharmacokinetics of 2 3 pf-06700841 were studied in sprague–dawley rats following intravenous and oral administration ( 1 and 3 mg/kg respectively ) of the tosylate salt , where the compound showed a plasma clearance of 3 1', 'ed50_an': '3 . 3 8 , and δg = 4 . 0 9 and 4 . 2 2 for w1 and w6 respectively ) . as with tyk2 , a relatively stable water ( w29 ) would also be expected to be displaced by', 't_half_an': '6', 'auc_an': '2 7 5', 'bioavailability_an': '8 3 %', 'compound_drug': 'pf-06700841'}

original_dict: {'ic50_mc': '1 6 nm', 'ki_mc': '6 0 %', 'kd_mc': '2', 'selectivity_mc': '9', 'ic50_ce': '2', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '7', 'selectivity_ce': '1 8 . 8 × 10–6 cm/s ) . the pharmacokinetics of 2 3 pf-06700841 were studied in sprague–dawley rats following intravenous and oral administration ( 1 and 3 mg/kg respectively ) of the tosylate salt , where the compound showed a plasma clearance of 3 1', 'herg_ce': '1 0', 'solubility_ce': '2', 'ed50_an': '3 . 3 8 , and δg = 4 . 0 9 and 4 . 2 2 for w1 and w6 respectively ) . as with tyk2 , a relatively stable water ( w29 ) would also be expected to be displaced by', 't_half_an': '6', 'auc_an': '2 7 5', 'bioavailability_an': '8 3 %', 'compound_drug': 'pf-06700841', 'compound': '<b> 2 3'}
====================
45
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
2-aminothiazole derivatives as selective allosteric modulators of the protein kinase ck2. 2. structure-based optimization and investigation of effects specific to the allosteric mode of action
nlpDict: 
single_dict: {'compound': '2 7', 'ic50_mc': '0 . 6 μm', 'ki_mc': '0 . 1 8 μm', 'kd_mc': '0 . 1 1 μm', 'selectivity_mc': '9', 'ic50_ce': '2 0', 'kd_ce': '2', 'ec50_ce': '2 5 μm', 'ed50_an': '7 which was commercially available .', 't_half_an': '3', 'bioavailability_an': '3 8', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion the inhibitory potency of the allosteric ligands is substrate-dependent another major survival pathway that is constitutively upregulated in cancer with the participation of ck2 is the stat3 pathway . because of its importance as a target for potential anticancer therapies , we wondered whether the ck2 recruited to this pathway would be sensitive toward our allosteric inhibitors or show only a low response like in the case of nucleolin . stat3-tyr705 phosphorylation is the critical step in triggering the transcription factor activity of stat3 , while ser727 phosphorylation is involved in the regulation of the phospho-tyr705 levels . ( 5 5 ) inhibition or overexpression of ck2 was shown to influence the ser727 phosphorylation levels , but dependent on the cell type , either a positive ( 5 6 , 5 7 ) or negative ( 5 5 ) correlation with the tyr705 phosphorylation status was observed . because stat3-tyr705 phosphorylation had been consistently diminished in all cell types after treatment by ck2 inhibitors , we used an anti-phospho-stat3-tyr705 antibody to analyze the effects of 2 7 and cx-4945 in 786-o cells . interestingly , 2 7 had a somewhat stronger impact on the stat3-tyr705 phosphorylation levels than cx-4945 ( figure 6c ) , suggesting that the cellular ck2 pool engaged in the stat3 activation pathway is ( at least in the 786-o renal cancer cells ) more amenable to allosteric inhibition than to atp binding site-directed inhibition .'}

original_dict: {'ic50_mc': '0 . 6 μm', 'ki_mc': '0 . 1 8 μm', 'kd_mc': '2 7', 'selectivity_mc': '9', 'ic50_ce': '2 0', 'ki_ce': '2 0', 'kd_ce': '2', 'ec50_ce': '2 7', 'selectivity_ce': '2 0', 'herg_ce': '2 0', 'solubility_ce': '2', 'ed50_an': '7 which was commercially available .', 't_half_an': '3', 'auc_an': '2', 'bioavailability_an': '3 8', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion the inhibitory potency of the allosteric ligands is substrate-dependent another major survival pathway that is constitutively upregulated in cancer with the participation of ck2 is the stat3 pathway . because of its importance as a target for potential anticancer therapies , we wondered whether the ck2 recruited to this pathway would be sensitive toward our allosteric inhibitors or show only a low response like in the case of nucleolin . stat3-tyr705 phosphorylation is the critical step in triggering the transcription factor activity of stat3 , while ser727 phosphorylation is involved in the regulation of the phospho-tyr705 levels . ( 5 5 ) inhibition or overexpression of ck2 was shown to influence the ser727 phosphorylation levels , but dependent on the cell type , either a positive ( 5 6 , 5 7 ) or negative ( 5 5 ) correlation with the tyr705 phosphorylation status was observed . because stat3-tyr705 phosphorylation had been consistently diminished in all cell types after treatment by ck2 inhibitors , we used an anti-phospho-stat3-tyr705 antibody to analyze the effects of 2 7 and cx-4945 in 786-o cells . interestingly , 2 7 had a somewhat stronger impact on the stat3-tyr705 phosphorylation levels than cx-4945 ( figure 6c ) , suggesting that the cellular ck2 pool engaged in the stat3 activation pathway is ( at least in the 786-o renal cancer cells ) more amenable to allosteric inhibition than to atp binding site-directed inhibition .', 'compound': '2 7'}
====================
46
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
design, synthesis and biological evaluation of novel potent stat3 inhibitors based on bbi608 for cancer therapy
nlpDict: 
single_dict: {'compound': 'a11', 'ic50_mc': '7', 'ki_mc': '0 . 94–1 . 9 7 μm', 'kd_mc': '1 7 4 nm', 'selectivity_mc': '9', 'ic50_ce': '0 . 6 7 ± 0 . 0 2', 'ki_ce': '1 with bbi608 and stattic as positive controls . in line with our expectations , all compounds displayed potent antiproliferative activities against tested cancer cells and their ic50 values ranged from sub-micromole to micromole . apparently , compounds a6 and a11 exhibited considerable or even better inhibitory activities against two breast cancer cell lines compared to bbi608 . the preliminary sar that the additional functional groups occupied the side pocket was summarized as follows: compound a6 possessing a 2-ch3 and compound a11 containing a 4-och3 showed better efficiency than other compounds with a single substituent group installed on the benzene ring ( a7-a10 , a12-a20 ) . incorporation of two or more substituents on the benzene ring ( a21-a25 ) caused a slight decrease in activities . changing phenyl substituent to different size of cycloalkyl substituents ( a26-a29 ) led to the poor outcome that their corresponding derivatives except for cyclopropyl compound a26 ( 0 . 94–1 . 9 7', 'kd_ce': '1 7 4 nm in our experiment , which was almost equivalent to the reported value ( kd = 1 5 0 nm ) by berg and coworker [47] . then , compound binding assays were performed in a 1 0 0 μl volume at a concentration of 1 0 nm 5-fam-gpylpqtv-nh2 probe and 1 6 0 nm stat3 protein . as demonstrated in fig . 5 , compounds a6 and a11 bound to stat3 protein in a concentration-dependent manner with ic50 values of 5 . 5 5 μm and 5', 'selectivity_ce': '2 4', 'herg_ce': '1 0', 'solubility_ce': '2 . 0', 'ed50_an': '7 μm ) had relatively low potency . in addition , replacement of cyclohexyl group with tetrahydropyranyl substituent had no obvious effect on activities ( compounds a29 vs a30 ) . taken together , compound a11 showed', 'auc_an': '1 7 4 nm in our experiment , which was almost equivalent to the reported value ( kd = 1 5 0 nm ) by berg and coworker [47] . then , compound binding assays were performed in a 1 0 0 μl volume at a concentration of 1 0 nm 5-fam-gpylpqtv-nh2 probe and 1 6 0 nm stat3 protein . as demonstrated in fig . 5 , compounds a6 and a11 bound to stat3 protein in a concentration-dependent manner with ic50 values of 5 . 5 5', 'bioavailability_an': ') led to the poor outcome that their corresponding derivatives except for cyclopropyl compound a26 ( 0 . 94–1 . 9 7 μm', 'compound_drug': 'a11 using a mouse xenograft model bearing inoculation of human breast cancer cells mda-mb-231 . after the solid tumors were established , compound a11 was intraperitoneally ( i . p . ) administered once daily at two doses ( 5 and 1 0 mg/kg ) for 2 1 days . as demonstrated in fig . 1 0 a and b , the treatment with compound a11 brought in an obvious reduction of the tumor volume at the dose of 1 0 mg/kg compared to control group on the twenty-first day ( tgitv = 5 4 . 6 2 % ) . besides , the tumor weights of mice were notably abated by 4 5 . 1 9 % with a dosage of a11 at 1 0 mg/kg ( fig . 10c ) . what’s more , there was no apparent body-weight loss for those mice treated with compound a11 at both dosage ( fig . 9d ) . furthermore , the immunofluorescent assay of the tumor tissue revealed that the level of p-stat3 ( y705'}

original_dict: {'ic50_mc': '7', 'ki_mc': '0 . 94–1 . 9 7 μm', 'kd_mc': '1 7 4 nm', 'selectivity_mc': '9', 'ic50_ce': '0 . 6 7 ± 0 . 0 2', 'ki_ce': '1 with bbi608 and stattic as positive controls . in line with our expectations , all compounds displayed potent antiproliferative activities against tested cancer cells and their ic50 values ranged from sub-micromole to micromole . apparently , compounds a6 and a11 exhibited considerable or even better inhibitory activities against two breast cancer cell lines compared to bbi608 . the preliminary sar that the additional functional groups occupied the side pocket was summarized as follows: compound a6 possessing a 2-ch3 and compound a11 containing a 4-och3 showed better efficiency than other compounds with a single substituent group installed on the benzene ring ( a7-a10 , a12-a20 ) . incorporation of two or more substituents on the benzene ring ( a21-a25 ) caused a slight decrease in activities . changing phenyl substituent to different size of cycloalkyl substituents ( a26-a29 ) led to the poor outcome that their corresponding derivatives except for cyclopropyl compound a26 ( 0 . 94–1 . 9 7', 'kd_ce': '1 7 4 nm in our experiment , which was almost equivalent to the reported value ( kd = 1 5 0 nm ) by berg and coworker [47] . then , compound binding assays were performed in a 1 0 0 μl volume at a concentration of 1 0 nm 5-fam-gpylpqtv-nh2 probe and 1 6 0 nm stat3 protein . as demonstrated in fig . 5 , compounds a6 and a11 bound to stat3 protein in a concentration-dependent manner with ic50 values of 5 . 5 5 μm and 5', 'ec50_ce': '7', 'selectivity_ce': '2 4', 'herg_ce': '1 0', 'solubility_ce': '2 . 0', 'ed50_an': '7 μm ) had relatively low potency . in addition , replacement of cyclohexyl group with tetrahydropyranyl substituent had no obvious effect on activities ( compounds a29 vs a30 ) . taken together , compound a11 showed', 't_half_an': '2 4', 'auc_an': '1 7 4 nm in our experiment , which was almost equivalent to the reported value ( kd = 1 5 0 nm ) by berg and coworker [47] . then , compound binding assays were performed in a 1 0 0 μl volume at a concentration of 1 0 nm 5-fam-gpylpqtv-nh2 probe and 1 6 0 nm stat3 protein . as demonstrated in fig . 5 , compounds a6 and a11 bound to stat3 protein in a concentration-dependent manner with ic50 values of 5 . 5 5', 'bioavailability_an': ') led to the poor outcome that their corresponding derivatives except for cyclopropyl compound a26 ( 0 . 94–1 . 9 7 μm', 'compound_drug': 'a11 using a mouse xenograft model bearing inoculation of human breast cancer cells mda-mb-231 . after the solid tumors were established , compound a11 was intraperitoneally ( i . p . ) administered once daily at two doses ( 5 and 1 0 mg/kg ) for 2 1 days . as demonstrated in fig . 1 0 a and b , the treatment with compound a11 brought in an obvious reduction of the tumor volume at the dose of 1 0 mg/kg compared to control group on the twenty-first day ( tgitv = 5 4 . 6 2 % ) . besides , the tumor weights of mice were notably abated by 4 5 . 1 9 % with a dosage of a11 at 1 0 mg/kg ( fig . 10c ) . what’s more , there was no apparent body-weight loss for those mice treated with compound a11 at both dosage ( fig . 9d ) . furthermore , the immunofluorescent assay of the tumor tissue revealed that the level of p-stat3 ( y705', 'compound': 'a11'}
====================
47
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
discovery of a potent dual inhibitor of acetylcholinesterase and butyrylcholinesterase with antioxidant activity that alleviates alzheimer-like pathology in old app/ps1 mice
nlpDict: 
single_dict: {'compound': '5i', 'ic50_mc': '7 . 3 nm', 'ki_mc': '0 . 0 5', 'kd_mc': '0 . 6 8 and 0 . 9 4 nm', 'selectivity_mc': '7', 'ic50_ce': '1 . 0 6 nm', 'ki_ce': '1 0', 'kd_ce': '2', 'solubility_ce': '8', 'ed50_an': '2 mg/kg', 't_half_an': '3', 'auc_an': '7 0', 'bioavailability_an': '5c: 3 . 4 4', 'compound_drug': 'lof ) , novel object recognition ( nor ) , novel object localization ( nol ) , and memory flexibility tests . initially , despite the apparent healthy status of the treated mice , we wanted to additionally rule out movement or stress problems due to treatment . to this end , the general behavior and the locomotor activity of treated and control mice were studied using the lof test . this test measures the time spent by the animal moving along the field and the number of times that the animal crosses the central area of a transparent cage . no significant change among groups was observed , thereby confirming that treatment with 5c and 5i did not alter the general behavior of the animals , both young and old ( one-way anova , p < 0 . 0 5 , followed by appropriate post hoc testing ) ( figure 7 ) . thus , the basal status of the treated animals did not affect their performance in the subsequent behavioral tests , in which the effects of the compounds on memory and learning functions were assessed .'}

original_dict: {'ic50_mc': '7 . 3 nm', 'ki_mc': '0 . 0 5', 'kd_mc': '0 . 6 8 and 0 . 9 4 nm', 'selectivity_mc': '7', 'ic50_ce': '1 . 0 6 nm', 'ki_ce': '1 0', 'kd_ce': '2', 'ec50_ce': '7', 'selectivity_ce': '1 0', 'herg_ce': '1 0', 'solubility_ce': '8', 'ed50_an': '2 mg/kg', 't_half_an': '3', 'auc_an': '7 0', 'bioavailability_an': '5c: 3 . 4 4', 'compound_drug': 'lof ) , novel object recognition ( nor ) , novel object localization ( nol ) , and memory flexibility tests . initially , despite the apparent healthy status of the treated mice , we wanted to additionally rule out movement or stress problems due to treatment . to this end , the general behavior and the locomotor activity of treated and control mice were studied using the lof test . this test measures the time spent by the animal moving along the field and the number of times that the animal crosses the central area of a transparent cage . no significant change among groups was observed , thereby confirming that treatment with 5c and 5i did not alter the general behavior of the animals , both young and old ( one-way anova , p < 0 . 0 5 , followed by appropriate post hoc testing ) ( figure 7 ) . thus , the basal status of the treated animals did not affect their performance in the subsequent behavioral tests , in which the effects of the compounds on memory and learning functions were assessed .', 'compound': '5i'}
====================
48
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
discovery of cyclic sulfone hydroxyethylamines as potent and selective β-site app-cleaving enzyme 1 (bace1) inhibitors: structure-based design and in vivo reduction of amyloid β-peptides
nlpDict: 
single_dict: {'compound': '60p', 'ic50_mc': '5 5 nm', 'ki_mc': '5 0 nm', 'kd_mc': '0 . 3 → 9 . 2 μm ) as compared to 60j . unfortunately , the improved profile of 62g did not have an impact on the large shift between the enzymatic and the cellular activity ( ic50 = 4 4', 'selectivity_mc': '50-fold', 'ki_ce': '1', 'kd_ce': '2 8 nm ) and 4 8 ( ic50 = 4 9 nm ) . unfortunately , the newly introduced hbd moieties contributing to improved potency were equally well recognized by p-gp , resulting in high p-gp-mediated efflux , as illustrated by 45b , c and 4', 'ec50_ce': '2', 'selectivity_ce': '1 8 was prepared , as it contains a stronger hbd functionality for the h-bonding interaction to phe108 . because this modification lowered the potency and induced a strong p-gp-mediated efflux ( er = 1 6 ) , no further extensions into the s3 pocket were explored for this series . on the other hand , the good cellular activity of 14c ( table 1 , ic50 2 5 0 nm ) and the promising in vivo brain/blood concentration ratios of 14b , c , e and 1', 'herg_ce': '9 . 2', 'solubility_ce': '9 5 0', 'ed50_an': '2 nm , selectivity > 100-fold ) with equal cellular activity ( ic50 = 5 0 nm ) and an improved profile ( reduced clog p = 4 .', 't_half_an': '3', 'auc_an': '4 4 and 45b–c ( table 3 ) . the analysis of the cocrystal structure of 14d ( figure 6 ) suggested that additional potency could be gained by optimizing potential h-bonds to proximal residues and deeply buried water molecules at the surface of the s3 pocket . this could be confirmed by examples 45a ( ic50 = 2 8 nm ) and 4 8 ( ic50 = 4 9 nm ) . unfortunately , the newly introduced hbd moieties contributing to improved potency were equally well recognized by p-gp , resulting in high p-gp-mediated efflux , as illustrated by 45b , c and 4 7 versus 45a and 4', 'bioavailability_an': '3 0 nm/s ) caused by the lipophilic hexafluoroisopropoxy fragment ( clog p = 4 . 2 for 60j ) , one of its cf3 groups was substituted by an alkyl-ether moiety ( 60m–q ) , to reduce lipophilicity and to increase solubility . previously established sar indicated that distal methyl-ether containing p3 fragments did retain good cellular activity and permeability ( 60k , papp = 2 5 0 nm/s ) , and triggered only a minor increase in p-gp-mediated efflux ( 4 9 and 60k ) . gratifyingly , the further optimization of the p3 fragment led to the identification of the ( r ) -1-methoxymethyl-2 , 2 , 2-trifluoro-ethoxy substituted inhibitor 60p , a highly potent and selective analogue of 60j ( ic50 = 2 nm , selectivity > 100-fold ) with equal cellular activity ( ic50 = 5 0 nm', 'compound_drug': '60m–q'}

original_dict: {'ic50_mc': '5 5 nm', 'ki_mc': '5 0 nm', 'kd_mc': '0 . 3 → 9 . 2 μm ) as compared to 60j . unfortunately , the improved profile of 62g did not have an impact on the large shift between the enzymatic and the cellular activity ( ic50 = 4 4', 'selectivity_mc': '50-fold', 'ic50_ce': '5 0 nm', 'ki_ce': '1', 'kd_ce': '2 8 nm ) and 4 8 ( ic50 = 4 9 nm ) . unfortunately , the newly introduced hbd moieties contributing to improved potency were equally well recognized by p-gp , resulting in high p-gp-mediated efflux , as illustrated by 45b , c and 4', 'ec50_ce': '2', 'selectivity_ce': '1 8 was prepared , as it contains a stronger hbd functionality for the h-bonding interaction to phe108 . because this modification lowered the potency and induced a strong p-gp-mediated efflux ( er = 1 6 ) , no further extensions into the s3 pocket were explored for this series . on the other hand , the good cellular activity of 14c ( table 1 , ic50 2 5 0 nm ) and the promising in vivo brain/blood concentration ratios of 14b , c , e and 1', 'herg_ce': '9 . 2', 'solubility_ce': '9 5 0', 'ed50_an': '2 nm , selectivity > 100-fold ) with equal cellular activity ( ic50 = 5 0 nm ) and an improved profile ( reduced clog p = 4 .', 't_half_an': '3', 'auc_an': '4 4 and 45b–c ( table 3 ) . the analysis of the cocrystal structure of 14d ( figure 6 ) suggested that additional potency could be gained by optimizing potential h-bonds to proximal residues and deeply buried water molecules at the surface of the s3 pocket . this could be confirmed by examples 45a ( ic50 = 2 8 nm ) and 4 8 ( ic50 = 4 9 nm ) . unfortunately , the newly introduced hbd moieties contributing to improved potency were equally well recognized by p-gp , resulting in high p-gp-mediated efflux , as illustrated by 45b , c and 4 7 versus 45a and 4', 'bioavailability_an': '3 0 nm/s ) caused by the lipophilic hexafluoroisopropoxy fragment ( clog p = 4 . 2 for 60j ) , one of its cf3 groups was substituted by an alkyl-ether moiety ( 60m–q ) , to reduce lipophilicity and to increase solubility . previously established sar indicated that distal methyl-ether containing p3 fragments did retain good cellular activity and permeability ( 60k , papp = 2 5 0 nm/s ) , and triggered only a minor increase in p-gp-mediated efflux ( 4 9 and 60k ) . gratifyingly , the further optimization of the p3 fragment led to the identification of the ( r ) -1-methoxymethyl-2 , 2 , 2-trifluoro-ethoxy substituted inhibitor 60p , a highly potent and selective analogue of 60j ( ic50 = 2 nm , selectivity > 100-fold ) with equal cellular activity ( ic50 = 5 0 nm', 'compound_drug': '60m–q', 'compound': '60p'}
====================
49
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors: from hit to lowering of cerebrospinal fluid (csf) amyloid β in a higher species
nlpDict: 
single_dict: {'compound': '-50', 'ic50_mc': '4 5 5 nm', 'ki_mc': '5 3 nm', 'kd_mc': '3', 'selectivity_mc': '55-fold', 'ic50_ce': '2', 'ki_ce': '1', 'ec50_ce': '3 0', 'selectivity_ce': '1 and difluoro analogue 5 2 ) led to significant losses in potency and selectivity . although we were pleased overall with the low mw , limited molecular flexibility , potency , and selectivity found in these cores , the efflux liability remained . we expected that analogues with tpsa of <70 would reach minimal efflux ratios of <2 . ( 2 6 ) unfortunately , this effort did not reach fruition , as even compounds with a tpsa value of <60 ( analogues 4 2 and 4 3 ) remained efflux substrates ( efflux ratios of 4 . 8', 'herg_ce': '1 0', 'solubility_ce': '2 ) was similar for bace1 enzyme potency , catd enzyme potency , and efflux . the cellular potency was found to be slightly divergent , with differences up to 6-fold favoring the thn core when compared to the chroman core ( 4 6 vs 3 7 , 4 8 vs 3 4 , and 5 0 vs 3 9 ) . the improved cellular potency of the thn core brought compounds such as pyrimidine 5 0 into consideration for in vivo studies . attempts to further increase the potency of the thn core by benzylic substitution ( ketone 5 1 and difluoro analogue 5 2 ) led to significant losses in potency and selectivity . although we were pleased overall with the low mw , limited molecular flexibility , potency , and selectivity found in these cores , the efflux liability remained . we expected that analogues with tpsa of <70 would reach minimal efflux ratios of <2 . ( 2 6 ) unfortunately , this effort did not reach fruition , as even compounds with a tpsa value of <60 ( analogues 4 2', 'ed50_an': '7 nm , respectively ) . in contrast , difluorination of the 3-methoxy group of analogue 1 4 provided ∼2-fold potency improvement for analogue 2 6 . no benefit was seen with the smaller 3-f analogue 2 7 vs 12; however , the 3-cn analogue 1 3 provided improved cellular potency vs 1 2 ( 3 6 vs 1 0 7 nm ) . the bace1 cocrystal structures of 1 2 and 1 3 again provide insight into these trends as the pocket accepting the meta substituents is limited in width ( decreased bace1 potency for 2 2 and 2 5 ) but extends deeply enough to accept the linear nitrile of 1 3 .', 'auc_an': '5', 'bioavailability_an': '5 0', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion the compounds in table 4 demonstrating the best brain pk were scaled , resolved , and profiled . we found that the bace1 potency resided primarily within the ( r ) -enantiomers , as they were roughly twice as potent as the corresponding racemates ( table 5 ) . fortunately , the ( r ) -enantiomers did not consistently show increased affinity for catd , effectively increasing the catd/bace1 window for most compounds . the increase in bace1 affinity translated into improved cell potency for each ( r ) -enantiomer evaluated raising promise for in vivo cns aβ lowering . liver microsomal assays predicted low to medium cl across species ( mouse , rat , guinea pig , cynomolgus monkey , and human ) for the compounds in table 5 with the exception of ( r ) -46 in the rat . though pleased with predicted stability of the single enantiomers , as well as the potency and selectivity increases , all compounds remained efflux substrates . progression to pharmacodynamic assays would ascertain if permeable , low mw , limited molecular flexibility compounds could affect cns aβ1–40 production despite the efflux liability .'}

original_dict: {'ic50_mc': '4 5 5 nm', 'ki_mc': '5 3 nm', 'kd_mc': '3', 'selectivity_mc': '55-fold', 'ic50_ce': '2', 'ki_ce': '1', 'kd_ce': '2', 'ec50_ce': '3 0', 'selectivity_ce': '1 and difluoro analogue 5 2 ) led to significant losses in potency and selectivity . although we were pleased overall with the low mw , limited molecular flexibility , potency , and selectivity found in these cores , the efflux liability remained . we expected that analogues with tpsa of <70 would reach minimal efflux ratios of <2 . ( 2 6 ) unfortunately , this effort did not reach fruition , as even compounds with a tpsa value of <60 ( analogues 4 2 and 4 3 ) remained efflux substrates ( efflux ratios of 4 . 8', 'herg_ce': '1 0', 'solubility_ce': '2 ) was similar for bace1 enzyme potency , catd enzyme potency , and efflux . the cellular potency was found to be slightly divergent , with differences up to 6-fold favoring the thn core when compared to the chroman core ( 4 6 vs 3 7 , 4 8 vs 3 4 , and 5 0 vs 3 9 ) . the improved cellular potency of the thn core brought compounds such as pyrimidine 5 0 into consideration for in vivo studies . attempts to further increase the potency of the thn core by benzylic substitution ( ketone 5 1 and difluoro analogue 5 2 ) led to significant losses in potency and selectivity . although we were pleased overall with the low mw , limited molecular flexibility , potency , and selectivity found in these cores , the efflux liability remained . we expected that analogues with tpsa of <70 would reach minimal efflux ratios of <2 . ( 2 6 ) unfortunately , this effort did not reach fruition , as even compounds with a tpsa value of <60 ( analogues 4 2', 'ed50_an': '7 nm , respectively ) . in contrast , difluorination of the 3-methoxy group of analogue 1 4 provided ∼2-fold potency improvement for analogue 2 6 . no benefit was seen with the smaller 3-f analogue 2 7 vs 12; however , the 3-cn analogue 1 3 provided improved cellular potency vs 1 2 ( 3 6 vs 1 0 7 nm ) . the bace1 cocrystal structures of 1 2 and 1 3 again provide insight into these trends as the pocket accepting the meta substituents is limited in width ( decreased bace1 potency for 2 2 and 2 5 ) but extends deeply enough to accept the linear nitrile of 1 3 .', 't_half_an': '3', 'auc_an': '5', 'bioavailability_an': '5 0', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion the compounds in table 4 demonstrating the best brain pk were scaled , resolved , and profiled . we found that the bace1 potency resided primarily within the ( r ) -enantiomers , as they were roughly twice as potent as the corresponding racemates ( table 5 ) . fortunately , the ( r ) -enantiomers did not consistently show increased affinity for catd , effectively increasing the catd/bace1 window for most compounds . the increase in bace1 affinity translated into improved cell potency for each ( r ) -enantiomer evaluated raising promise for in vivo cns aβ lowering . liver microsomal assays predicted low to medium cl across species ( mouse , rat , guinea pig , cynomolgus monkey , and human ) for the compounds in table 5 with the exception of ( r ) -46 in the rat . though pleased with predicted stability of the single enantiomers , as well as the potency and selectivity increases , all compounds remained efflux substrates . progression to pharmacodynamic assays would ascertain if permeable , low mw , limited molecular flexibility compounds could affect cns aβ1–40 production despite the efflux liability .', 'compound': '-50'}
====================
50
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of alzheimer's disease
nlpDict: 
single_dict: {'compound': '5c', 'ic50_mc': '8 5 nм', 'ki_mc': '2 0 μm', 'kd_mc': '5 1 nм', 'selectivity_mc': 'trp 2 8 6 . in the bottom of the gorge , the charged nitrogen of piperidine ring and the f-substituted phenyl ring could bind to cas by establishing cation-π and π-π interactions with trp 8 6 ( fig . 3 a and c ) , respectively . interestingly , similar interactions between compound 5c and hache were observed in fig . 3 b and d . indanone moiety preferably occupied the pas via a π-π interaction with trp 2 8 6', 'ic50_ce': '7', 'ki_ce': '5', 'kd_ce': '2', 'ec50_ce': '9', 'selectivity_ce': '1 0', 'solubility_ce': '3 2 nм ) , revealing that a 2-f in the benzene ring was the best choice for ache inhibition and more active than donepezil ( ic50 = 5 1', 'ed50_an': '1 0 mg/kg', 'auc_an': '2 0', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion cholinesterase inhibition and sar discussion inhibitory activities of the target compounds on ache ( from electric eel and human ) and buche ( from equine serum and human ) were tested by the spectrophotometric method of ellman et al . with donepezil and tacrine as the reference standards [41] . the ic50 values for eeache ( hache ) and eqbuche ( hbuche ) inhibition were summarized in table 1 . it could be seen from table 1 that most of the synthesized compounds showed high inhibitory activities to ache with ic50 values at nanomolar range . similarly , all of the donepezil derivatives showed higher inhibitory potency against the ache than the buche , indicating that the introduction of different small ( 3a-o ) or large ( 5a-h'}

original_dict: {'ic50_mc': '8 5 nм', 'ki_mc': '2 0 μm', 'kd_mc': '5 1 nм', 'selectivity_mc': 'trp 2 8 6 . in the bottom of the gorge , the charged nitrogen of piperidine ring and the f-substituted phenyl ring could bind to cas by establishing cation-π and π-π interactions with trp 8 6 ( fig . 3 a and c ) , respectively . interestingly , similar interactions between compound 5c and hache were observed in fig . 3 b and d . indanone moiety preferably occupied the pas via a π-π interaction with trp 2 8 6', 'ic50_ce': '7', 'ki_ce': '5', 'kd_ce': '2', 'ec50_ce': '9', 'selectivity_ce': '1 0', 'herg_ce': '1 0', 'solubility_ce': '3 2 nм ) , revealing that a 2-f in the benzene ring was the best choice for ache inhibition and more active than donepezil ( ic50 = 5 1', 'ed50_an': '1 0 mg/kg', 't_half_an': '2', 'auc_an': '2 0', 'bioavailability_an': '2', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results and discussion cholinesterase inhibition and sar discussion inhibitory activities of the target compounds on ache ( from electric eel and human ) and buche ( from equine serum and human ) were tested by the spectrophotometric method of ellman et al . with donepezil and tacrine as the reference standards [41] . the ic50 values for eeache ( hache ) and eqbuche ( hbuche ) inhibition were summarized in table 1 . it could be seen from table 1 that most of the synthesized compounds showed high inhibitory activities to ache with ic50 values at nanomolar range . similarly , all of the donepezil derivatives showed higher inhibitory potency against the ache than the buche , indicating that the introduction of different small ( 3a-o ) or large ( 5a-h', 'compound': '5c'}
====================
51
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues
nlpDict: 
single_dict: {'compound': '26a', 'ic50_mc': '2 9 , 8 5 , 1 6 8 nm', 'ki_mc': '1 0 0 mg/kg po dosing . terminal brain and plasma samples taken from the test animals showed that the brain to plasma ( b/p ) ratio was close to 3 0 at the 3 0', 'kd_mc': '2', 'selectivity_mc': '9 9 and 3 . 7 3 , respectively . racemic octahydro-1h-isoindole methoxy phenyl substituted compounds 4e , 4d , and 4f were also standouts in sert lle , with values of 3 . 5 8', 'ki_ce': '3', 'selectivity_ce': '1 0', 'herg_ce': '1 μm', 'ed50_an': '1 μm . there was no clear distinction in stability , cyp inhibition , or herg inhibition for either the octahydrocyclopenta[c]pyrrole and octahydro-1h-isoindoles dichlorophenyl compounds secondary amines ( compare 26a to 27a ) : both compounds showed excellent stability and moderate cyp and herg inhibition profiles . the standout in the dichlorophenyl series from an adme perspective was secondary amine 26a; for tertiary amines both 23a and 22a showed good profiles , albeit with decreased stability compared to secondary amine 26a . the 2-naphthyl compounds 21d and 23d showed significantly decreased microsomal stability compared to the 3 , 4-dichlorophenyl counterparts for both n-h and n-me and were not profiled extensively for that reason . finally , the 3 , 4-dichlorobenzyl compounds 3 0 ( n-ch3 )', 'auc_an': '1 0 , and 3 0 mg/kg po in male mice in the tst . a 6 0 min pretreatment time was used based on exposure work prior to the assay , which showed maximal brain levels 6 0 min after po dosing . 26a dose dependently reduced in immobility , which was statistically significant compared to vehicle at 1 0 and 3 0 mg/kg doses ( figure 2a ) . the positive control , desipramine , also showed a statistically significant reduction in immobility at 1 0 0 mg/kg po dosing . terminal brain and plasma samples taken from the test animals showed that the brain to plasma ( b/p ) ratio was close to 3 0 at the 3 0 mg/kg dose , and approximately 5 0', 'bioavailability_an': '23c showed a preference for the serotonin transporter over the dopamine and norepinephrine transporters', 'compound_drug': 'n-ch3'}

original_dict: {'ic50_mc': '2 9 , 8 5 , 1 6 8 nm', 'ki_mc': '1 0 0 mg/kg po dosing . terminal brain and plasma samples taken from the test animals showed that the brain to plasma ( b/p ) ratio was close to 3 0 at the 3 0', 'kd_mc': '2', 'selectivity_mc': '9 9 and 3 . 7 3 , respectively . racemic octahydro-1h-isoindole methoxy phenyl substituted compounds 4e , 4d , and 4f were also standouts in sert lle , with values of 3 . 5 8', 'ic50_ce': '2', 'ki_ce': '3', 'kd_ce': '3', 'ec50_ce': '3', 'selectivity_ce': '1 0', 'herg_ce': '1 μm', 'solubility_ce': '3', 'ed50_an': '1 μm . there was no clear distinction in stability , cyp inhibition , or herg inhibition for either the octahydrocyclopenta[c]pyrrole and octahydro-1h-isoindoles dichlorophenyl compounds secondary amines ( compare 26a to 27a ) : both compounds showed excellent stability and moderate cyp and herg inhibition profiles . the standout in the dichlorophenyl series from an adme perspective was secondary amine 26a; for tertiary amines both 23a and 22a showed good profiles , albeit with decreased stability compared to secondary amine 26a . the 2-naphthyl compounds 21d and 23d showed significantly decreased microsomal stability compared to the 3 , 4-dichlorophenyl counterparts for both n-h and n-me and were not profiled extensively for that reason . finally , the 3 , 4-dichlorobenzyl compounds 3 0 ( n-ch3 )', 't_half_an': '3', 'auc_an': '1 0 , and 3 0 mg/kg po in male mice in the tst . a 6 0 min pretreatment time was used based on exposure work prior to the assay , which showed maximal brain levels 6 0 min after po dosing . 26a dose dependently reduced in immobility , which was statistically significant compared to vehicle at 1 0 and 3 0 mg/kg doses ( figure 2a ) . the positive control , desipramine , also showed a statistically significant reduction in immobility at 1 0 0 mg/kg po dosing . terminal brain and plasma samples taken from the test animals showed that the brain to plasma ( b/p ) ratio was close to 3 0 at the 3 0 mg/kg dose , and approximately 5 0', 'bioavailability_an': '23c showed a preference for the serotonin transporter over the dopamine and norepinephrine transporters', 'compound_drug': 'n-ch3', 'compound': '26a'}
====================
52
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers
nlpDict: 
single_dict: {'compound': '2e', 'ic50_mc': '1 . 1−23 nm', 'ki_mc': '1 0 0', 'kd_mc': '3 reported that the 2α , 3β-isomer , 4a , was much less potent than the 2β , 3β-isomer , 2a , in da and 5-ht uptake using striatum or rat cortex . ritz et al . 2 4', 'selectivity_mc': '4‘-iodo ( 2e ) > 4‘-bromo ( 2d ) = 4‘-methyl ( 2f ) > 4‘-fluoro ( 2b ) , > 4‘-hydrogen ( 2a', 'ic50_ce': '0', 'ki_ce': '1 0', 'kd_ce': '2e produced death at 1', 'ec50_ce': '7', 'selectivity_ce': '100-fold spread between stimulation and other symptoms . the 2β , 3α-compounds were stimulants at 1 0 mg/kg and only stimulation was seen at a 10-fold', 'solubility_ce': '0 . 1 to 1 . 2 mg/kg . the ed50s for the 2β , 3α-compounds were 6 . 6−21 . 8 mg/kg , and for the 2α , 3β-compounds , 2 . 4−11 . 7 mg/kg ( but 4f did not have an ed50 ) ; thus , they were approximately equipotent and at least 10-fold weaker than the 2β , 3β-compounds . the compounds can also be examined for their effects during the first hour after administration , where cocaine exerts its peak effect . five of the six 2β , 3β-compounds produced greater effects than cocaine during hour 1 , with ratios ranging from 1 . 6 to 4 . 4 . compound 2d actually produced less activity stimulation than cocaine , with a ratio of 0 . 8; however , the rapid onset of intense stereotypy probably artificially lowered this ratio . the 2β , 3α-compounds produced equivalent or greater activity than cocaine in hour 1 , with ratios ranging from 1 to 2 . 6 . the 2α , 3β-compounds 4a−f produced less stimulation in hour 1 than cocaine , with ratios ranging from 0 . 1 to 0 . 7 . the 2α , 3α-compounds were almost without effect in hour 1 , with ratios of 0 . 0', 'ed50_an': '1 0 mg/kg', 'auc_an': '1 , with ratios ranging from 1 . 6 to 4 . 4 . compound 2d actually produced less activity stimulation than cocaine , with a ratio of 0 . 8; however , the rapid onset of intense stereotypy probably artificially lowered this ratio . the 2β , 3α-compounds produced equivalent or greater activity than cocaine in hour 1 , with ratios ranging from 1 to 2 . 6 . the 2α , 3β-compounds 4a−f produced less stimulation in hour 1 than cocaine , with ratios ranging from 0 . 1 to 0 . 7', 'compound_drug': '3β-isomer , 4b'}

original_dict: {'ic50_mc': '1 . 1−23 nm', 'ki_mc': '1 0 0', 'kd_mc': '3 reported that the 2α , 3β-isomer , 4a , was much less potent than the 2β , 3β-isomer , 2a , in da and 5-ht uptake using striatum or rat cortex . ritz et al . 2 4', 'selectivity_mc': '4‘-iodo ( 2e ) > 4‘-bromo ( 2d ) = 4‘-methyl ( 2f ) > 4‘-fluoro ( 2b ) , > 4‘-hydrogen ( 2a', 'ic50_ce': '0', 'ki_ce': '1 0', 'kd_ce': '2e produced death at 1', 'ec50_ce': '7', 'selectivity_ce': '100-fold spread between stimulation and other symptoms . the 2β , 3α-compounds were stimulants at 1 0 mg/kg and only stimulation was seen at a 10-fold', 'herg_ce': '1 0 0', 'solubility_ce': '0 . 1 to 1 . 2 mg/kg . the ed50s for the 2β , 3α-compounds were 6 . 6−21 . 8 mg/kg , and for the 2α , 3β-compounds , 2 . 4−11 . 7 mg/kg ( but 4f did not have an ed50 ) ; thus , they were approximately equipotent and at least 10-fold weaker than the 2β , 3β-compounds . the compounds can also be examined for their effects during the first hour after administration , where cocaine exerts its peak effect . five of the six 2β , 3β-compounds produced greater effects than cocaine during hour 1 , with ratios ranging from 1 . 6 to 4 . 4 . compound 2d actually produced less activity stimulation than cocaine , with a ratio of 0 . 8; however , the rapid onset of intense stereotypy probably artificially lowered this ratio . the 2β , 3α-compounds produced equivalent or greater activity than cocaine in hour 1 , with ratios ranging from 1 to 2 . 6 . the 2α , 3β-compounds 4a−f produced less stimulation in hour 1 than cocaine , with ratios ranging from 0 . 1 to 0 . 7 . the 2α , 3α-compounds were almost without effect in hour 1 , with ratios of 0 . 0', 'ed50_an': '1 0 mg/kg', 't_half_an': '7', 'auc_an': '1 , with ratios ranging from 1 . 6 to 4 . 4 . compound 2d actually produced less activity stimulation than cocaine , with a ratio of 0 . 8; however , the rapid onset of intense stereotypy probably artificially lowered this ratio . the 2β , 3α-compounds produced equivalent or greater activity than cocaine in hour 1 , with ratios ranging from 1 to 2 . 6 . the 2α , 3β-compounds 4a−f produced less stimulation in hour 1 than cocaine , with ratios ranging from 0 . 1 to 0 . 7', 'bioavailability_an': '1 0 0', 'compound_drug': '3β-isomer , 4b', 'compound': '2e'}
====================
53
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
design, synthesis, and structure–activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors
nlpDict: 
single_dict: {'compound': '3', 'ic50_mc': '1 8 nm', 'ki_mc': '( see supporting information ) . adding one hydroxyl structure to form a hydroxylamine group ( 4 4 ) produces a binding mode featuring no stacking', 'kd_mc': '2', 'selectivity_mc': '1 8 ) the best affinity score pose obtained by docking was very similar to its crystal position , reflecting the capacity of the docking procedure in evaluating other compounds . docking of 5-fluorotryptamine to the active site of mpo showed that its best affinity position features stacking ( as in the mpo–sha crystal structure ) of the indole six-membered ring onto the pyrrole ring d of the heme ( figure 2 ) . ( 2 7', 'ic50_ce': '7', 'selectivity_ce': '1 8', 'herg_ce': 'one hydroxyl structure to form a hydroxylamine group ( 4 4 ) produces a binding mode featuring no stacking', 'solubility_ce': '4 2', 'ed50_an': '8 ) the binding modes obtained with an induced-fit protocol feature unusual concomitant interactions: stacking with the heme and three hydrogen bonds , two of the hydroxyl with his95 and gln91 and one of the amine with asp94 . this mode is very similar to the mpo–sha complex structure . the fluorine atom hydrogen bonds with gln91 ( see supporting information ) . compound 4 5 , with a thiocyanate group at the side-chain extremity , features two different positions . one shows shifted stacking and one hydrogen bond between indole nh and heme propionate . interestingly , the other depicts the thiocyanate group at the same position as the cyanide in the crystal mpo structure ( pdb code 1dnw ) and forms a hydrogen bond with gln91 but no stacking ( see supporting information ) .', 't_half_an': '7 on the indole ring brings no significant change in the predicted affinity relative to compounds with fluorine at position 5 . the docked poses show that the orientation of the indole ring differs and that a fluorine atom in position 7 does not point toward the heme iron as does fluorine in position 5 ( see supporting information ) . compounds 2', 'auc_an': '4 2 and 4 3 ) exhibit shifted stacking and one h-bond between the sulfonyl and either arg424 ( for 4 2 ) or phe147 backbone ( for 4 3 ) . the indole nh group hydrogen binds to the propionate group ( see supporting information ) . adding one hydroxyl structure to form a hydroxylamine group ( 4', 'bioavailability_an': '4 3 ) exhibit shifted stacking and one h-bond between the sulfonyl and either arg424 ( for 4 2 ) or phe147 backbone ( for 4 3 ) . the indole nh group hydrogen binds to the propionate group ( see supporting information ) . adding one hydroxyl structure to form a hydroxylamine group ( 4 4', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results replacement of side-chain amino group by different groups the lack of a polar group at the extremity of the side chain was examined by removing the amino group . a shifted stacking is observed in the binding modes of 39–41 and only one h-bond is formed between the indole nh group and one propionate ( see supporting information ) . the lack of specific interactions ( h-bonds , salt bridges etc . ) is illustrated by relatively low affinity ( <−5 . 5 kcal/mol ) . a second series of compounds was designed with replacement of the amino group by different polar groups on the alkyl side chain of 5-fluorotryptamine . the idea was to maintain a potential interaction with glu102 and/or the propionic heme group or even to reach further residues , such as glu116 , asp214 , or the c-terminus of ala104 . the binding modes of compounds containing one sulfonamide group at the side-chain extremity ( 4 2 and 4 3 ) exhibit shifted stacking and one h-bond between the sulfonyl and either arg424 ( for 4 2 ) or phe147 backbone ( for 4 3 ) . the indole nh group hydrogen binds to the propionate group ( see supporting information ) . adding one hydroxyl structure to form a hydroxylamine group ( 4 4 ) produces a binding mode featuring no stacking but with the hydroxylamine pointing toward the heme iron and forming two hydrogen bonds with the distal histidine ( his95'}

original_dict: {'ic50_mc': '1 8 nm', 'ki_mc': '( see supporting information ) . adding one hydroxyl structure to form a hydroxylamine group ( 4 4 ) produces a binding mode featuring no stacking', 'kd_mc': '2', 'selectivity_mc': '1 8 ) the best affinity score pose obtained by docking was very similar to its crystal position , reflecting the capacity of the docking procedure in evaluating other compounds . docking of 5-fluorotryptamine to the active site of mpo showed that its best affinity position features stacking ( as in the mpo–sha crystal structure ) of the indole six-membered ring onto the pyrrole ring d of the heme ( figure 2 ) . ( 2 7', 'ic50_ce': '7', 'ki_ce': '2', 'kd_ce': '2', 'ec50_ce': '2', 'selectivity_ce': '1 8', 'herg_ce': 'one hydroxyl structure to form a hydroxylamine group ( 4 4 ) produces a binding mode featuring no stacking', 'solubility_ce': '4 2', 'ed50_an': '8 ) the binding modes obtained with an induced-fit protocol feature unusual concomitant interactions: stacking with the heme and three hydrogen bonds , two of the hydroxyl with his95 and gln91 and one of the amine with asp94 . this mode is very similar to the mpo–sha complex structure . the fluorine atom hydrogen bonds with gln91 ( see supporting information ) . compound 4 5 , with a thiocyanate group at the side-chain extremity , features two different positions . one shows shifted stacking and one hydrogen bond between indole nh and heme propionate . interestingly , the other depicts the thiocyanate group at the same position as the cyanide in the crystal mpo structure ( pdb code 1dnw ) and forms a hydrogen bond with gln91 but no stacking ( see supporting information ) .', 't_half_an': '7 on the indole ring brings no significant change in the predicted affinity relative to compounds with fluorine at position 5 . the docked poses show that the orientation of the indole ring differs and that a fluorine atom in position 7 does not point toward the heme iron as does fluorine in position 5 ( see supporting information ) . compounds 2', 'auc_an': '4 2 and 4 3 ) exhibit shifted stacking and one h-bond between the sulfonyl and either arg424 ( for 4 2 ) or phe147 backbone ( for 4 3 ) . the indole nh group hydrogen binds to the propionate group ( see supporting information ) . adding one hydroxyl structure to form a hydroxylamine group ( 4', 'bioavailability_an': '4 3 ) exhibit shifted stacking and one h-bond between the sulfonyl and either arg424 ( for 4 2 ) or phe147 backbone ( for 4 3 ) . the indole nh group hydrogen binds to the propionate group ( see supporting information ) . adding one hydroxyl structure to form a hydroxylamine group ( 4 4', 'compound_drug': '<unk> . in this paragraph , can you find out the result of compound_drug ? [SEP] results replacement of side-chain amino group by different groups the lack of a polar group at the extremity of the side chain was examined by removing the amino group . a shifted stacking is observed in the binding modes of 39–41 and only one h-bond is formed between the indole nh group and one propionate ( see supporting information ) . the lack of specific interactions ( h-bonds , salt bridges etc . ) is illustrated by relatively low affinity ( <−5 . 5 kcal/mol ) . a second series of compounds was designed with replacement of the amino group by different polar groups on the alkyl side chain of 5-fluorotryptamine . the idea was to maintain a potential interaction with glu102 and/or the propionic heme group or even to reach further residues , such as glu116 , asp214 , or the c-terminus of ala104 . the binding modes of compounds containing one sulfonamide group at the side-chain extremity ( 4 2 and 4 3 ) exhibit shifted stacking and one h-bond between the sulfonyl and either arg424 ( for 4 2 ) or phe147 backbone ( for 4 3 ) . the indole nh group hydrogen binds to the propionate group ( see supporting information ) . adding one hydroxyl structure to form a hydroxylamine group ( 4 4 ) produces a binding mode featuring no stacking but with the hydroxylamine pointing toward the heme iron and forming two hydrogen bonds with the distal histidine ( his95', 'compound': '3'}/data4/chuhan/Chemical_Intuition_Backend/testSimles/chemical-metrics/nlp_implementation.py:332: UserWarning: solubility_an not found!
  warnings.warn(f'{metric} not found!')

====================
54
['IC50_MC', 'Ki_MC', 'Kd_MC', 'selectivity_MC', 'IC50_Ce', 'Ki_Ce', 'Kd_Ce', 'EC50_Ce', 'selectivity_Ce', 'hERG_Ce', 'solubility_Ce', 'ED50_An', 't_half_An', 'AUC_An', 'bioavailability_An', 'solubility_An', 'compound_drug']

title:
synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual ache and sert ligands for alzheimer’s disease
nlpDict: 
single_dict: {'compound': '1 8', 'ic50_mc': '9 . 2 nm', 'ki_mc': '3 7 . 3 μm ) . thus , the presence of a methoxyl group at this position led to low activity or inactive compounds . on the other hand , the presence of a hydrogen or fluorine atom at the 5-indolic position , led to moderate to very active compounds , depending on the benzamide substituent . thus , compounds 1 1 ( r1 = h , r2 = 3-br , ic50 = 2 3 . 0 μm', 'kd_mc': '4', 'selectivity_mc': '9', 'ic50_ce': '2', 'ki_ce': '3', 'kd_ce': '2 1 2 nm ) , 2 0 ( r2 = 3-cl , ic50 = 1 4 9 nm ) , 2 3 ( r2 = 3-f , ic50 = 6 9 nm ) and 2 4 ( r2 = 2-br ) showed affinities in the nanomolar range . moreover , compounds 1 7 ( r2 = 4-br , ic50 = 9', 'ec50_ce': '8 0', 'selectivity_ce': '1 7 ( ic50 = 9 . 2 nm ) and 2 4 ( ic50 = 1 . 9 nm ) and other selected compounds ( supplementary material ) in the human sert structure ( pdb 5i73 ) . the binding modes show that both compounds interact with the binding site adopting a u shape conformation . in the case of compound 2 4 , an additional h-bond is observed between the carbonyl group of the amide , and the tyr95 residue , which justifies its higher potency . compound 1 7 shows a π-stacking interaction between the benzamide fragment and trp103 and a halogen bond with arg104 . in the case of compound 2 4 , the π-stacking occurs between the benzamide fragment and the tyr176 residue , and a halogen bond with the carbonyl backbone of tyr95 . both compounds exhibit a π-stacking interaction between the indole ring and phe335 , which allows the stabilization of the bonding of the molecules to the hsert pocket and facilitates the formation of the h-bond between the indole hydrogen and glu494 . a π-stacking interaction between cationic hydrogen of piperazine and phe335 is observed for both analogues . a new π-stacking interaction between the piperazine cationic nitrogen of compound 1 7 and tyr176 is observed . the most potent compounds ( 1 7 and 2 4 ) contain a bromine atom at positions 4', 'solubility_ce': '2 0 ( r2 = 3-cl , ic50 = 1 4 9 nm ) , 2 3 ( r2 = 3-f , ic50 = 6 9 nm ) and 2 4 ( r2 = 2-br ) showed affinities in the nanomolar range . moreover , compounds 1 7 ( r2 = 4-br , ic50 = 9 . 2 nm ) and 2 4 ( r2 = 2-br , ic50 = 1 . 9', 'ed50_an': '1 . 9 nm', 't_half_an': '7', 'auc_an': '1 1 ( r1 = h , r2 = 3-br , ic50 = 2 3 . 0 μm ) and 1', 'bioavailability_an': '2 4', 'compound_drug': 'r1'}

original_dict: {'ic50_mc': '9 . 2 nm', 'ki_mc': '3 7 . 3 μm ) . thus , the presence of a methoxyl group at this position led to low activity or inactive compounds . on the other hand , the presence of a hydrogen or fluorine atom at the 5-indolic position , led to moderate to very active compounds , depending on the benzamide substituent . thus , compounds 1 1 ( r1 = h , r2 = 3-br , ic50 = 2 3 . 0 μm', 'kd_mc': '4', 'selectivity_mc': '9', 'ic50_ce': '2', 'ki_ce': '3', 'kd_ce': '2 1 2 nm ) , 2 0 ( r2 = 3-cl , ic50 = 1 4 9 nm ) , 2 3 ( r2 = 3-f , ic50 = 6 9 nm ) and 2 4 ( r2 = 2-br ) showed affinities in the nanomolar range . moreover , compounds 1 7 ( r2 = 4-br , ic50 = 9', 'ec50_ce': '8 0', 'selectivity_ce': '1 7 ( ic50 = 9 . 2 nm ) and 2 4 ( ic50 = 1 . 9 nm ) and other selected compounds ( supplementary material ) in the human sert structure ( pdb 5i73 ) . the binding modes show that both compounds interact with the binding site adopting a u shape conformation . in the case of compound 2 4 , an additional h-bond is observed between the carbonyl group of the amide , and the tyr95 residue , which justifies its higher potency . compound 1 7 shows a π-stacking interaction between the benzamide fragment and trp103 and a halogen bond with arg104 . in the case of compound 2 4 , the π-stacking occurs between the benzamide fragment and the tyr176 residue , and a halogen bond with the carbonyl backbone of tyr95 . both compounds exhibit a π-stacking interaction between the indole ring and phe335 , which allows the stabilization of the bonding of the molecules to the hsert pocket and facilitates the formation of the h-bond between the indole hydrogen and glu494 . a π-stacking interaction between cationic hydrogen of piperazine and phe335 is observed for both analogues . a new π-stacking interaction between the piperazine cationic nitrogen of compound 1 7 and tyr176 is observed . the most potent compounds ( 1 7 and 2 4 ) contain a bromine atom at positions 4', 'herg_ce': '8 0', 'solubility_ce': '2 0 ( r2 = 3-cl , ic50 = 1 4 9 nm ) , 2 3 ( r2 = 3-f , ic50 = 6 9 nm ) and 2 4 ( r2 = 2-br ) showed affinities in the nanomolar range . moreover , compounds 1 7 ( r2 = 4-br , ic50 = 9 . 2 nm ) and 2 4 ( r2 = 2-br , ic50 = 1 . 9', 'ed50_an': '1 . 9 nm', 't_half_an': '7', 'auc_an': '1 1 ( r1 = h , r2 = 3-br , ic50 = 2 3 . 0 μm ) and 1', 'bioavailability_an': '2 4', 'compound_drug': 'r1', 'compound': '1 8'}
====================
